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IV. Abstract 
The hedgehog signalling pathway plays a crucial role during regulation of hair cycle and 
homeostasis of mammalian skin. Furthermore, misregulation of this pathway is attributed to a 
range of skin diseases and cancers. In previous studies Indian hedgehog was identified to be 
the only Hedgehog ligand expressed in sebaceous glands. Moreover, modulation of 
hedgehog pathway activity was shown to affect size and number of sebaceous glands in the 
skin. Thereby, local inactivation of the canonical Wnt pathway seems to be prerequisite for 
correct sebaceous gland development. However, the underlying molecular mechanism has 
not been clarified, yet. 
Therefore, we hypothesise that Indian hedgehog signalling regulates proliferation and/or 
differentiation in human sebocytes. Thereby, activation of Hedgehog pathway and 
inactivation of canonical Wnt signalling might be cross-linked. 
To test this, we applied the human sebocyte cell line SZ95 as in vitro model by comparing 
three distinct sebocyte populations depending on their differentiation state: “undifferentiated”, 
“differentiating” and “terminally differentiated” after induction by arachidonic acid treatment. 
Terminally differentiated sebocytes displayed increased expression of IHH without 
endogenous pathway activation. In contrast, undifferentiated sebocyte displayed increased 
proliferation rate upon pathway activation by GLI1 and GLI2 expression. Additionally, our 
findings point to a role of the lipid metabolism in regulating these processes as shown by 
modulation of gene expression by addition of arachidonic acid. 
Importantly, overexpression of GLI1, GLI2 and GLI3 also revealed that each GLI transcription 
factors preferentially activates a distinct set of established and potentially new Hedgehog 
target genes in human sebocytes. 
Additionally, we identified a new mechanism of mutual regulation between Hedgehog and 
Wnt pathways on protein level in human sebocytes. More precisely, overexpression of GLI3 
and GLI2 transcription factors resulted in accumulation of non-phosphorylated, active β-
CATENIN, although Wnt pathway activity was not increased. Conversely, augmented levels 
of β-CATENIN in combination with GLI1 activator dramatically increased Gli reporter activity.  
In summary, we propose the following model where undifferentiated sebocytes are the target 
cells of Hedgehog signals originating from mature sebocytes and GLI repressors might block 
endogenous Wnt pathway by interference with β-CATENIN. 
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V. Zusammenfassung 
Der Hedgehog-Signalweg spielt eine entscheidende Rolle bei der Regulation des Haarzyklus 
und der Homöostase in der Haut von Säugetieren. Darüber hinaus sind Fehlregulationen 
dieses Signalweges mit einer Reihe von Hautkrankheiten und Hauttumoren assoziiert. In 
früheren Arbeiten wurde Indian Hedgehog als der einzige Hedgehog Ligand identifiziert, 
welcher in Talgdrüsen expremiert wird. Zudem wurde mittels Manipulation der Hedgehog-
Signalweg-Aktivität gezeigt, dass Größe und Anzahl der Talgdrüsen in der Haut durch diesen 
reguliert werden. Dabei scheint die lokale Inaktivierung des kanonischen Wnt-Signalwegs 
eine Voraussetzung für eine korrekte Talgdrüsen-Entwicklung zu sein. Allerdings konnten die 
zugrunde liegenden molekularen Mechanismen noch nicht geklärt werden. 
Daher stellen wir die Hypothese auf, dass der Indian Hedgehog-Signalweg Proliferation 
und/oder Differenzierung von humanen Sebozyten regelt. Dabei könnten die Aktivierung des 
Hedgehog-Signalwegs und die Inaktivierung des kanonischen Wnt-Signalwegs miteinander 
verknüpft sein. 
Um dies zu prüfen, verwendeten wir die humane Talgdrüsen-Zelllinie SZ95 als in vitro-Modell 
und verglichen dabei drei distinkte Sebozyten-Populationen in Abhängigkeit ihres 
Reifegrades: "undifferenziert", "differenzierende" und "ausdifferenziert" nach Induktion mittels 
Arachidonsäure-Behandlung. 
Ausdifferenzierte Sebozyten zeigten eine erhöhte Expression von IHH ohne endogene 
Signalwegsaktivierung. Im Gegensatz dazu zeigten undifferenzierte Sebozyten erhöhte 
Proliferationsrate und Hedgehog-Signalaktivität nach Überexpression von GLI1 und GLI2. 
Zusätzlich konnten wir Hinweise auf eine Rolle des Fettstoffwechsels bei der Regulation 
dieser Prozesse mittels Genexpressionsanalyse nach Zugabe von Arachidonsäure finden. 
Interessanterweise, führte GLI1-, GLI2- und GLI3-Überexpression jeweils zur spezifischen 
Aktivierung von etablierten und potenziell neuen Zielgenen in humanen Sebozyten. 
Zusätzlich identifizierten wir einen neuen Mechanismus der die gegenseitige Regulation 
zwischen den Hedgehog- und Wnt-Signalwegen auf Protein-Ebene in humanen Sebozyten 
ermöglicht. Dabei führte die Überexpression von GLI3 und Gli2 zur Akkumulation von nicht-
phosphoryliertem, aktivem β-CATENIN, obwohl gleichzeitig die Wnt-Signalweg-Aktivität 
gesenkt wurde. Umgekehrt führte die Co-Expression von β-CATENIN mit dem 
Transkriptionsaktivator GLI1 zu einer drastischen Erhöhung der Gli Reporter Aktivität. 
Zusammenfassend, schlagen wir folgendes Modell vor, bei dem undifferenzierte Sebozyten 
die Zielzellen der Ihh-Signale darstellen, die aus reifen Sebozyten sezerniert werden. Dabei 
könnten GLI-Repressoren den endogenen Wnt-Signalweg mittels Interferenz mit β-CATENIN 
blockieren.
1. Introduction 
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1. Introduction 
 
1.1. The Hedgehog signalling pathway in mammals 
 
1.1.1. Biological functions of the Hedgehog ligands 
 
The Hedgehog (Hh) pathway controls a variety of fundamental processes such as pattern 
formation, differentiation, proliferation and organogenesis in embryonic development, as well 
as, in adult tissue maintenance. The Hh family of secreted signalling proteins was first 
characterised in Drosophila by Nüsselein-Volhard and Wieschaus in 1980, where a mutation 
of the single hh gene resulted in a “hedgehog” like phenotype of the embryo and revealed its 
function as morphogen [1]. The hh gene has been duplicated during evolution. In mammals, 
there are three Hh genes [2-3]: Sonic hedgehog (Shh), Desert hedgehog (Dhh), and Indian 
Hedgehog (Ihh). Shh is the most broadly expressed mammalian Hh signalling molecule and, 
as consequence, the most studied. In particular, it is involved in neural tube development [3-
8], patterning of left-right and dorso-ventral axes of the embryo [9-13], morphogenesis of 
different organs such as lung [14-17], skin [18-24], limbs [7, 25-27], teeth [23, 28-29], and 
together with Ihh it regulates skeletal development [25, 30-31]. Shh knockout mice display 
severe developmental defects and/or abnormalities in these tissues including foregut [32], 
pancreas [33], left-right asymmetry [34], lung [14], hair follicle [21, 35] and teeth [36]. Dhh 
expression is largely restricted to gonads, including sertoli cells of testis and granulosa cells 
of ovaries [37-39]. Dhh-deficient mice show no notable phenotypic defects except of 
complete lack of mature sperms. Thus, infertility found in mutant males confirms a crucial 
role for Dhh signalling during spermatogenesis [37]. Besides its expression in 
prehypertrophic chondrocytes in the growth plates of bones [30, 40], Ihh is specifically 
expressed in primitive endoderm [41], gut [42], sebaceous glands [43] and together with Shh 
in mammary glands [44-45]. Deletion of Ihh gene reveals a direct role of Ihh, for example, in 
regulation of chondrocyte proliferation [46], during pancreas [33], sclera and retina 
development [47], and also in bone formation [48]. 
Since its discovery, Hh/Gli signal transduction has also attracted considerable interest in the 
field of cancer research besides its crucial roles in embryogenesis. A series of publications 
has implicated aberrant pathway activation in the growth and maintenance of common  
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Figure 1: A schematic model depicting the Hh signalling pathway in mammals. [Off-State] In the 
absence of Hh signal, Ptc inhibits Smo. Gli transcription factors interact with a protein complex that 
prevents the activator full-length Glis from entering the nucleus. Consequently, cleavage of Gli 
molecules is induced to generate truncated forms of the transcription factors acting as repressors. 
[On-State] Hh acts by repressing its receptor Ptc thereby alleviating its inhibitory effect on Smo. 
Consequently, activator Gli transcription factors translocate to the nucleus inducing expression of 
target genes. 
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malignancies such as basal cell carcinoma (BCC), lung, esophageal and biliary cancer, as 
well as pancreatic and prostate cancer. Specific targeting of Hh/Gli-signalling may therefore 
offer a highly effective therapeutic strategy for the treatment of a variety of lethal tumours. 
Overall, most of the components in Hh signalling are conserved from insects to vertebrates, 
with a main difference in the number of genes in each species [49]. However, it appears that 
there are also interspicific differences in the underlying signalling mechanisms [50]. Thus, 
according to this study, the following pathway description focuses on the actual knowledge 
regarding the mammal system (Fig. 1): 
 
 
1.1.2. Production and secretion of the Hedgehog ligand 
 
After translation, the Hh ligands (45 kDa) undergo multiple processing steps that are 
evolutionary conserved and are required for complete functionality of the Hh protein, as well 
as, its release from the producing cell [49-55]. These comprise autoproteolytic cleavage of 
the functional N-terminus from the C-terminal protease domain. Lipid modification by addition 
of cholesterol and palmitoyl moieties with the help of the transmembrane aclytransferase 
Skinny hedgehog (Ski) results in the functional Hh ligand (HhN) [51, 56-57]. 
Then, the lipidated Hh proteins (19 kDa) are secreted by the macromolecule Dispatched 
(Disp) into the extracellular matrix to exert short and long range effects by building up a 
concentration gradient [49, 58]. Heparin sulfate proteoglycans (HSPGs) are suggested to be 
involved in stabilization and transport of Hh [58-59]. 
Furthermore, in vertebrates the transmembrane Hedgehog interacting protein (Hhip) can 
bind to Hh and reduce its range of movement [58, 60]. Importantly, Hhip itself is a target 
gene of the Hedgehog pathway [60], thus providing a negative feedback on pathway 
activation (Fig. 1). 
 
 
1.1.3. Hedgehog signal reception 
 
Downstream of Hh there are two isoforms of Patched receptors in vertebrates, Patched 1 
(Ptc1) and Patched 2 (Ptc2). Both are target genes of the Hh pathway [61-62] and seem to 
be equivalent in terms of binding the three Hh isoforms [63]. On the one hand, Ptc2 is likely 
to be dispensable during embryonic development, but on the other hand, Ptc2 deficiency in 
conjunction with Ptc1 haplo-insufficiency increases the incidence of several types of tumour 
[64]. As the Ptc amino-acid sequence is distantly related to bacterial resistance-nodulation-
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division (RND) pumps, it is noteworthy, that these proteins are homotrimers, and that 
biochemical and genetic data also confirmed that Ptc functions as a multimer [65-67]. In the 
absence of the Hh ligand, Ptc receptors inhibit the function of a 7-pass transmembrane 
protein, called Smoothened (Smo) [68]. Thus, binding of Hh to Ptc results in the alleviation of 
inhibition on Smo, and consequently transduces the Hh signal to the cytoplasm [68-69]. The 
nature of this inhibitory effect seems to be catalytic as one molecule of Ptc1 can inactivate 
approx. 250 molecules of Smo, but the underlying mechanism still remains unsolved [68]. 
However, it is suggested that reciprocal changes in the subcelluar location of Ptc and Smo 
occur during pathway activation. Thereby, in the absence of the Hh ligand, Ptc shuttles 
between the plasma membrane and internal vesicles containing the inactive form of Smo. As 
consequence, Smo is prevented to move from these vesicles to the cell surface. After 
binding of Hh, Ptc is internalised from the plasma membrane, while Smo moves in the 
opposite direction and is released from vesicles to the cell surface by acquiring an active 
conformation [70-75]. In this context, a fundamental role for the primary cilia arises as 
subcellular location for coordination of Hedgehog signal transduction specifically in mammals 
[76-80]. The primary cilium is a single, immotile cell surface projection found on most 
vertebrate cells [81]. Activated mammalian Smo has been found to accumulate to primary 
cilia in response to Shh treatment [82], whereas this process is inhibited by Ptc when the Hh 
ligand is missing [83]. Therefore, endogenous Ptc localises to both, the membrane 
enveloping the shaft of the cilium, and to a prominent skirt-like domain around the base. One 
can envision Ptc as gatekeeper controlling precise localisation of Smo. 
Hedgehog signal reception by target cells is facilitated by three classes of accessory 
receptors: the glypican-family of cell surface proteoglycans [84-89], the 
glycosylphosphatidylinositol (GPI-) anchored membrane-bound Growth-arrest-specific 1 
(Gas1) [90] and the transmembrane proteins Cdo (also named Cdon, Cell adhesion 
molecule-related/down-regulated by oncogenes) as well as Brother of Cdo (Boc) in 
vertebrates [90-93]. Cdo and Boc belong to the immunoglobin superfamily of single-
transmembrane proteins. The lack of these proteins is accompanied with unresponsiveness 
of cells towards ShhN stimulation, and severe developmental defects have been observed in 
deficient mice. 
 
 
1.1.4. The cytoplasmic complex and Gli transcription factors 
 
Upon recruitment to the cell membrane, active Smo interacts with a cytoplasmic protein 
complex. It consists amongst others of the mammalian ortholog of Cos2 (Costal2), Kif7, the 
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Suppressor of fused (Sufu) and the protein kinase A (Pka). But the underlying mechanism of 
how activation of Smo is coupled to these cytoplasmic proteins remains unclear. Importantly, 
this complex controls activation and proteolytic cleavage of Gli transcription factors, the 
effectors of the pathway [94-97]. 
In vertebrates, there are three Gli transcription factors, Gli1 (glioma-associated oncogene 
homolog 1), Gli2 and Gli3, which mediate Hedgehog signalling [98-99] (Fig. 2). The three 
isoforms contain five zinc-finger DNA-binding domains, but their N-terminal domains exhibit 
important differences. Gli1 functions as a strong transcriptional activator. It lacks a repressor 
domain found in the N-terminus of Gli2 and Gli3. Gli1 expression also depends on Gli2 
and/or Gli3-mediated transcription since it constitutes a direct target gene of the Hh pathway. 
Compared to Gli2, Gli1 exerts the largest part of activator functions by providing a positive 
feedback-loop. However, Gli2 represents the primary downstream activator and is 
indispensable to initiate activation of target genes of the Hedgehog pathway. Thereby, both 
factors display identical or very similar DNA binding specificities [96, 100-102]. By contrast, 
Gli3 exerts a role as a repressor [97, 103]. 
In absence of the Hh ligand, Su(Fu) acts as scaffold and brings together the Gli proteins with 
the negative regulator Pka [104]. Thereby, the Gli transcription factors are retained in the 
cytoplasmic complex and undergo an initial phosphorylation step mediated by Pka. 
Subsequent phosphorylation by Gsk3β (glycogen synthase kinase 3 beta) and CKIα (Casein 
kinase I α) follows. The hyperphosphorylation of the Gli proteins promote recognition and 
ubiquitination by the ubiquitin E3 ligase β-TrCP (β-transducin-repeat-containing protein) 
leading to proteolytical processing and generation of a truncated transcriptional repressor 
form in the case of Gli3 [96-97, 105]. With exception of Gli1, similar processing has been 
documented for Gli2. But it is still controversially discussed, whether it results in the complete 
degradation or in the generation of a truncated repressor form of the Gli2 protein [96, 106].  
Gli1 contains two degradation sequences, dregon N and dregon C, which allow recognition, 
as well as, ubiquitination by β-TrCP and hence proteasomal degradation. Contrary to Gli2 
and Gli3, the proteasomal degradation is complete and no truncated repressor variant of Gli1 
is produced [107]. Moreover, studies on the efficiency of processing revealed that the ratio of 
Gli2 full-length/truncated form is 6:1, whereas the Gli3 full-length/truncated form ratio is about 
1:1. These results demonstrate that Gli2 is inefficiently processed compared to Gli3 [96]. 
Therefore, the lack of transcriptional Gli activators as well as the production of repressors 
leads to repression of Hedgehog target genes. 
In the presence of Hh ligand, active Smo disables the cytoplasmic complex, and hence, 
processing and degradation of the Gli transcription factors do not occur. This leads to 
accumulation of full-length forms of both, Gli2 and Gli3 and up-regulation of the 
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transcriptional activator Gli1. Consequently, target genes of the Hedgehog pathway are 
activated [77]. 
 
 
Figure 2: A schematic diagram of protein structure of Gli transcription factors. All members 
possess the zinc-finger domain (ZFD) and the activator domain in the C-termini. Contrary to Gli1, Gli2 
and Gli3 additionally have a repressor domain in the N-terminal part of the protein, and therefore can 
function as repressors after processing at the proteolytic cleavage site. 
 
 
1.2. The role of the Hedgehog pathway in skin homeostasis 
 
In mammalian skin, many studies describe an important role for Hh signalling in the 
regulation of hair cycle and in the homeostasis of sebaceous glands. 
In particular, Shh deficient mice lack hair follicles and sebaceous glands [21, 35]. Thus, Shh 
signalling is required for the control of hair growth and morphogenesis of hair follicles, in part 
through regulating the Gli transcription factors [108]. Therefore, Shh expression and 
responsiveness are spatially and temporally tightly regulated and only occur in the anagen 
stage of the hair cycle [109]. Shh knockout embryos display hair germs, comprising 
epidermal placodes and associated dermal condensates, like the wild type controls. 
However, the progression through subsequent stages of hair follicle development is blocked 
in skin of mutant mice [110]. Consistently, reduced expression of the target genes Gli1 and 
Ptc1 are found in Shh deficient dermal condensates, which fail to evolve into hair follicle 
dermal papillae [111]. 
Previous work in our group demonstrated that transgenic mice expressing a dominant 
negative variant of the transcription factor Lef1 (∆NLef1) under the control of Keratin 14 
promoter  exhibit enhanced sebaceous differentiation accompanied by increased expression 
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of Ihh in the skin [43]. Noteworthy, the β-catenin binding site is lacking in ∆NLef1, rendering 
the transcription factor unresponsive to Wnt/β-catenin pathway and blocking downstream 
target genes. Ihh expression is particularly found in the more differentiated compartment of 
sebaceous glands, whereas Gli1 expression mainly in sebocyte precursors, suggesting a 
paracrine signalling mechanism in vivo. Additionally, in vitro studies in the human sebocyte 
cell line SZ95 revealed that PTC1 and IHH are up-regulated during differentiation and 
blocking signalling by cyclopamine treatment inhibits their proliferation and stimulates their 
differentiation [43]. 
Epidermal stem cells, in particular their daughter cells, termed transit amplifying cells (TA), 
are able to give rise to multiple lineages in skin, comprising the hair follicles, the associated 
sebaceous glands and the overlying interfollicular epidermis. Skin-specific inhibition of the Hh 
pathway by expression of a repressor variant of Gli2 (K5Gli2∆C4) leads to a selective 
suppression of sebocyte development [112]. On the other hand, its overactivation by skin-
specific expression of Smo (K5M2Smo) results in an enhancement in both size and number 
of sebaceous glands [112]. In this context, ectopic Hh signalling has also been found to 
induce sebaceous gland development from footpad epidermis, which is normally devoid of 
hair follicles and associated structures. 
Shh and Ihh knockout mice die at late embryogenesis due to severe developmental defects 
[44]. Transplantation experiments of mammary epithelium with hair follicles derived from 
Shh-null and Ihh-null mice into wild-type skin reveal no difference in mammary gland 
morphogenesis compared to control skin. Interestingly, hair follicles from Shh-deficient skin 
fail to evolve while Ihh-deficient skin develops apparently normally [44]. These findings 
suggest that both Hedgehog ligands have redundant functions in the skin. 
 
 
1.3. The role of the Hedgehog pathway in human diseases and skin cancer 
development 
 
1.3.1. Human diseases associated with inhibition of the Hedgehog pathway 
 
The lack of activity of the Hedgehog pathway during embryogenesis have been found in a 
range of developmental defects like holoprosencephaly (due to loss of Shh or generation of 
an insensitive variant of Ptc1 by mutation) [113-116], cephalopolysyndactyly, Pallister-Hall 
syndrome, Postaxial Polydactyly (all three induced by a dominant negative variant of Gli3) 
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[117-118], Vacterl syndrome (possibly due to combined loss of function of Gli2 and Gli3) 
[119] and Smith-Lemli-Optitz syndrome (based on a defect of cholesterol biosynthesis, and 
hence, on inappropriately modified Hh ligands) [120-122]. 
 
 
1.3.2. Human diseases associated with abnormal activation of the Hedgehog pathway 
 
One of the most important diseases associated with activation of the pathway is the Gorlin 
syndrome (also known as the nevoid BCC syndrome, NBCCS, or the basal-cell nevus 
syndrome) [123-124]. It is an autosomal dominant disorder usually characterised by the 
predisposition to develop basal cell carcinomas (BCCs) of the skin, medulloblastomas, and 
ovarian fibromas. Inactivating mutations of the PTC1 gene have been identified as cause for 
this disorder [125-128]. In addition, activating mutations in the SMO gene have been 
detected in 10-20% of sporadic BCCs, which result in a similar effect like inactivation of 
PTC1 [129-130]. 
Analogously, these types of mutations were also found in sporadic medulloblastomas, 
primitive neuroectodermal tumours [131-133] and in a range of other tumour types, like 
trichoepitheliomas, esophageal squamous cell carcinomas, and transitional cell carcinomas 
of the bladder [134-135]. 
Deregulation of Hedgehog signalling pathway has also been shown to be implicated in the 
development of rhabdomyoma and rhabdomyosarcoma in humans. Thereby, 
haploinsufficiency of the two tumour suppressor genes PTC1 and SUFU may play a key role 
in tumour progression [136]. 
The most frequent and lethal tumour of the central nervous system are glioblastoma [137-
138]. GLI1 was originally characterised as an oncogene for this tumour since amplifications 
of the chromosomal region 12q13-q14 containing the GLI1 gene have been identified [138-
141]. 
Taken together, abnormal activation and inactivation of the Hedgehog pathway lead to a 
variety of developmental defects as well as of tumour formations in humans. 
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1.4. The Wnt signalling pathway in mammals 
 
1.4.1. Biological functions of the Wnt signalling pathway 
 
Another important signalling network is the Wnt pathway, which diversifies into at least three 
branches: 1) the β-catenin pathway (canonical Wnt pathway), 2) the planar cell polarity 
pathway involving JNK (c-Jun N-terminal kinase) and 3) the Wnt/Ca2+ pathway including PLC 
(Phospholipase C) and PKC (protein kinase C) recruitment [142-143]. The name “Wnt” is an 
amalgam of Wg (Wingless) and Int (Integration 1, Int1) [144]. Int1 was identified as proto- 
 
 
Figure 3: A schematic overview of the canonical Wnt signalling pathway. [Off-state] In the 
absence of a Wnt signal, β-catenin is captured by Apc and Axin within the destruction complex. There, 
it undergoes several phosphorylation steps for subsequent degradation by the proteasomes. As a 
result, nuclear DNA-binding proteins of the Tcf/Lef transcription factor family actively repress target 
genes by recruiting transcriptional co-repressors (Groucho/Tle). [On-state] Binding of Wnt ligands to 
the receptor complex containing Fzd and Lrp triggers the inactivation of the cytoplasmic destruction 
box. This allows β-catenin to accumulate and enter the nucleus, where it interacts with members of the 
Tcf/Lef family to activate transcription of target genes. 
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oncogene in association with MMTV (mouse mammary tumour virus) -induced mammary 
gland tumours by Roel Nusse and Harold Varmus [145]. Wg has been identified in 
Drosophila by several mutants displaying segmentation defects in fly embryos [1, 146-147]. 
This project focuses on the canonical Wnt pathway (Fig. 3), which orchestrates proper tissue 
development in embryos and tissue maintenance in adults similar to the Hedgehog pathway. 
Noteworthy, the key mediator of the canonical Wnt/β-catenin signal transduction cascade is 
β-catenin. It is a member of the armadillo protein family containing 12 armadillo repeats that 
are required for protein-protein interactions [148]. Despite its role in the canonical Wnt 
pathway, β-catenin was first discovered in cell-adhesion complexes, where it is bound to the 
cytoplasmic domain of cadherins and to cytoskeleton-linked α-catenin. In this context, 
cadherins are likely to antagonise accumulation of β-catenin in the cytoplasm by recruiting it 
to the cell membrane. Studies in different model systems demonstrate a negative correlation 
between the expression levels of cadherins and Wnt signalling activity [149-151]. Moreover, 
the conformation of β-catenin protein may also be important for directing its binding affinity 
towards either cadherins or members of Tcf/Lef (Lymphoid enhancer binding factor/T cell 
factor) transcription factor family. Thereby, a structural variant of β-catenin containing an 
intramolecular fold-back of the COOH terminus was found to activate Wnt signalling as 
monomer [152]. In contrast, cadherins were found to preferentially bind β-catenin-α-catenin 
complexes. Thus, these findings emphasise the dual role of β-catenin and suggest a model 
of precise regulation of β-catenin to function in cell adhesion and nuclear signalling [153]. 
 
 
1.4.2. Production and secretion of the Wnt ligand 
 
The Wnt ligand family comprises 19 members, which vary in length between 350 and 400 
amino acids. The members of this family undergo several posttranslational modifications. 
Following cleavage of the signal sequence, the Wnt molecules translocate into the 
endoplasmatic reticulum (ER). For subsequent transport from ER to cell surface, N-linked 
glycosylation and palmitoylation take place to generate the hydrophobic nature and ensure 
proper signalling capacity of these ligands [154-163]. These processes are supported by 
several components like the integral membrane protein Wntless (Wls) (found in Golgi, 
plasma membrane and endosomes) [164-168], the Retromer (a multiprotein complex that 
shuttles cargo from endosomes to the trans-Golgi) [169], and Porcupine (Porc) (localised in 
the ER) [155, 170]. Finally, Wnt ligands are secreted and move away from the signalling 
cells, thereby establishing a morphogen gradient to regulate short-, as well as long-range 
targets in a concentration-dependent manner [171-172]. In analogy to the Hedgehog 
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morphogens, translocation of Wnt molecules is influenced by heparin sulphate 
proteoglycans, namely Dally (Dly) and Dally-like, which are anchored to the cell membranes 
via a GPI linker [173-175]. 
 
 
1.4.3. Degradation of β-catenin by cytoplasmic destruction complex in the absence of 
Wnt ligands 
 
In the absence of a Wnt signal, the main mediator β-catenin is captured by Axin 1 (Axis 
inhibition 1) and the tumour suppressor protein Apc (adenomatous polyposis coli protein) 
within the pentameric β-catenin destruction complex [176-177]. In addition, this complex is 
composed of CkIα and Gsk3β. By bringing together these components, the pentameric β-
catenin destruction complex facilitates phosphorylation of β-catenin by the kinases Ck1α and 
Gsk3β at conserved serine and threonine residues at the amino terminus. In turn, this 
promotes binding of β-TrCP, which subsequently mediates the ubiquitinylation and efficient 
proteasomal degradation of β-catenin. Consequently, lack of cytoplasmic free β-catenin 
ensures that nuclear DNA-binding proteins of the Tcf/Lef transcription factor family (Tcf1, 
Tcf3, Tcf4 and Lef1) actively repress target genes by recruiting transcriptional co-repressors 
(Groucho/Tle)[178-180]. 
 
 
1.4.4. Signal transduction by β-catenin in presence of Wnt ligands 
 
Wnt/β-catenin signalling is mediated by a complex of two families of cell surface proteins: the 
Frizzled (Fzd) family of 7 trans-membrane serpentine receptors and the mammalian 
lipoprotein receptor-related proteins (Lrp) Lrp5 and Lrp6 [181-187]. Fzd proteins are the 
primary receptors for Wnt molecules, whereas Lrps are likely to act as co-receptors. 
Upon binding the Wnt ligands, phosphorylation of the conserved PPPSPxS motifs is induced 
in the cytoplasmic tail of Lrps by Gsk3β and CKIα [176-177, 188-189]. Then, Axin 1 is 
recruited to the plasma membrane to interact with the phosphorylated Lrp, thereby 
disengaging the pentameric β-catenin destruction complex. Other effects of Wnt stimulation 
are the polymerisation of Lrps into large structures, namely the Lrp5/6 signalosome, and the 
recruitment of Disheveled (Dvl), which further helps to disable the destruction complex by 
localising its components to the cell membrane. Consequently, unphosphorylated β-catenin 
is more stable and accumulates in the cytoplasm leading to its translocation into the nucleus 
[190-192]. 
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In the nucleus, β-catenin forms a transcriptionally active complex with members of the 
Lef/Tcf family of transcription factors [193-195] by binding to their N-terminus and displacing 
repressors like Grouchos [178]. Also interaction with co-activators such as Bcl9 (B-cell 
lymphoma 9) [196-197], Pygopus (Pygo) [198-201] and Cbp (CREB binding protein) [202] or 
Hyrax [203-204] have been described. 
There are four Tcf/Lef genes in vertebrates, Tcf-1, Lef-1, Tcf-3, and Tcf-4, which have 
evolved by alternative splicing and promoter usage [205]. They are characterised by high 
sequence homology in their DNA-binding domains, the high mobility groups (HMG), 
responsible for specific binding of target genes [205-206]. In addition, the N-terminal β-
catenin binding domain is also highly conserved among orthologs which all bind to β-catenin 
[205]. 
The broad spectrum of Wnt target genes include proliferation promoting factors like Cycd1 
(Cyclin D1) [207] and c-Myc [208], as well as a range of factors, which are part of the 
canonical Wnt pathway themselves by positively or negatively influencing the signal cascade 
(e.g. members of the Frizzeld and Dickkopf families, LRP’s, Axin 2, β-TrCP and Lef-Tcf 
transcription factors; see Roel Nusse’s webpage for more references: 
http://www.stanford.edu/~rnusse/wntwindow.html). 
 
 
1.5. The canonical Wnt pathway in mammalian skin homeostasis and 
diseases 
 
In mammalian skin, the canonical Wnt/β-catenin signalling pathway is required for skin 
morphogenesis including its appendages like hair follicles, sebaceous glands, teeth and 
mammary glands. Thereby, it regulates a variety of processes such as proliferation, 
differentiation, cell migration, cell polarity and cell adhesion [209].  
Skin-specific expression of a constitutively active form of ß-catenin or overexpression of Lef1 
results in de novo hair follicle formation [22, 210-211]. Accordingly, ectopic expression of 
these factors promotes differentiation towards hair-shaft but not interfollicular epidermis [212-
213]. 
Loss-of-function mutations in ß-catenin or Lef1 led to a phenotype with a decreased number 
of hair follicles [214-216]. Specifically, deletion of the transcription factor Lef-1 in mice leads 
to lethality shortly after birth. Transgenic embryos display a reduced number of hair follicles 
and mammary glands, abortive tooth growth and missing whiskers [215]. Furthermore, skin-
specific expression of a truncated Lef1 variant, ∆NLef1, which lacks the β-catenin binding 
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site, results in the formation of epidermal cysts and a progressive hair loss in mouse skin 
[217]. It has been shown that combined interaction of β-catenin and Lef1 is necessary to 
repress E-cadherin expression during hair follicle development [218]. 
With regard to sebaceous gland development, evidences indicate the necessity of Wnt 
pathway inhibition for sebaceous fate selection in the skin. For example, ectopic expression 
of the dominant negative construct ∆NLef1, and thus canonical Wnt pathway inhibition on 
transcriptional level in transgenic mouse skin results in an augmentation of sebaceous gland 
differentiation apparently at the expense of hair follicle differentiation [43, 217, 219]. 
Furthermore, expression of a stable, dominant negative form of β-catenin in basal 
keratinocytes of transgenic mice blocks hair formation and creates epidermal cysts while 
inducing hair germ formation in the interfollicular epithelium [220]. This construct lacks the 
amino terminal degradation domain and the carboxy terminal activation domain but is still 
able to bind members of the Tcf/Lef transcription factors family. 
Suppressing β-catenin expression in basal keratinocytes of conditional knockout mice 
revealed that β-catenin is also required to govern homeostasis of the self-renewing skin by 
inducing anagen phase during the hair cycles [24, 216]. During the hair cycle, Wnt activity is 
detected in the bulge region of hair follicles at the onset of anagen, and, subsequently, in the 
hair shaft precursor cells along this stage. 
The function of the canonical Wnt/β-catenin pathway in cell fate determination is also 
manifested in different types of skin tumours, where Wnt activity is up- or down-regulated by 
mutations of pathway components. In particular, increased Wnt signalling favours the 
development of hair follicle tumours, for example spontaneous pilomatricomas [210, 221] and 
tricholofolliculomas [222] in mouse and human skin. Thereby, continuous activation of β-
catenin signalling is also required to maintain these hair follicle tumours. 
By contrast, transgenic mice expressing ∆NLef1 preferentially develop spontaneous 
sebaceous tumours or squamous epidermal cysts exhibiting sebaceous differentiation [43, 
223]. Accordingly, human sebaceous tumours have been found to harbour such inactivating 
mutations in LEF1 [224]. 
In summary, β-catenin levels are responsible for lineage selection of progenitor cells of hair 
follicles, whereby high levels of β-catenin stimulate the formation of hair follicles, whereas 
low levels favour differentiation into interfollicular epidermis and sebocytes. 
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1.6. Crosstalk between the Hedgehog and Wnt signalling pathways 
 
Complex processes like embryonic development and organogenesis, as well as tissue 
homeostasis in adults require tightly regulated interactions between different signalling 
pathways (e.g. Wnt, Hh, Tgf-β/Bmp and, Notch). An Imbalance or deregulation of this 
network is sufficient to promote malformations and cancer. 
 
 
1.6.1. Crosstalk between Hedgehog and Wnt signalling pathways in invertebrates and 
vertebrates 
 
First evidence for interconnection between Hedgehog and Wnt signalling pathways was 
found in Drosophila, where reciprocal signals between Wnt and Hh producing cells contribute 
to the definition of segment boundaries [225]. 
In vertebrates, dorsoventral patterning of the nervous system is achieved by the combined 
activity of the Wnt and Hh pathways. On the one hand, Shh/Gli morphogenetic activity 
specifies the ventral fate of the neural tubes. On the other hand, the canonical Wnt/β-catenin 
pathway, which is induced by the Wnt1/Wnt3 ligands in this region, counteracts this Gli-
dependent program in the dorsal part of the neural tube by directly inducing Gli3 expression. 
Gli3 limits the graded Shh/Gli ventral activity in the dorsal department by acting as a 
transcriptional repressor [226]. 
Another interaction between these pathways has also been identified during neural tube 
formation. Shh-deficient chicken embryos display reduced Wnt activity under the influence of 
the Hh-regulated repressor form of Gli3 (Gli3R) [227]. A model has been proposed, where 
Gli3R antagonizes active forms of β-catenin by physically interacting with the carboxy-
terminal domain of β-catenin containing the transactivation domain. 
Van den Brink and colleagues reported that Ihh is expressed by mature colonocytes and 
regulates their differentiation [228]. Thereby, Hh signalling restricts the expression of Wnt 
target genes to the base of colonic crypts in vivo. Additional in vitro assays showed that 
introduction of Ihh into colon cancer cells results in a downregulation of both components of 
the nuclear TCF4–β-catenin complex thereby abrogating local response to Wnt signals. In 
turn, expression of Ihh is downregulated in polyps of individuals with familial adenomatous 
polyposis coli (FAP) owing to activation of Wnt signalling as consequence of a mutation in 
APC. This observation was supported by transfecting APC mutant DLD-1 colon cancer cells 
with a dominant-negative TCF4 mutant which restores expression of Ihh in these cells [228]. 
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More recently, Hedgehog pathway was shown to be required for the lethality and intestinal 
phenotypes of mice with hyperactive Wnt signalling due to loss of Apc function. Thereby, 
conditional knock-out models were used to inhibit the function of the critical Hh mediator 
Smo. As a consequence, lethality and intestinal phenotypes of loss of Apc were rescued in 
these mice [229]. 
There are also multiple factors apart from typical Wnt and Hh signalling components, which 
are crucial to simultaneously regulate both, Gli and β-catenin functionality and turnover. For 
example, β-TrcP marks ubiquitinated Gli proteins, as well as β-catenin for proteasomal 
degradation after priming by phosphorylation events through the kinases Gsk3β and CkI 
[105, 230-234]. Another negative regulator of both pathways, Su(Fu), has been shown to 
directly interact with Gli and β-catenin, thereby impeding their activation capacities [235-237]. 
On the other hand, Cbp is recruited by Glis and β-catenin and increase their activation 
potential as transcriptional co-activator [238-240]. Consequently, inappropriate activation of 
either Hedgehog or Wnt signalling cascade may have severe impact on the local distribution 
and concentration levels of these common factors. Thus, β-TrcP, Gsk3β, CkI, Su(Fu) and 
Cpb represent additional interconnection points for mutual regulation of the Hedgehog and 
Wnt pathways. 
 
 
1.6.2. Wnt and Hedgehog pathway interaction in the skin and sebaceous gland 
 
Several studies in transgenic mouse models and humans demonstrated that Wnt and Hh 
pathways also act in concert during development and regeneration of mammalian skin. 
Previous work of our laboratory indicated that Hh signalling acts downstream of the canonical 
Wnt cascade. Particularly, Wnt/β-catenin signalling was blocked in the skin by expression of 
dominant negative Lef1 (∆NLef1) under the control of the Keratin 14 promoter in transgenic 
mice, which leads to loss of Shh and Ptc1 expression in the affected regions due to complete 
change of the differentiation program from hair type to interfollicular epidermis [217].  
Further analysis of this mouse model also revealed enhanced formation of sebaceous skin 
tumours [43]. Interestingly, inhibition of β-catenin leads not only to sebaceous lineage 
selection but also to expression of Ihh and Ptc1 in these types of cells. 
Augmented IHH and PTC1 expression has also been detected in the human sebocyte cell 
line SZ95 undergoing differentiation, as well as after transfection of the ∆NLef1 construct into 
undifferentiated cells. 
Smad7 was shown to induce degradation of β-catenin in an inducible mouse model 
overexpressing Smad7 in the skin [241]. Interestingly, when Smad7 was induced during 
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embryogenesis, hair follicle development was inhibited, but the formation of sebaceous 
glands was accelerated. Postnatal expression of Smad7 resulted in a complete block of hair 
follicle entry into a new growth phase and in hair follicle degeneration. Contrary to this, 
sebaceous glands of these mice were found to be significantly enlarged. Moreover, Indian 
Hedgehog expression was also increased in sebocytes of transgenic mice [241]. Thus, 
increased Indian Hedgehog expression seems to correlate with inhibition of Wnt/β-catenin 
pathway. 
These findings suggest that IHH expression requires an inactivated Wnt/β-catenin pathway, 
proposing a mutually exclusive model of interaction, which could also be applicable for other 
tissues [43, 242-243]. 
In addition, other studies demonstrated the requirement of β-catenin for placode formation 
upstream of Shh (and also Bmp). Thereby, Shh is induced by Wnt signals and subsequently 
serves as effector for subsequent cell proliferation or migration [210, 213, 216, 244]. This 
may explain why deletion of β-catenin following the hair follicle formation leads to complete 
hair loss after the first hair cycle [216]. Accordingly, β-catenin fails to trigger hair follicle 
formation when blocking Hh pathway by cyclopamine treatment [22]. 
Conversely, the Hh pathway can also act upstream of the Wnt pathway, as exemplified in 
studies of transgenic mice and human BCCs. In these cases, Gli1 induces expression of Wnt 
ligands, and the ligand-driven, canonical Wnt/β-catenin signalling seems to be required for 
Hh-pathway-driven tumourigenesis [245-246]. 
 
 
1.7. The sebaceous gland 
 
1.7.1. Sebaceous gland development and regeneration 
 
Sebaceous glands are holocrine glands and are located in the skin of mammals. They 
secrete an oily/waxy liquid, called the sebum, by rupture of individual sebocytes to lubricate 
the skin and hair. In humans, they reside all over the body except on the palms of the hands 
and soles of the feet, and are found in greatest abundance on the face and scalp with a 
density of 400-900 glands/cm2 contrary to the sparse distribution on the back [247]. 
The majority of sebaceous glands develop in close association with the differentiation 
process of hair follicles during the 13th to 16th weeks of gestation from the bulge on evolving 
hair follicles [248-249]. They are localised to the upper portion of the hair follicles in adults, 
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building up the pilosebaceous unit. But some glands are also found apart from hair follicles 
like on lips, oral cavity, genitalia, eye lid and mamillas [248-249]. 
Ducts are established between hair follicles and associated sebaceous glands to purge the 
sebum into the hair shaft channel and at least to the skin surface. 
At least two pathways have been presented to play crucial roles in the fate decision of 
sebocytes, and thus in sebaceous gland development, namely the Wnt and its target gene c-
Myc as well as Hh signalling pathways. Depending on their activity levels the number and 
sizes of sebaceous glands are affected. In this context, decreased Wnt signalling through 
inactivating mutations in Lef1 or β-catenin promotes sebocyte lineage selection at the 
expense of hair follicle differentiation [217, 219]. Mice overexpressing c-Myc show an 
increase in sebaceous differentiation and size of sebaceous glands in combination with a 
reduction of hair follicles [250-252]. Finally, increased Hh pathway activity and decreased 
Wnt signalling also lead to an increase in total amount of sebaceous glands, which could be 
shown by mutations in Ptc1 and Lef1, respectively [43, 112, 253]. 
As a holocrine gland, the sebaceous gland sacrifices own cells for secretion, and hence 
needs to be replenished by new cells. The question arises: Where are sebocyte progenitor 
cells localised? And how is the regeneration of the sebaceous gland regulated? In this 
context, bulge cells were the first adult stem cells of the hair follicle which have been 
identified and later shown to be capable of forming hair follicle, interfollicular epidermis and 
sebaceous glands [254-255]. Keratin 15 (K15), a type I keratin, has been described as a 
marker for epithelial stem cells in the hair follicle bulge of human scalp [256-257] and mouse 
skin [258]. Interestingly, previous publications [254, 259] and actual work in our laboratory 
(Phd thesis of Monika Petersson and Petersson et al., submitted) also indicate that K15-
positive cells derived from the bulge region can give rise not only to hair follicles but also to 
the associated sebaceous glands in mice. Besides their important role in the sebaceous 
gland renewal, K15-positive cells have also been assigned to the development of human hair 
follicle-related neoplasms with sebaceous differentiation including sebaceomas, sebaceous 
neoplasms in Muir-Torre syndrome and sebaceous carcinomas [260-261]. Thereby, K15 
expression was also documented in the mantles of normal human vellus hair follicles, the 
source of matured sebaceous glands and ducts. 
In addition, recent findings propose two different compartments of sebaceous gland stem 
cells directly above the bulge region of hair follicles (Lgr6+ cells) [262]  as well as in the hair 
follicle junctional zone adjacent to the sebaceous glands and infundibulum (Lrig1+ cells) 
[263]. 
Another marker to monitor sebocyte differentiation is the transcriptional repressor B-
lymphocyte-induced maturation protein 1 (Blimp1) or PR domain zinc finger protein 1 
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(PRDM1) in rodents and humans, respectively, which was first suggested as sebocyte 
progenitor marker in mouse skin by Horsley and colleagues [264]. Blimp1 expression 
constitutes an important feature of sebocyte progenitors that are distinct from pluripotent 
stem cells of the hair follicle. A crucial role of these cells in controlling proliferation of 
sebaceous progenitors was suggested, since ablation of Blimp1 positive population was 
found to cause increased sebocyte growth rate and sebaceous gland hyperplasia in mouse 
[264]. However, the role of Blimp1 as a specific progenitor marker for the sebaceous gland is 
discussed controversially, since Blimp1 has been identified in the outer root sheath of the 
hair follicle and mature sebocytes, thus dealt more as an early differentiation marker than 
progenitor marker [265-266]. 
 
 
 
Figure 4: Schematic representation of the pilosebaceous unit. The pilosebaceous unit is made of 
a hair follicle and sebaceous gland. The outer layer of the sebaceous gland consists of 
undifferentiated and mitotically active sebocytes. It is assumed that these cells would then migrate to 
the centre of the gland during the differentiation process, where mature cells burst and release the 
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sebum into the hair shaft channel by holocrine secretion. Abbreviations: HS, hair shaft; PZ, peripheral 
zone; MZ, maturation zone; NZ, necrosis zone. 
 
Accordingly, the sebaceous glands consist of two types of cells (sebocytes) [267-268]: 
peripheral, immature cells and central, differentiated cells (Fig. 4). The peripheral sebocytes 
have been characterised as the undifferentiated and mitotically active population of the 
sebaceous gland and are cubodial or flattened lacking lipid droplets. They have been 
proposed to be the source of new cellular material in the sebocyte turnover process. During 
maturation, these cells differentiate into the centre of the gland displaying an increase in cell 
size, number of endoplasmatic reticulum (ER) and Golgi apparatus as well as an 
accumulation of lipid droplets [269]. As a result of enhanced lipid production and cell growth, 
the fully differentiated sebocytes burst and release their content consisting of cholesterol, 
fatty acids, triglycerides and diglycerides into the hair follicles [268-269]. Sebum composition 
varies among species. For example, in human sebum there are unique lipids such as 
squalene and wax esters. These are not found anywhere else in the body [270]. 
 
 
1.7.2. Functions of the sebaceous gland 
 
The sebaceous glands exert different important functions, which comprise the lubrication, 
maintenance of flexibility and protection against dehydration in hair and skin. Furthermore, a 
variety of other tasks have been proposed such as transport of fat-soluble antioxidants and 
pheromones to the skin surface, natural photoprotection, as well as the modulation of pro- 
and anti-inflammatory processes in the course of the innate antimicrobial defence [269-271]. 
For example, Vitamin E can act as antioxidant, and may therefore be delivered to the skin 
surface by sebum secretion to build up a protection against reactive oxygen species, which 
otherwise would impair the barrier function of the skin [272]. Sebum has also been shown to 
harm certain micro-organisms as Streptococcus [273], thereby minimising the risk of skin 
infections [274]. Among others, the sebum contains glycerol, which may support the 
maintenance of skin hydration [275]. With regards to the integrity of hairs, some observations 
lead to the assumption that sebaceous glands are essential for the correct structural 
unfolding and maintenance of hair follicle structure. Mutant mice containing a dysfunction of 
sebocytes, particularly due to a loss of function of lipid metabolic enzymes in the skin, display 
dehydrated fur and increased hair loss, resulting in an alopecia phenotype with only 
rudimentary sebaceous glands [276-280]. These findings strengthen the idea of a cross-
dependence between hair follicle and sebaceous gland. 
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1.7.3. Regulation of sebaceous gland function 
 
There are many factors, which regulate these functions (see also review by K. R. Smith and 
D.M. Thiboutot, JLR, 2008). Among these are androgens, which were shown to induce 
proliferation and lipid synthesis in the sebaceous glands. Particularly, androgen receptors 
(AR) are expressed in the basal layer of the gland, where they bind 5a-dihydrosterone 
(DHT), a product of testosterone [281-282]. DHT is then translocated to the nucleus and 
initiates the transcription of androgen-responsive genes [283], which are involved in fatty 
acid, triglyceride, squalene, and cholesterol synthesis, through the lipogenic transcription 
factor SREBP (Sterol-response element-binding protein) [284-285]. Accordingly in humans, 
DHT treatment results in enlarged sebaceous glands, whereas individuals lacking the 
androgen receptor are androgen-insensitive and have no sebum production [286-287]. 
Conversely, estrogens like estradiol, found in the ovary, adipose tissue and skin, suppress 
human sebum production, and are applied in the treatment for acne in women, although the 
underlying mechanism is not fully understood [288]. Estradiol is also a derivate of 
testosterone synthesised by the action of the enzyme aromatase, and hence may act 
through a negative feedback loop to antagonise the effect of DHT [289-290]. Thus, a tightly 
regulated equilibrium between different hormonal signals is crucial for the overall sebum 
production. 
Treatment of acne skin revealed an inhibitory effect of retinoids (e.g. isotretinoin, 13-cis-RA), 
a class of vitamin A-derivative pharmacological agents, on sebum production. As 
consequence, treated skin displayed a reduced size of the glands and their retention in an 
undifferentiated state. Furthermore, treatment of the immortalised human sebocyte cell lines 
Seb-1 and SZ95 with 13-cis-RA leads to cell cycle arrest and apoptosis [291-293]. 
Unfortunately, 13-cis-RA is a teratogen and can cause deformities during pregnancy. Thus 
alternative, non-teratogenic agents have to be found to inhibit sebum production in the 
treatment for acne. 
LXR (Liver X receptor) is another nuclear receptor, which plays a critical role in cholesterol 
homeostasis and lipid metabolism. It has been found to be expressed in the human 
sebaceous gland cell line SZ95 and to modulate lipid synthesis and differentiation in these 
cells [294-295]. 
PPARs (Peroxisome proliferator-activated receptors) are members of the ligand-activated 
nuclear hormone receptor superfamily, which includes receptors for thyroid hormones, 
retinoids, steroid hormones, and vitamin D, and are also involved in the regulation of 
sebaceous gland function [296]. PPARα regulates sebocyte differentiation and epidermal 
permeability barrier by increasing lipid metabolism and expression of structural differentiation 
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markers. PPARβ was found to be the predominant isotype in the skin and to play a major 
role as modulator of cell differentiation in both keratinocytes and sebocytes. PPARγ was 
shown to be involved in the regulation of sebocyte function like lipogenesis and sebocyte 
development [297]. Accordingly, skin with suppressed PPARy expression was found to lack 
adipose tissue and sebaceous glands [298], underlining the necessity of PPARγ for 
differentiation of sebocytes. 
Insulin and IGF (Insulin-like growth factor) were shown to promote sebaceous gland lipid 
production [299]. IGF-1 increases the expression of SREBP-1 (sterol response element-
binding protein-1), a transcription factor that regulates numerous genes involved in lipid 
biosynthesis, which in turn stimulates lipogenesis in sebocytes. This is achieved through 
activation of the PI3-K (phosphoinositide) pathway [300]. 
Peptide hormones are also involved in sebocyte differentiation through cyclic adenosine 
monophosphate (cAMP) which acts as signalling mediator inside the cells upon binding of 
melanocortins to their receptors, for example melanocortin 5 receptor (MC5R) [301]. MC5R 
is a G protein coupled receptor (GPCR) and has a preferential affinity for α-melanocyte-
stimulating hormone (α-MSH), followed by adrenocorticotropic hormone (ACTH) and β-MSH 
[302]. In human sebaceous glands, MC5R expression is found in the differentiated central 
part of the gland and not in the periphery, where immature sebocytes are localised [303-304]. 
Furthermore, MC5R is detected in cultured sebocytes after treatment with cholera toxin to 
promote cAMP formation, and thus differentiation [305]. The physiological role of MC5R 
remains still a matter of debate. The targeted deletion of this receptor resulted in reduced 
sebum secretion [306] and has been proposed as marker for terminally differentiated 
sebocytes [305]. 
Previous studies have shown that Stearoyl-CoA desaturase 1 (SCD1) null mice show 
atrophic sebaceous glands as well as narrow eye fissures. The function of this enzyme 
comprises the conversion of saturated to unsaturated fatty acid. Thereby, accumulation of 
unsaturated end products as arachidonic acid was found to have a negative effect on Scd1 
expression [279, 307-309]. Its expression is regulated by diet, hormones and developmental 
processes. However, SCD1 has not been described in the context of sebocyte differentiation 
yet. In our laboratory, it was found to be up-regulated during early sebaceous gland 
morphogenesis and expressed in differentiated sebocytes in mouse epidermis (unpublished 
data). 
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1.7.4. Sebaceous gland associated skin disorders 
 
Dysfunction of sebaceous glands results in skin diseases such as acne, seborrhea, 
sebaceoma, and sebaceous carcinoma. 
Acne occurs most commonly during adolescence, affecting more than 96% of teenagers, and 
frequently continues into adulthood. The disorder is accompanied by increased sebum 
production, hyperkeratinisation of the upper follicle and release of proinflammatory factors 
upon infection by Propionibacterium acnes [310]. Thereby, sebum takes a central role 
serving as nutrient source for P. acnes. 
Seborrhea is a chronic inflammatory skin disorder that affects the areas of the head and 
trunk that have a higher density of sebaceous glands. However, the cause of seborrhea 
remains unknown [311-312]. The yeast Pityrosporum ovale is known for its affinity for 
sebaceous glands and has been proposed to be the cause of seborrhoea. Growing colonies 
lead to skin irritation causing redness and flaking. 
 
 
1.7.5. Sebaceous gland associated tumours 
 
Sebaceoma has been defined as benign neoplasm of basaloid cells with varying numbers of 
mature sebocytes by Troy and Ackerman [313]. The histology shows irregular shaped cell 
masses, in which more than 50% of the cells are undifferentiated consisting of basaloid cells 
together with large aggregates of sebocytes and transitional cells. In addition, cysts and duct-
like structures are found and contain holocrine secretion and cellular debris. 
Sebaceous carcinoma is an aggressive, but uncommon tumour. It has been first described 
by Allaire in 1891, and arises from sebaceous glands in the skin [314-315]. Thereby, 
approximately 75% of these tumours arise in the periocular region, which is rich in a variety 
of types of sebaceous glands [315-316]. 
 
 
1.7.6. Impact of ageing on sebaceous glands  
 
In addition, ageing also affects the integrity of sebaceous glands. While the number of 
sebaceous glands remains approximately the same throughout life, their size tends to 
decrease with age [317]. Thereby, sebum production in the aged is decreased compared to 
young adults. 
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1.8. The human sebocyte cell line SZ95 as in vitro model 
 
In order to investigate the molecular mechanism of Indian Hedgehog signalling and its role in 
human sebocytes, the human facial sebaceous gland cell line SZ95 was selected in the 
present study. This immortalised cell line has been established and characterised by 
Zouboulis and colleagues in 1999 [318]. Importantly, this sebocyte cell line preserves major 
characteristics of sebaceous gland cells in vivo such as the polygonal cell shape with a large 
nucleus, as well as the polymorphic cell population of different sizes and intracellular 
structures indicating different stages of cell maturation [319-321]. The size of cultured 
sebocytes was shown to significantly increase with progressive differentiation up to 4- to 5.5-
fold. In addition, SZ95 cells respond to different signals as androgens [322] and retinoids 
[292], and express the receptors LRX [294-295], and PPARs [323-324], which are shown to 
play a role in the regulation of sebaceous gland function in vivo. 
Importantly, SZ95 cells have the advantage that they can be induced to differentiate upon 
confluent growth or fatty acid treatment (e.g. arachidonic acid, linoleic acid) culminating in the 
production of lipids like triglycerides, squalene and wax esters. Subsequently, these products 
accumulate in cytoplasmic lipid droplets as seen under normal physiological conditions in 
vivo. Accordingly, unconfluent growing sebocytes comprise undifferentiated cells, whereas 
populations with high confluence additionally consist of differentiating cells. Furthermore, 
application of arachidonic acid or linoleic acid induces terminal differentiation in SZ95 cells, 
which results in holocrine secretion of sebum and cell death as typically observed in mature 
sebocytes [323, 325-329]. 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
 
37 
 
1.9. Objectives of this thesis 
 
Previous work of our workgroup suggested that Indian hedgehog (Ihh) is up-regulated in 
sebaceous tumours and in the human sebaceous cell line SZ95 undergoing differentiation 
[43]. Therefore, we hypothesise that Indian hedgehog signalling is important for sebocyte 
proliferation and differentiation, as well as for formation of sebaceous skin tumour. To test 
this hypothesis the aim of this work is to specifically address the following questions: 
 
- What is the underlying molecular mechanism of Indian Hedgehog signalling in human 
sebocytes? 
- Does Indian Hedgehog signalling regulate proliferation and differentiation in human 
sebocytes? 
- If so, which of the three Gli transcription factors is specifically involved in these 
processes? 
- Does Indian Hedgehog signalling interact with canonical Wnt/β-catenin signalling in 
human sebocytes? 
 
To address these crucial questions, the human sebocyte cell line SZ95 was utilised. 
Thereby, further understanding in the underlying molecular mechanism of Hedgehog 
signalling in this cell type will help to develop specific and potent therapeutics against 
diseases associated with impaired regulation of sebaceous glands. Moreover, owing to the 
widespread role of Hedgehog signalling in the whole organism, gained knowledge in these 
processes could also be applied for other type of tissues and of Hh pathway-dependent 
disorders in humans. 
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2. Material and Methods 
 
2.1. Reporter and expression constructs 
 
2.1.1. Reporter constructs 
 
The following luciferase reporter constructs were kindly provided by H. Clevers [330] and 
H.Sasaki [331], respectively, and used for transient transfection: 
 
TOPFLASH (functional Tcf reporter plasmid): 
The TOPFLASH reporter plasmid contains three copies of the wild type TCF binding site 
(CCTTTGATC) upstream of a thymidine kinase (TK) minimal promoter and the Luciferase 
open reading frame (Fig. 5A). The plasmid has a size of 5.5 kbp and serves as a sensitive 
reporter for the Wnt/β-catenin activity. 
 
FOPFLASH (non-functional Tcf reporter plasmid containing mutated TCF binding 
sites): 
The FOPFLASH reporter plasmid contains three copies of a mutated Tcf binding site 
(CCTTTGgcC) upstream of a TK minimal promoter and the Luciferase open reading frame 
(Fig. 5B). The plasmid has a size of 5.5 kbp and serves as a negative control for 
TOPFLASH. 
 
                                                 
 
Figure 5: Vector maps of (A) TOPFLASH and (B) FOPFLASH reporter plasmids (Upstate, USA). 
A 
B 
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8 x 3'Gli-BS Luc (functional Gli reporter plasmid): 
The 8 x 3'Gli-BS luciferase reporter construct contains eight copies of the wild type 3’Gli 
binding site motif (GAACACCCA) upstream of a δ-crystallin basal promoter and the 
luciferase open reading frame, (Fig. 6). The plasmid serves as a sensitive reporter for the 
Hh/Gli activity. 
 
8 x m3'Gli-BS Luc (non-functional Gli reporter plasmid containing mutated Gli binding 
sites): 
The 8 x m3'Gli-BS luciferase reporter construct contains eight copies of a mutated variant of 
the 3’Gli binding site motif (GAAgtgggA) upstream of a δ-crystallin basal promoter and the 
luciferase open reading frame (Fig. 6). The plasmid serves as a negative control to 8 x 3'Gli-
BS luc. 
 
 
 
Figure 6: Scheme of Gli reporter constructs for luciferase assay with 8x wild type 3’Gli binding 
sites (dark cycles) and 8x mutated 3’Gli binding sites (light circles) [331]. 
 
pRL-TK (Renilla luciferase reporter plasmid): 
The pRL-TK plasmid contains the herpes simplex virus thymidine kinase (HSV-TK) promoter 
to provide low to moderate levels of Renilla luciferase expression (Fig. 7). The size of the 
plasmid is 4 kbp (Promega, USA).This vector was co-transfected as an internal control 
reporter for transfection efficiency with any of the previously mentioned experimental reporter 
vectors depending on the experimental settings. 
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Figure 7: Vector map of pRL-TK (Promega, USA). 
 
 
2.1.2. Expression constructs 
 
The human full-length Gli expressing vectors were kindly provided by Asa Bergström and 
Rune Toftgård (Karolinska Institute, department for Biosciences, Sweden). 
 
Human GLI1 HA-tagged expression construct: 
Full-length HA-hGli1 cDNA was inserted into the HindIII/SalI restriction site of a pCMV5 
vector with ampicillin resistance. 
 
Human GLI2 Myc-tagged expression construct: 
Full-length hGli2 cDNA was inserted into pCS2+MT vector with ampicillin resistance and a 
strong enhancer element (simian CMV IE94). 
 
Human GLI3-GFP fusion protein expressing plasmid: 
Full-length hGli3 was cloned in a pEGFP-C2 vector with kanamycin resistance using the 
SacI/SalI restriction sites.  
 
N-terminally truncated β-catenin expressing plasmid (T2): 
The T2 mutant form of β-catenin contains a deletion of the N-terminal 147 amino acids and 
was cloned in a pCMV5 backbone with ampicillin resistance. This N-terminal sequence 
includes the phosphorylation sites, which are essential for targeting the β-catenin protein for 
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degradation. Thus, T2 is a non-degradable and constitutively active variant of this protein 
[332-333]. The cDNA of this construct originates from Xenopus, and, therefore, can be 
distinguished from the endogenous human β-catenin expression by PCR. 
 
Control vectors pCMV5, pCS2+ and pEGFP-1: 
The empty vectors contain an ampicillin (pCMV5, pCS2+) or a kanamycin (pEGFP-1, BD 
Biosciences Clontech) resistance cassette and were applied as mock controls in transfection 
experiments. 
 
 
2.2. Molecular methods 
 
2.2.1. Bacteria strain 
 
TZ101α (Trendzyme, Konstanz) 
TZ101α is a chemically competent E. coli strain suitable for most applications. Due to a recA 
mutation, this strain exhibits a reduction of recombination events. An additional endA 
mutation ensures an improved DNA plasmid quality. 
Transformation efficiency > 1 x 108 cfu/µg (cfu: colony-forming unit) 
Genotype: F’/ endA1 hsdR17 glnV44 thi-1 recA1 gyrA relA1 ∆(lacIZYA-argF)U169 deoR 
(Φ80dlac∆(lacZ)M15) 
 
 
2.2.2. Chemical transformation of competent bacteria 
 
Most of the chemical methods currently used for bacterial transformation are based on the 
observations of Mandel and Higa, who showed that bacteria treated with ice-cold solutions of 
CaCl2 and then briefly heated to 37°C or 42°C could be t ransformed with bacteriophage T 
DNA. The same method was subsequently used to transform bacteria with plasmid DNA and 
E. coli chromosomal DNA as follows: 
According to the information given by the provider (Trendzyme, Konstanz), an aliquot of 
competent TZ101α bacteria was thawed and mixed with 1 µg plasmid DNA. The mixture was 
incubated on ice for 15 minutes and afterwards, heat shocked for 30 seconds at 42°C. 
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Subsequently, cells were cooled on ice for 2 minutes before addition of 75 µl SOC-Medium 
(Invitrogen, Heidelberg). After an incubation period for 1 hour at 37°C on a shaker, the 
transformed bacteria were plated on an agar plate containing 50µg/ml ampicilin or 50 µg/ml 
kanamycin for selection and were grown overnight at 37°C (agar agar and antibiotics were 
purchased from Sigma-Aldrich, Hamburg).  
 
 
2.2.3. Plasmid DNA isolation 
 
After transformation and selection of the bacteria, 5 ml LB medium (Sigma-Aldrich, Hamburg) 
were inoculated with the appropriate strain of bacteria and incubated overnight at 37°C on a 
shaking agitator in the presence of ampicillin (50µg/ml) or kanamycin (50µg/ml). An aliquot 
(1-2 ml) of the resulting culture was taken to check the correct amplification of the plasmid by 
restriction digestion following the Mini-Prep kit (Qiagen, Hilden) instructions from the 
manufacturer. Subsequently, for large scale isolation of up to 500 µg plasmid DNA, 250-500 
ml LB medium were inoculated with 3-4 ml of the overnight culture and the culture was grown 
until it reached an OD600 = 0.4. The culture was transferred to centrifugation tubes and left on 
ice for 15 minutes to stop the growth. The following plasmid DNA isolation was performed 
using the Maxi-Prep kit (Qiagen, Hilden) according to the manufacturer´s instructions. 
The DNA concentration was measured photometrically at 260 nm (Eppendorf, Hamburg) and 
calculated on the basis that an optical density of 1 equals a concentration of 50 µg/ml double 
stranded DNA. Purity was determined by measuring OD
260nm
/OD
280nm
. 
Successfully transformed bacteria strains were stored at -80°C after addition of 1 ml glycerol 
to 1 ml culture in a cryogenic vial. 
   
 
2.2.4. Restriction digestion 
 
Restriction enzyme digestion was used to cut plasmid DNA molecules at defined sites 
resulting in DNA fragments of defined length. The fragment pattern served as a quality 
control of the amplified plasmid DNA by the bacteria transformation. 
 
Restriction digestions were performed as follows: 
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 Plasmid DNA   1 – 5 µg 
 Restriction Enzyme  at least 1 U / µg DNA 
10x reaction buffer  3 µl 
ddH2O    ad 30 µl 
 
For some enzymes, the addition of bovine serum albumin (BSA, 1/100 of total volume) was 
necessary. The digestion was done at the appropriate enzyme reaction temperature (mostly 
37°C) for 1 hour to overnight. All restriction enzy mes were purchased from NEB (USA). 
 
 
2.2.5. Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA strands by size, thus allowing 
identity and quality check of restriction digestion or PCR products. Gels were prepared by 
boiling 1-2% agarose in 1xTAE. After cooling down to about 70°C, ethidium bromide was 
added. Ethidium bromide intercalates in double stranded DNA and emits light when it is 
excited under UV light, which allows visualising the DNA fragments. Gels were run at 120 V 
for 45-60 minutes. High range or low range DNA ladders (Fermentas, St. Leon-Rot) were 
used for the determination of the DNA fragment sizes, depending on the expected length of 
the DNA product.  
Additional to non-template and no reverse transcriptase controls, cDNA from total RNA of 
human fetal thymus (BioChain Institute Inc., USA) was taken for a positive control. 
 
 
2.2.6. Isolation of mRNA from animal and human cells 
 
Total RNA was purified using the RNeasy Plus Mini Kit (Qiagen, Hilden) according to 
the manufacturer’s protocol, which includes one genomic DNA elimination step. 
The total RNA concentration was measured photometrically at 260 nm (Eppendorf, 
Hamburg) and calculated on the basis that an optical density of 1 equals a concentration of 
40 µg/ml single stranded RNA. Purity was determined by measuring the OD
260nm
/OD
280nm
. 
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2.2.7. cDNA synthesis 
 
cDNA synthesis was performed using the QuantiTect Reverse transcription kit (Qiagen, 
Hilden) at 42°C for 30 minutes with 1 µg of total R NA according to the manufacturer’s 
protocol, which includes a second genomic DNA elimination step. 
 
 
2.2.8. Primer design 
 
For quantitative real-time PCR using the SYBR Green technique, all primers were designed 
to generate a PCR product with similar sizes of 150-300 kb by sharing similar nucleotide 
sequence length (18-20 kb) and annealing temperatures (57-60°C).  
To prevent non-specific binding to residual genomic DNA fragments, sequences spanning 
more than one target exon were selected if possible. Information on the exon structure of the 
genes was obtained from the Ensembl database (http://www.ensembl.org/). Primers were 
designed with the help of Primer3 software (http://frodo.wi.mit.edu/primer3/) and, 
subsequently, were checked for their quality with FastPCR software 
(http://www.biocenter.helsinki.fi/bi/Programs/fastpcr.htm) to exclude primer dimer formation. 
Furthermore, specificity of primer pairs was verified by the nucleotide blast function of the 
NCBI homepage (http://www.ncbi.nlm.nih.gov/). All primers were purchased from Eurofins 
MWG GmbH (Ebersberg) and their sequences are listed in the following table (Tab. 1): 
 
Table 1: Primer sequences for qRT-PCR 
Target Primer Sequence Product size 
ACTG1 
(actin gamma 1) 
forward 
reverse 
5'-CAGACACCAGGGCGTCAT-3' 
5'-CTCGGTCAGCAGCACTGG-3' 251 
ADFP 
(Adipophilin) 
forward 
reverse 
5'-CAGAAGCTAGAGCCGCAAAT-3' 
5'-CTTCTCCACACTGCCAGTCA-3' 201 
α-Tubulin 
(alpha tubulin) 
forward 
reverse 
5'-TCCTTCAACACCTTCTTCAGTG-3' 
5'-GCATCTTCCTTGCCTGTGAT-3' 155 
AR 
(Androgen receptor) 
forward 
reverse 
5'-GCCTTGCTCTCTAGCCTCAA-3' 
5'-CCTCATTCGGACACACTGG-3' 270 
AXIN1 
(axis inhibition protein 
1) 
forward 
reverse 
5'-ATGAGGACGATGGCAGAGAC-3' 
5'-CCGGCATTGACATAATAGGG-3' 166 
AXIN2 
(axis inhibition protein 
forward 
reverse 
5'-AATGCAAAAGCCACTCCAAG-3' 
5'-GCTCACTCTCCAGCATCCAC-3' 222 
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2) 
β-catenin 
(beta catenin) 
(human) 
forward 
reverse 
5'-TGGAATGCAAGCTTTAGGAC-3' 
5'-TCTGAACCCAGAAGCTGAAC-3' 153 
β-catenin 
(beta catenin) 
(Xenopus) 
forward 
reverse 
5'-GGGTGTCCGTATGGAAGAGA-3' 
5'-AGCAGTTGCACCTTCAGCTT-3' 229 
BLIMP1/PRDM1 
(PR domain zinc 
finger protein 1) 
forward 
reverse 
5'-GTGTCAGAACGGGATGAACA-3' 
5'-CTTTCCTTTGGAGGGGTTG-3' 268 
CBY1 
(chibby homolog 1) 
forward 
reverse 
5'-GCAGAGACAGGGGTTAGTGG-3' 
5'-AAGTGGGATTCAGCAGTGGA-3' 152 
CHOP/DDIT3 
(DNA damage-
inducible transcript 3) 
forward 
reverse 
5'-GAGCTGGAAGCCTGGTATGA-3' 
5'-TGTGACCTCTGCTGGTTCTG-3' 174 
DHH 
(Desert hedgehog) 
forward 
reverse 
5'-CGTGTCGGTCAAAGCTGATA-3' 
5'-TCTCCACAGCCACAAATGAA-3' 224 
DKK1 
(Dickkopf-related 
protein 1 precursor) 
forward 
reverse 
5'-TCCAACGCTATCAAGAACCTG-3' 
5'-CAGGCGAGACAGATTTGCAC-3' 227 
DKK2 
(Dickkopf-related 
protein 2 precursor) 
forward 
reverse 
5'-GCCAAACTCAACTCCATCAA-3' 
5'-GCAATACCTCCCAACTTCACA-3' 174 
DKK3 
(Dickkopf-related 
protein 3 precursor) 
forward 
reverse 
5'-CGAGGTTGAGGAACTGATGG-3' 
5'-CCTTCGTGTCTGTGTTGGTC-3' 155 
DKK4 
(Dickkopf-related 
protein 4 precursor) 
forward 
reverse 
5'-AGGAAAACCAACCCAAAAGG-3' 
5'-TCCCTCCAAAAGGACTGG-3' 158 
GAPDH 
(Glyceraldehyde-3-
phosphate 
dehydrogenase) 
forward 
reverse 
5'-TCACCAGGGCTGCTTTTAAC-3' 
5'-GACAAGCTTCCCGTTCTCAG-3' 152 
GLI1 
(Glioma-associated 
oncogene homolog 1) 
forward 
reverse 
5'-CCCATTCCAATGAGAAGCCG-3' 
5'-GCTTGGCTGTGGCTTCAT-3' 260 
GLI2 
(GLI-Kruppel family 
member GLI2) 
forward 
reverse 
5'-GTAAGCAGGAGGCTGAGGTG-3' 
5'-CACTTGTGGGGCTTCTCG-3' 238 
GLI3 
(Zinc finger protein 
GLI3) 
forward 
reverse 
5'-CCAACTCCTTGGTCACGATT-3' 
5'-AGCTCTGTTGTCGGCTTAGG-3' 168 
HHIP 
(Hedgehog 
interacting protein) 
forward 
reverse 
5'-GCTCTGTCGAAACGGCTACT-3' 
5'-TCACTCTGCGGATGTTTCTG-3' 200 
IHH 
(Indian hedgehog) 
forward 
reverse 
5'-AAGGCCCACGTGCATTGC-3' 
5'-TCGCTGAAGGTGGGGCTC-3' 179 
K6a forward 5'-TGAGATCGACCACGTCAAGA-3' 242 
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(Keratin 6A) reverse 5'-ACTCCTCACCCTCCAGCAG-3' 
K15 
(Keratin 15) 
forward 
reverse 
5'-AGCCCAGAATGCGACTACAG-3' 
5'-CTGCATCTCCAGGTCAGTCC-3' 246 
MAPK1 
(Mitogen-activated 
protein kinase 1) 
forward 
reverse 
5’-CTAACAGGCCCATCTTTCCA-3’ 
5’-CTCGTCACTCGGGTCGTAAT-3’ 299 
MC5R 
(Melanocortin 5 
receptor) 
forward 
reverse 
5'-CTCAACCTGAATGCCACAGAG-3' 
5'-GTCTGCTATCACTAGGTGCTTG-3' 291 
c-Myc 
(Myc proto-oncogene 
protein) 
forward 
reverse 
5'-CCTACCCTCTCAACGACAGC-3' 
5'-CTCTGACCTTTTGCCAGGAG-3' 248 
PTC1 
(Patched homolog 1) 
forward 
reverse 
5'-GAGCAGATTTCCAAGGGGAAGG-3' 
5'-ACTCGTCCTCCAACTTCCACC-3' 221 
PTC2 
(Patched homolog 2) 
forward 
reverse 
5'-TCACAGGCCAACTTCTACCC-3' 
5'-GCCCAGATACTGTTCCCAGA-3' 258 
PPARγ 
(Peroxisome 
proliferator-activated 
receptor gamma) 
forward 
reverse 
5'-AGCCTTTTGGTGACTTTATGGA-3' 
5'-AGGACTCAGGGTGGTTCAGC-3' 213 
SCD1 
(Acyl-CoA 
desaturase) 
forward 
reverse 
5'-GATGTCTATGAATGGGCTCGTG-3' 
5'-CCAGGTTTGTAGTACCTCCTCTG-3' 218 
SFRP1 
(Secreted frizzled-
related protein 1 
precursor) 
forward 
reverse 
5'-CATGCAGTTCTTCGGCTTCT-3' 
5'-GCTTCTTCTTCTTGGGGACA-3' 266 
SFRP2 
(Secreted frizzled-
related protein 2 
precursor) 
forward 
reverse 
5'-GCTTGAGTGCGACCGTTT-3' 
5'-CTTTCGGACACACCGTTCAG-3' 273 
SFRP3 
(Secreted frizzled-
related protein 3 
precursor) 
forward 
reverse 
5'-AAACTGTAGAGGGGCAAGCA-3' 
5'-CCCGTGGAATGTTTACCAGA-3' 194 
SFRP4 
(Secreted frizzled-
related protein 4 
precursor) 
forward 
reverse 
5'-TCTATGACCGTGGCGTGTG-3' 
5'-TTGTAATGAGCGGGACTTGA-3' 330 
SFRP5 
(Secreted frizzled-
related protein 5 
precursor) 
forward 
reverse 
5'-GGACAACGACCTCTGCATC-3' 
5'-TGGGCTCCAATCAGCTTC-3' 201 
SHH 
(Sonic hedgehog) 
forward 
reverse 
5'-AGGGCACCATTCTCATCAAC-3' 
5'-GGAGCGGTTAGGGCTACTCT-3' 202 
SMAD7 
(Mothers against 
decapentaplegic 
homolog 7) 
forward 
reverse 
5'-GCAACCCCCATCACCTTA-3' 
5'-CCCCACTCTCGTCTTCTCCT-3' 245 
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SMO 
(Smoothened 
homolog) 
forward 
reverse 
5'-CCGGGACTATGTGCTATGTCA-3' 
5'-ACTCTGCCCAGTCAACCTG-3' 217 
TBP 
(TATA box binding 
protein) 
forward 
reverse 
5'-TGCACAGGAGCCAAGAGTGAA-3' 
5'-CACATCACAGCTCCCCACCA-3' 132 
WIF1 
(Wnt inhibitory factor 
1 precursor) 
forward 
reverse 
5'-CCGAAATGGAGGCTTTTGTA-3' 
5'-TGGTTGAGCAGTTTGCTTTG-3' 188 
 
 
 
2.2.9. Polymerase chain reaction (PCR) 
 
Endpoint PCR samples were set up by adding 100-500 ng cDNA and 0.25 µM of gene 
specific primers to 12.5 µl REDTaq
TM (Sigma-Aldrich, Hamburg) in a 25 µl reaction volume. 
REDTaq
TM 
is a PCR readymade, 2-fold concentrated reaction mix containing dNTPs, Taq 
DNA polymerase and MgCl
2
. The template DNA was denaturised at 95°C for 2 mi nutes 
followed by 30-40 amplification cycles each consisting of 1 minute incubation at 95°C, 30 
seconds incubation at 55°C for annealing the primer s and 30 seconds at 72°C for the 
elongation step. 
 
 
2.2.10. Quantitative real-time PCR (qRT-PCR) 
 
Gene expression and down-regulation by siRNA were determined by quantitative real-time 
RT-PCR on an ABI StepOnePlus Real-Time PCR System (Applied Biosystems, Darmstadt) 
with the RT2 SYBR Green qPCR Master Mix (SuperArray, BIOMOL GmbH, Hamburg) 
according to the manufacturer’s instructions. All measurements were standardized with the 
corresponding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA internal 
control. For validation, GAPDH was used as an endogenous control for the comparison of 
expression levels of other potential reference/housekeeping genes in an initial experiment 
(Fig. 8). As shown below, the expression of these genes did not vary significantly in 
undifferentiated and differentiated SZ95 cells, so GAPDH was employed as the normalisation 
gene of choice. 
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Figure 8: Validation of GAPDH as reference gene. Expression levels of alternative 
reference/housekeeping genes in undifferentiated and differentiating SZ95 cells were determined by 
quantitative real-time PCR after normalisation over GAPDH in the appropriate samples. Results are 
presented as mean values ± SD of triplicates from an experiment that was repeated at least three 
times. 
 
Depending on the experimental setting, cDNA of either undifferentiated, mock transfected or 
non-target siRNA treated cells was used as a reference sample.  
In addition to the non-template and no reverse transcriptase controls, cDNA from total RNA 
of SZ95 cells, only treated with EtOH, was taken for the solvent control of arachidonic acid 
treated cells. 
The primers used for expression analysis are displayed in table 2. 
 
 
2.3. Cell culture 
 
2.3.1. Cell lines 
 
Immortalized human sebaceous gland cell line SZ95: 
In this study, SZ95 cells derived from facial human sebaceous glands were chosen as an in 
vitro model to investigate the role of Wnt and Hh signalling pathway during sebocyte 
differentiation [318]. This cell line has the benefit of reflecting various features of the human 
sebaceous gland, such as androgen responsiveness [268]. The differentiation of SZ95 cells 
is induced by cell density. Cultures of unconfluent growing populations consist of 
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undifferentiated, proliferating cells, whereas high density cultures consist of proliferating and 
differentiating cells. As seen under normal physiological conditions in vivo, the process of 
SZ95 cell differentiation culminates in the production of lipids like triglycerides, squalene and 
wax esters that accumulate in cytoplasmic lipid droplets. Application of arachidonic acid (AA) 
or linoleic acid (LA) was found to induce terminal differentiation leading to holocrine secretion 
and death of the cells [318, 327, 334]. 
 
Human colon adenocarcinoma cell line SW480: 
The SW480 cell line was established from a primary adenocarcinoma of the colon [335]. 
These cells are epithelial like in morphology and used as an in vitro model for colorectal 
cancer to study tumour markers, carcinoembryonic antigen (CEA) production, biochemistry 
of tumorigenicity, pharmacodynamics, hormone sensibility and as a positive control for the 
nuclear protein β-catenin. In this thesis, SW480 cells were used as transfection and 
expression control, because this cell line can be easily transfected with high efficiency in 
contrast to SZ95 cells. 
 
Hedgehog pathway reporter cell line Shh Light II: 
Shh Light II cells were derived from the NIH/3T3 cell line and are employed as stable Gli 
reporter transfectants [336]. These cells include the GLI-responsive Firefly luciferase reporter 
from H. Sasaki [331], and a pVgRXR vector (Invitrogen, Karlsruhe) encoding a Zeocin 
resistance marker for selection. These cells respond to the activation of the hedgehog 
signalling cascade in presence of hedgehog ligands resulting in an increase of luciferase 
activity which can be measured by a luminometer. 
 
 
2.3.2. Cultivation of SZ95 cells 
 
SZ95 cells were cultured in Sebomed medium (Biochrom, Berlin) containing 10% FCS 
(Biochrom, Berlin) supplemented with 3 ng/ml keratinocyte growth factor (rHuKGF, Pan 
Biotech GmbH, Aidenbach), and 20 ng/ml epidermal growth factor (EGF, Biochrom, Berlin) at 
37°C in a humidified incubator with 5% CO 2. Undifferentiated/immature SZ95 cells were 
typically seeded at a density of 2-4 x 105 cells per 25-cm2 flask and passaged before 
reaching confluency. To induce differentiation, SZ95 cells were cultured at high density for 1-
3 days or treated with 100 µM arachidonic acid or 100 µM linoleic acid both purchased from 
Sigma-Aldrich (Hamburg) [318, 327, 334]. For Smooth
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cyclopamine (Biomol, Hamburg) or 10-100 µM GANT61 (Calbiochem, Darmstadt) were 
added to the growth medium, respectively. For stimulation of the Hedgehog pathway, 1-5 µg 
recombinant SHH ligand protein per 500 µl growth medium were applied on cells grown in 
24-well cell culture plates. Subsequently, proliferation was assessed by BrdU incorporation 
assays. 
 
 
2.3.3. Cultivation of SW480 cells 
 
SW480 cells were cultured in DMEM (GIBCO, Karlsruhe) containing 10% FCS (PAA, Cölbe) 
supplemented with 100 U/ml penicillin (Biochrom, Berlin) and 100 µg/ml streptomycin 
(Biochrom, Berlin). The cells were grown at 37°C in  a humidified incubator with 5% CO2. 
 
 
2.3.4. Cultivation of Shh light II cells 
 
Shh light II cells were cultured in DMEM (GIBCO, Karlsruhe) containing 10% FCS (PAA, 
Cölbe) supplemented with 100 U/ml penicillin (Biochrom, Berlin), 100 µg/ml streptomycin 
(Biochrom, Berlin), 0.4 mg/ml G-418 (Sigma-Aldrich, Hamburg) and 0.15 mg/ml Zeocin 
(Invitrogen, Karlsruhe). Cells were grown at 37°C i n a humidified incubator with 5% CO2. 
 
 
2.3.5. Thawing and freezing cells 
 
For long-term storage, cells were trypsinised, spinned down after which the pellet was 
resuspended in freezing medium containing 10% DMSO (dimethyl sulfoxide) in FCS (see 
FCS used in growth media) and transferred to cryogenic vials. These were transferred into a 
freezer box, allowing controlled cooling down with a rate of 1°C per minute which improves 
the survival of the cells. After 24 hours, the cells were transferred to liquid nitrogen (-196°C). 
For thawing, frozen cells were immediately transferred from liquid nitrogen into a 37°C water 
bath as quickly as possible in order to prevent the formation of ice crystals during 
rehydration. Then, the cells were promptly washed to remove DMSO included in the freezing 
medium. Therefore, 5 ml of cell culture medium was added, after which the cells were 
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pelleted by centrifugation for 5 minutes at 800 rpm. Cells were resuspended in an 
appropriate volume of culture medium and transferred to a culture dish or flask. 
 
 
2.3.6. Transient transfection of cells by lipofection 
 
For luciferase reporter and/or expression assays, SZ95 and SW480 cells were transiently 
transfected with the Lipofectamine 2000 reagent (Invitrogen, Karlsruhe). Therefore, cells 
were plated in 24 well plates (1x105 cells per well), and cultivated for 24-48 hours before 
transfection. Transfection was performed as specified by the manufacturer’s protocol. 
OptimemI (GIBCO, Karlsruhe) was used as serum-free, and thus, transfection medium. For 
the transfection mixture, 500 ng of the appropriate plasmid DNA (GLI1-HA/pCMV5, GLI2-
Myc/pCS2+, GLI3/pEGFP-C2, T2/pCMV5, empty plasmids as mock control), in combination 
with 500 ng Firefly (8x3’Gli-BS/m8x3’Gli-BS; TOP/FOP) and 500 ng of Renilla (pRLTK) 
reporter plasmids for luciferase assays, were added to 2 µl Lipofectamine 2000 diluted in 100 
µl OptimemI. After 5 hours, the transfection medium was replaced by normal growth medium 
and cells were cultured under normal conditions for further 48 hours before collection for 
analysis. For larger scale transfections, cell number and amounts of transfection agents were 
adapted to the size of the cell culture plate. 
For siRNA knockdown assays, cells were transfected with HiPerFect transfection reagent 
(Qiagen, Hilden) according to the manufacturer’s protocol (also see 2.3.7). 
 
 
2.3.7. siRNA knockdown assay 
 
For knock-down experiments, SZ95 cells were seeded as previously described (2.3.6) and 
transfected with 37.,5 ng siRNA Oligos (Qiagen, Hilden) in combination with 3 µl HiPerFect 
transfection reagent (Qiagen, Hilden) according to the manufacturer’s protocol. After 24-48 
hours, the cells were collected for further analysis. Human-specific siRNA directed against 
Gli transcription factors as well as AllStars negative control siRNA (including the fluorescent 
label Alexa Fluor 488) and anti mouse/human MAPK1 positive control siRNA (Tab. 2) were 
purchased from Qiagen. The knockdown efficiency was verified on transcript level by 
quantitative real-time PCR. 
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Table 2: List of siRNA oligonucleotides 
Oligo name Catalogue no. Manufacturer 
Hs_GLI2_7 SI03078215 Qiagen, Hilden 
Hs_GLI2_8 SI03091445 Qiagen, Hilden 
Hs_GLI3_2 SI00003577 Qiagen, Hilden 
Hs_GLI3_3 SI00003584 Qiagen, Hilden 
Allstars neg. ctrl siRNA AF 488 
 
Qiagen, Hilden 
Mm/Hs MAPK1 ctrl siRNA 
 
Qiagen, Hilden 
 
 
2.3.8. Generation of stable cell lines with shRNA expressing constructs by lentiviral 
transfection 
 
MISSION shRNA transduction-ready lentiviral particles directed against the human GLI 
transcription factors, MISSION control transduction-ready lentiviral particles containing non-
target shRNA and TurboGFP expression vector (Tab. 3) were purchased from Sigma-Aldrich 
(USA) and used for the infection of SZ95 cells according to the manufacturer’s protocol for 
gene silencing in mammalian cells. Thereby, the multiplicity of infection (MOI) was set to 5 
(number of transducing particles per cell) according to the concentrations of the viral 
supernatants provided by the manufacturer. After successful infection, the cells were cultured 
in selection medium containing 1 µg/ml puromycin (Sigma, Hamburg). 
 
Table 3: List of shRNA lentiviral transduction particles 
Name Clone ID Manufacturer 
SHVRS GLI2 NM_005269 TRCN0000033329 Sigma-Aldrich, USA 
SHVRS GLI2 NM_005269 TRCN0000033330 Sigma-Aldrich, USA 
SHVRS GLI2 NM_005269 TRCN0000033331 Sigma-Aldrich, USA 
SHVRS GLI2 NM_005269 TRCN0000033332 Sigma-Aldrich, USA 
SHVRS GLI2 NM_005269 TRCN0000033333 Sigma-Aldrich, USA 
SHVRS GLI3 NM_000168 TRCN0000020504 Sigma-Aldrich, USA 
SHVRS GLI3 NM_000168 TRCN0000020505 Sigma-Aldrich, USA 
SHVRS GLI3 NM_000168 TRCN0000020506 Sigma-Aldrich, USA 
SHVRS GLI3 NM_000168 TRCN0000020508 Sigma-Aldrich, USA 
SHC002V Non-Target Control 
 
Sigma-Aldrich, USA 
SHC003V TurboGFP Control 
 
Sigma-Aldrich, USA 
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2.3.9. Luciferase reporter assays 
 
Luciferase reporter assays were performed with the Dual-Luciferase Reporter Assay kit from 
Promega (Mannheim). 24-48 hours after transfection, cells were lysed, and the lysates were 
treated according to the manufacturer’s protocol. 10 µl of protein lysates were transferred to 
a 96-well luminometer plate. After addition of the firefly substrate LARII (supplied by kit), the 
luciferase activity was measured by a luminometer (TriStar LB941 from Berthold 
Technologies GmbH & Co. KG, Bad Wildbad). Stop & Glo solution (supplied by kit) was 
added to initiate the Renilla luciferase reaction in the same sample as transfection control. 
The measurement results were normalized for the transfection efficiency by dividing the 
firefly luminescence activity (FRLU) with Renilla luminescence activity (RRLU). All data are 
represented as-fold increase of the negative control activity value (m8x3’Gli-BS or 
FOPFLASH), which is set as one. 
 
 
2.3.10. BrdU proliferation assay 
 
For BrdU staining of proliferative cells, SZ95 cells were grown on glass cover slips on 24 well 
plates and exposed for 1 hour to 160 µg/ml BrdU-containing medium before fixation with 
4%PFA/1xPBS. Then, cells were permeabilised with 2N HCL and 0.5% Triton-X 100 in 
1xPBS for 10 minutes and washed in 1xPBS alone. To prevent unspecific antibody binding, 
the fixed cells were incubated in blocking buffer containing 3 g BSA, 10% FCS, 5 g milk 
powder, 10 µl Tween 20 diluted in 1xPBS with a total volume of 100 ml for 30 minutes. After 
washing with 1xPBS, cells were incubated with the primary monoclonal antibody anti-BrdU 
clone B44 (Beckton Dickinson, Heidelberg) diluted 1:25 in 1%BSA/1xPBS for 45 minutes. 
Afterwards, cells were washed with 0.01% Tween 20/1xPBS and incubated with the 
secondary antibody anti-mouse Alexa 594 (Invitrogen, Carlsbad) at a dilution of 1:500 for 30 
minutes. Finally, the cells were washed with 0.01% Tween 20/1xPBS and H2O before 
mounting with polvvinyl alcohol (Mowiol, Calbiochem, Darmstadt). All incubation steps were 
performed at room temperature. Proliferation rate was determined by the ratio of BrdU-
positive/proliferating cells to total number of cells which was determined by counterstaining 
the cell nuclei with DAPI (4',6-diamidino-2-phenylindole, Molecular Probes, Netherland) at a 
dilution of 1:1000. 
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2.4. Protein analysis 
 
2.4.1. Total cell protein extraction 
 
Cells were washed with ice-cold 1xPBS after and lysed in 500 µl or 1ml 1xNP40 lysis buffer 
(1% NP-40, 150 mM NaCl, 4 mM EDTA, 50 mM Tris pH 7.4, supplemented with protease 
inhibitor cocktail from Roche, Mannheim) was added to each well of a 6-well culture plate or 
a 6-cm dish, respectively, and left for 15 minutes at 4°C on a shaker. The lysates were 
transferred to reaction tubes and centrifuged at 13000 rpm at 4°C for 15 minutes. The 
supernatants containing soluble proteins were transferred to new reaction tubes and either 
directly used for further analysis or stored at -80°C. 
 
 
2.4.2. Cell fractionation 
 
Cells were grown on 6-cm dishes, washed with ice-cold hypotonic buffer (20 mM Hepes, pH 
7.4, 20 mM NaCl, 5 mM MgCl2, 1 mM ATP, supplemented with protease inhibitor cocktail 
from Roche, Mannheim) and collected on ice with a cell scraper in a sample tube. 
Afterwards, the swollen cells were homogenized with a glass douncer (10 strokes) and left 
on ice for 15 minutes. In the following step, the samples were centrifuged at 600 g for 5 
minutes at 4°C and the supernatant containing the c ytosolic protein fraction was collected. 
The remaining pellet was resolved in hypotonic buffer containing 0.5% NP-40 to break up the 
nuclear membrane and extract the nuclear protein fraction. 
Both fractions were either used directly for further analysis or frozen at -80°C. 
 
 
2.4.3. Protein precipitation (Wessel-Flügge) 
 
The chloroform/methanol precipitation of proteins from solution, including detergent 
solutions, has been established by Wessel and Flügge (1984). To 0.5 ml lysate 1 volume of 
methanol and ¼ volume of chloroform were added on ice. Then, the samples were mixed 
vigorously and centrifuged at 10000 g at 4°C for 5 minutes. The upper aqueous phase was 
removed and 0.5 ml methanol was added to the remaining sample which comprises the 
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lower phase containing chloroform and the interphase containing the precipitated proteins. 
Again, the solution was mixed and centrifuged at 10000 g at 4°C for 5 minutes to pellet the 
proteins and discard the residual chloroform. After air-drying, the protein pellet was 
redissolved in 50-100 µl 2% SDS/ddH2O on ice. 
 
 
2.4.4. Protein quantification 
 
The protein concentration of the lysates was quantified by the bicinchoninic acid (BCA) 
method using the Pierce BCA Protein Assay Kit (Pierce Biotechnology, Rockford USA) 
according to the manufacturer’s instructions. This method is based on a two step detection 
system. In an alkaline environment, proteins form complexes with Cu2+ ions thereby reducing 
them to Cu1+ ions (biuret method). Subsequently, the reduced Cu1+ ions form a soluble 
purple complex with bicinchoninic acid that has a maximal absorbance at 562 nm.   
For the quantification of the protein concentration, samples were diluted 1:10. Applying the 
protocol, 10 µl of the diluted sample as well as 10 µl of eight BSA samples with known 
concentrations for the standard curve were incubated with 200 µl supplied BCA-working 
solution and incubated for 30 minutes at 37°C in 96 -well plates (TPP, Switzerland). The 
absorbance of the reaction product was measured by a TriStar LB941 (Berthold 
Technologies GmbH & Co. KG, Bad Wildbad) at 578 nm. Protein concentration of each 
lysate was determined in triplicates. 
The standard curve was established by plotting the absorbance of the BSA standards 
against their concentration. The resulting equation of the standard curve was then used to 
calculate the unknown protein concentration of the analysed samples.  
 
 
2.4.5. Protein electrophoresis (SDS-Page) and Immunoblotting 
 
Sodium Dodecyl (lauryl) Sulfate Poly-Acrylamide Gel Electrophoresis (SDS-PAGE) provides 
information about molecular size and purity of proteins as well as about the number and 
molecular size of subunits. SDS functions as an anionic detergent that binds and denatures 
proteins, resulting in a net negative charge for all proteins. Therefore, proteins are separated 
on the basis of their size. 
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Under reducing conditions, 5-40 µg of lysates were denatured by boiling for 5 minutes at 
70°C and run on NuPAGE Novex Tris Acetate 3-8% or N uPAGE Novex Bis-Tris 4-12% gels 
as described in the manufacturer’s protocol (Invitrogen, Karlsruhe). Afterwards, the proteins 
were blotted to polyvinylidene membranes (GE Healthcare, München) which were probed 
with the appropriate primary antibodies diluted according to table 4. The primary antibodies 
were detected by using horseradish peroxidase-conjugated anti-rabbit, -goat, or -mouse IgG 
antibodies (see dilution also on table 5),respectively, and visualized with enhanced 
chemiluminescence (ECL + Western blotting detection kit, GE Healthcare, München), 
followed by exposure to Hyperfilm ECL (GE Healthcare, München). 
Protein band intensities were determined and compared by ImageJ analysis software 
(http://rsbweb.nih.gov/ij/). Thereby, detection of GAPDH and α-Tubulin proteins served as 
loading control of each sample. 
 
 
2.4.6. Immunocytochemistry and lipid staining 
 
For immuno and lipid staining techniques, SZ95 cells were grown on glass cover slips in 24 
well culture plates until 60% confluency for analysing undifferentiated cells or 100% 
confluency for characterising differentiating populations. In some experiments, SZ95 cultures 
were treated with 100 µM arachidonic acid to induce terminal differentiation of the cells. After 
24-48 hours, cells were washed with 1xPBS and fixed in 4% PFA/1xPBS for 10 minutes. 
For immunofluorescence staining, the cells were then permeabilised with 0.2% (v/v) Triton X-
100 (Merck, Darmstadt) in 1xPBS for 5 minutes. Nonspecific binding was blocked with 10% 
(v/v) goat (NGS) or donkey serum (NDS) in 1xPBS for 1 hour. Primary antibodies were 
diluted in blocking solution and incubated at 4°C o vernight or at room temperature for 90 
minutes (see table 4 for dilutions). Secondary antibodies were used in accordance with the 
manufacturer’s instructions, whereby optimal dilutions are listed on table 5. Cell nuclei were 
counterstained DAPI or propidium iodide (PI; Sigma, Hamburg). Coverslips were then 
mounted with polvvinyl alcohol (Mowiol, Calbiochem, Darmstadt), and immunolocalisation 
was visualised by Fluorescence Microscope Eclipse E800 (Nikon Instech Co., Ltd. 
Kanagawa, Japan) or Olympus Confocal Laser Scanning Microscope (Olympus, Münster). 
Oil red O (ORO) (Sigma, Hamburg) lipid droplet staining for detection of mature sebocytes 
was performed by incubating fixed SZ95 cells in 1% ORO in 60% IPA for 30 minutes, 
washed with H2O, and counterstained with Harris haematoxylin (Sigma-Aldrich, Hamburg). 
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Finally, cover slips were embedded in Kaiser's glycerin-gelatine (Merck, Darmstadt) and 
used for analysis by light microscopy (Nikon Instech Co., Ltd. Kanagawa, Japan). 
Analogously, lipid droplets were stained with the fluorescent dye Nile Red for analysis by 
fluorescence microscopy. To generate the stock solution, 1 µg Nile Red was dissolved in 1 
ml MeOH. A working solution was obtained after a dilution of 1:1000 of the stock solution in 
1xPBS. Fixed SZ95 cells on cover slips were washed with 1xPBS and incubated in Nile Red 
working solution for 30 minutes at RT. After washing with 1xPBS, the cover slips were 
mounted in polvvinyl alcohol (Mowiol, Calbiochem, Darmstadt) and analysed by fluorescence 
microscopy (Nikon Instech Co., Ltd. Kanagawa, Japan). 
 
 
2.4.7. Antibodies 
 
WB = Western Blot 
IF = Immunofluorescence 
 
Table 4: Primary Antibodies  
Name Epitope Host Dilution Reference/ Manufacturer 
monoclonal α-ABC clone 
8E7 
Human active ß-catenin 
amino acids 36-44 Mouse 
WB: 1:3000 Van Noort et al., 2002, 
Milipore, Schwalbach IF: 1:100 
monoclonal anti-β-
catenin 
Mouse β-catenin amino 
acids 571-781 Mouse WB: 1:3000 
BD Transduction 
Laboratories, USA 
VB2 β-catenin last 15 C-term. 
amino acids Rabbit 
WB: 1:1000 
Braga et al., 1995 
IF: 1:100 
monoclonal anti-Ihh 
clone EP1192Y Human N-terminus Rabbit WB:1:3000 Abcam, Cambridge, UK 
polyclonal anti-gli1 (sc-
6153) Human N-terminus Goat 
WB: 1:1000 Santa Cruz 
Biotechnology, USA IF:  1:50 
polyclonal anti-gli2 
(ab7195) 
Human Gli2 amino acids 
1193-1209 Rabbit 
WB: 1:3000 
Abcam, Cambridge, UK 
IF:  1:100 
polyclonal anti-gli3 (sc-
20688) 
Human Gli3 amino acids 
1-280 Goat 
WB: 1:3000 Santa Cruz 
Biotechnology, USA IF:  1:50 
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monoclonal anti-HA 
(clone 3F10) 
HA peptide sequence 
(YPYDVPDYA) derived 
from influenza virus) 
Rat WB: 1:3000 Roche Applied Science, Mannheim 
monoclonal anti-c-Myc 
(9E10) 
c-Myc amino acids 410-
419 Mouse WB: 1:3000 Abcam, Cambridge, UK 
polyclonal anti-GFP 
(ab290) 
full-length protein of 
Aequorea victoria Rabbit WB: 1:3000 Abcam, Cambridge, UK 
polyclonal anti-Gapdh 
(ab9485) Human full-length protein Rabbit WB: 1:3000 Abcam, Cambridge, UK 
monoclonal anti-TBP 
(1TBP18) Human Synthetic peptide Mouse WB: 1:3000 Abcam, Cambridge, UK 
monoclonal anti-α-tubulin Native chick brain 
microtubules mouse WB: 1:3000 Calbiochem, Darmstadt 
polyclonal anti-MC5-R 
(sc-7644) Human C-terminus Goat IF: 1:200 
Santa Cruz 
Biotechnology, USA 
polyclonal anti-SCD (sc-
23016) Human internal region Mouse IF: 1:200 
Santa Cruz 
Biotechnology, USA 
polyclonal anti-
PRDM1/Blimp1 
(ab13700) 
Human amino acids 778-
789 Goat IF: 1:200 Abcam, Cambridge, UK 
monoclonal anti-BrdU detects BrdU = analog of thymidine Mouse IF: 1:25 BD Pharmigen, USA 
 
Table 5: Secondary Antibodies  
Name Epitope Host Dilution Reference/ Manufacturer 
Alexa 488 anti-mouse mouse IgGs Donkey IF 1:1000 Invitrogen, USA 
Alexa 594 anti-rat rabbit IgGs Goat IF: 1:1000 Invitrogen, USA 
HRP-conjugate anti-
mouse IgG mouse IgGs Sheep WB: 1:3000 
GE Healthcare, 
Buckinhamshire, UK 
HRP-conjugate anti-
rabbit IgG rabbit IgGs Donkey WB: 1:3000 
GE Healthcare, 
Buckinhamshire, UK 
HRP-conjugate anti-rat 
IgG rat IgGs Goat WB: 1:3000 
GE Healthcare, 
Buckinhamshire, UK 
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2.5. Additional Software 
 
ABI StepOnePlus Software V.2.0, Applied Biosystems, Darmstadt, Germany 
Clone Manager Professional 8, Scientific & Educational Software, USA 
Lucia G & G/F V.4.82, Laboratory Imaging s.r.o., Czech Republic 
Photoshop, Adobe, USA 
Winglow, Berthold Technologies GmbH & Co. KG, Bad Wildbad, Germany 
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3. Results 
 
3.1. Characterisation of undifferentiated, differentiating and terminally 
differentiated human sebocytes by using SZ95 cell line as in vitro model 
 
We hypothesized that Ihh signalling plays a role in regulation of proliferation and/or 
differentiation in sebocytes. To test this, a flexible and comparable model system to the in 
vivo situation was required to investigate and compare different sebaceous differentiation 
states. As Ihh knockout mice early die during embryonic development [40], we tested if the 
human facial sebaceous gland cell line SZ95 would allow us to perform these analyses in 
vitro. As previously mentioned these cells share typical characteristics with the sebocytes in 
vivo and can be retained to an undifferentiated state when grown in low density. On the other 
hand, they can be easily induced to differentiate when cultivated to high confluency or 
treated with specific fatty acids (e.g. arachidonic acid and linoleic acid) [268, 318, 327].  
By taking advantage of these features, it was first necessary to identify and characterise all 
sebocyte populations in correlation with differentiation grade in initial experiments. For that 
reason, we first histologically analysed the differences in cytosolic lipid droplet accumulation 
as classical marker of sebaceous differentiation. Furthermore, we extended these analyses 
by determination of expression levels of well established (e.g. MC5R, AR, PPARγ) and 
potentially new (e.g. SCD1, PRDM1) molecular markers of sebocyte differentiation. Finally, 
we wanted to combine the obtained observation to establish a histological and molecular 
profile of human sebocytes according to their differentiation state. 
 
 
3.1.1. Lipid droplet production and cell size as indicators of sebocyte differentiation 
 
First, we addressed the question, whether lipid production correlates with maturation 
progress and/or increased cell size is required for human sebocyte differentiation in vitro like 
it has been suggested from in vivo observations [268]. Therefore, the differentiation states of 
unconfluent, confluent and arachidonic acid treated cell populations were investigated and 
compared with each other by cell shape analysis and by staining of intracellular lipid droplets 
under the light microscope. 
.  
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Figure 9: Characterisation of SZ95 cell differentiation on structural level. (A) Oil red o staining of 
intracellular lipid droplets in SZ95 cells under unconfluent (left) and confluent (middle), as well as, after 
arachidonic acid (right) treatment. White arrows mark differentiated cells with increased intracellular 
lipid droplet content. Gold arrows indicate terminally differentiated sebocytes with a large cell volume 
and an excess load of lipid droplets. (B) Quantification of sebocytes with or without visible lipid 
droplets by oil red o staining. (C) Classification of sebocytes according to their cell size. 
 
No lipid droplets were detected in unconfluent SZ95 cells attesting their undifferentiated state 
(Fig. 9 A, left and Fig. 9 B), although 36% of this population displayed a medium-size cell 
area ranging from 600 to 1200 µm2 (Fig. 9 C). In contrast to this, lipid droplets were found in 
46% of sebocytes growing to high confluency (Fig. 9 A, middle and Fig. 9 B), whereby the 
majority of these cells (79%) exhibited decreased cell areas ranging from 100-600 µm2, while 
only 18% of this population could be assigned to the group of 600-1200 µm2 (Fig. 9 C). 
Importantly, an additional group of large-sized sebocytes with a cell area exceeding 1200 
µm2 could be detected in confluent populations with a share of 4% of total cells. These cells 
particularly displayed strong accumulation of intracellular lipid droplets, thus representing 
sebocytes with an advanced differentiation status. Strikingly, 100% of all sebocytes treated 
with arachidonic acid (or linoleic acid, not shown) showed lipid droplet formation (Fig. 9 A, 
right and Fig. 9 B). Notably, 2% of this population exhibited a large size of about 1200 µm2, 
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whereas 32% of these cells were middle-sized (600-1200 µm2) and the rest even small-sized 
(100-600 µm2). 
As increased accumulation of lipid droplets did not correlate with increased cell size, lipid 
droplet production was handled as primary criterion for classification of mature sebocytes. A 
reason for the missing link between cell size and differentiation could be that sebocytes 
growing to high confluency do not have enough space to spread due to high population 
density in their environment. Also did fatty acid treated sebocytes not exhibit larger cell sizes 
although they were induced to differentiate. Hence, a large cell size is not a prerequisite for 
lipid production and differentiation. 
Based on these findings, we defined three populations which we used as representative 
sebaceous differentiation stages in the present study as follows: 
The first one comprised unconfluent cells representing the undifferentiated reference 
population. The second one consisted of confluent cultures including cells undergoing 
differentiation and more likely mimicking the heterogeneous in vivo situation of the 
sebaceous gland. Finally, SZ95 cells treated with arachidonic acid served as a differentiation 
control. 
For convenience, unconfluent populations are named “undifferentiated” (undiff.), while 
confluent populations “differentiating” (diff.) in the following data figures. Accordingly, 
SZ95 cells treated with arachidonic acid to induce terminal differentiation are termed as 
“terminally differentiated” (term. diff.). 
 
 
3.1.2. Correlation between expression of molecular markers and sebocyte 
differentiation state 
 
In order to establish a molecular readout of the three pre-defined differentiation states in 
human sebocytes, a range of established and potentially new markers from the literature or 
own work, respectively, have to be selected. Therefore, quantitative real-time PCR and 
immunofluorescence staining were performed to analyse and compare the expression 
pattern of these markers in undifferentiated, differentiating and terminally differentiated cells. 
Later on, these markers would be used to detect changes in differentiation behaviour after 
manipulation of human sebocytes. 
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Figure 10: Characterisation of SZ95 cell differentiation on molecular level. (A) Immunostaining 
for SCD-1, MC5R and PRDM1 in SZ95 cells. White arrows mark SCD-1 and MC5R positive cells, or 
individual large cells lacking BLIMP1 staining. (B) Determination of expression levels of indicated 
markers in undifferentiated, differentiating and terminally differentiated cultures by quantitative real-
time PCR. Results are presented as mean values ± SD of triplicates from an experiment that was 
repeated at least three times 
 
MC5R has been previously identified in human and rodent sebaceous glands and proposed 
to be essential for differentiation (see chapter 1.7.3.). Böhm and colleagues could not detect 
MC5R transcripts in SZ95 cells by in situ hybridisation [337]. In accordance with Böhm’s 
findings, we could confirm the lack of MC5R mRNA and protein in undifferentiated cells by 
quantitative real-time PCR and immunostaining, respectively, where no or very weak 
expression was found (Fig. 10 A+B, second row). Interestingly, in accordance with 
observation by Zhang and colleagues, MC5R transcript and protein levels were increased in 
differentiating SZ95 cells by 3.5-fold (Fig. 10 A+B, second row). Moreover, terminally 
differentiated SZ95 cells displayed an up-regulation of MC5R transcript levels by even 11-
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fold suggesting MC5R to be expressed only at late differentiation state in human sebocytes 
(Fig. 10 B, second graph). 
As mentioned before (see chapter 1.7.1.), Blimp1 was identified as marker for sebocyte 
differentiation. Consistent with these observations, expression of PRDM1 was significantly 
increased by 18-fold in differentiating SZ95 populations, but not in cells induced to terminally 
differentiate when compared to undifferentiated sebocytes (Fig. 10 B, lower graph). 
Interestingly, immunostaining also confirmed increased protein levels in differentiating 
sebocytes in comparison with undifferentiated SZ95 cells (Fig. 10 A, lower pictures). But 
prominent large-sized cells found in differentiating cultures completely lacked PRDM1 protein 
staining suggesting that these cells were mature sebocytes, and that PRDM1 is only 
expressed in the early phase of the differentiation process (Fig. 10 A, lower pictures). 
Next, we analysed the curse of expression levels of SCD1 (see chapter 1.7.3.) in SZ95 cells. 
In differentiating SZ95 cells, SCD1 expression was found up-regulated 3.5-fold compared to 
undifferentiated cells (Fig. 10 B, upper graph). However, after arachidonic acid treatment, its 
expression was similar to the level of undifferentiated cells, probably due to end-product 
repression [309] (Fig. 10 B, upper graph). Additional immunostaining for SCD1 protein 
revealed an analogical increase in protein levels ranging from undifferentiated to 
differentiating stage (Fig. 10 A, upper pictures). Thus, SCD1 expression occurs at early stage 
of differentiation in highly confluent SZ95 populations, but vanishes in terminally 
differentiated cells, at least by repression through arachidonic acid. 
We also selected K15 as potential marker for sebocyte progenitors (see chapter 1.7.1.). In 
order to assess its expression profile in human sebocytes, quantitative real-time PCR 
analyses were performed to determine its expression in undifferentiated, differentiating and 
terminally differentiated SZ95 cells. 
Surprisingly, K15 transcript levels were increased by 5.4-fold in differentiating SZ95 
populations, whereas expression in undifferentiated and terminally differentiated cultures did 
not differ significantly (Fig. 11). 
Adipophilin (ADFP), or adipose differentiation-related protein (formerly ADRP), has been 
initially described as a protein of lipid droplets (LDs) and marker of lipid accumulation in 
adipocytes [338]. So far, this protein is required for correct lipid transport, LD formation and 
turnover in the cell [339-341]. Because adipocytes share several features with sebocytes, 
this protein was taken in consideration as differentiation marker for the SZ95 cells. 
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Figure 11: Expression pattern of differentiation markers in SZ95 cells. Expression of the 
progenitor marker Keratin 15 and differentiation markers Adipophilin, Androgen receptor and PPARy 
were determined by quantitative real-time PCR in undifferentiated, differentiating and terminally 
differentiated cultures. Results are presented as mean values ± SD of triplicates from an experiment 
that was repeated at least three times. 
 
In fact, expression of ADFP correlated positively with number of lipid droplets seen in mature 
sebocytes. More precisely, ADFP expression was up-regulated by 8.3-fold in differentiating 
SZ95 populations compared to undifferentiated cells (Fig. 11). Furthermore, ADFP transcript 
levels were even increased by 24-fold in terminally differentiated SZ95 cells. Thus, 
analogous to oil red o staining (Fig. 9), strong ADFP expression reflected the enhanced 
differentiation status of differentiating and terminally differentiated SZ95 cells on molecular 
level. 
Additionally, we analysed AR expression as regulator of sebocyte proliferation and lipid 
production (see chapter 1.7.3.) at different stages of sebaceous differentiation. In 
differentiating SZ95 cells, AR expression was increased by 3.8-fold compared to 
undifferentiated cells, and thus confirmed increased differentiation in this population (Fig. 11). 
Interestingly, no increase of AR transcript levels could be detected in terminally differentiated 
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SZ95 suggesting that AR is not required for terminal differentiation after induction by 
arachidonic acid which could be a down-stream event of AR activity (Fig. 11). 
As previously described (see chapter 1.7.3), PPARγ has been shown to be required for the 
differentiation process in rodent sebocytes [297-298]. 
Assuming that this could also be applied for the human system, the expression of PPARy 
was examined in the three different populations of SZ95 cells. Interestingly, PPARγ 
expression did not differ significantly in undifferentiated, differentiating and terminally 
differentiated sebocytes (Fig. 11). It was found to be up-regulated by only 1.5-fold in 
confluent cultures. Thus, determination of PPARγ expression was not conclusive for the 
characterisation of the three differentiation populations of SZ95 cells. 
To sum up, increased expression of the sebaceous progenitor markers PRDM1 and Keratin 
15 in addition to that of differentiation markers was observed in differentiating SZ95 cultures, 
suggesting a heterogeneous character for this population. In contrast to this, the predominant 
increase in expression of the terminal differentiation marker MC5R and the lipid droplet factor 
ADFP was found in terminally differentiated cells and approved their terminally differentiated 
state. As expected, none of the presented sebaceous differentiation markers was up-
regulated in undifferentiated sebocytes. 
Taking advantage of these findings, a characteristic marker expression profile for each of the 
three specified SZ95 populations could be created (Fig. 12). Therefore, all collected SZ95 
cell samples of this study could be precisely assigned to one of the three differentiation 
states depending on their matching of molecular marker expression patterns determined by 
quantitative real-time PCR in addition to staining of lipid droplets.  
 
 
Figure 12: Schematic overview of expression patterns of molecular differentiation markers in 
SZ95 cells. Undifferentiated sebocytes served as reference and show lowest expression levels of all 
analyzed markers. Strongly up-regulated and differentiation-state specific markers in comparison to 
the other populations are highlighted by bold print. 
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3.2. Investigating the Hedgehog pathway in the human sebocyte cell line 
SZ95 
 
First of all, it was essential to analyse the expression levels of Hedgehog pathway 
components and Hedgehog signalling activity at the different differentiation states of human 
sebocytes. This is prerequisite to identify key players of the Hedgehog pathway in human 
sebocytes and to get an indication of the underlying signalling mechanism with respect to 
regulation of proliferation and/or differentiation in these cells. 
 
 
3.2.1. Hedgehog signalling components are up-regulated in differentiating SZ95 cells 
 
To determine the endogenous expression levels and potential regulation of the hedgehog 
pathway components in the differentiation process, mRNA from SZ95 cells of each 
differentiation state was isolated, transcribed into cDNA, and analysed by quantitative real-
time PCR. Undifferentiated cells served as reference sample and were used for comparison 
with the other differentiation stages. Quantitative real-time PCR was the method of choice to 
achieve the highest rate of target specificity and to directly quantify gene expression. 
 
 
Figure 13: Expression of components of the Hedgehog pathway in SZ95 cells at different 
differentiation stages. (A) Transcript levels of the key components of the hedgehog pathway, 
including Indian hedgehog (IHH), Patched 1 (PTC1), Smoothened (SMO), GLI2 and GLI3, were 
determined by quantitative real-time PCR. Results are presented as mean values ± SD of triplicates 
from an experiment that was repeated at least three times. (B) Endpoint PCR was applied to monitor 
expression of GLI1 (total PCR cycle #: 40) in sebocytes by subsequent determination of band 
intensities with ImageJ software. Note: GLI1 transcript levels were generally too low for detection by 
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quantitative real-time PCR in the reference sample resulting in bad signal-to-noise ratio. For that 
reason we had to apply endpoint PCR for GLI1 expression analysis. 
 
Strikingly, all three sebocyte populations were found positive for expression of the ligand 
IHH, its receptor PTC1, SMO, and the downstream transcription factors GLI1, GLI2 and GLI3 
(Fig. 13). 
Interestingly, compared to undifferentiated cells, IHH was highly up-regulated by 7- and 9-
fold in differentiating and terminally differentiated SZ95 cells, respectively (Fig. 13 A and 14, 
first row). This finding suggests that IHH expression is coupled to differentiation process or, 
alternatively, represents a direct target by lipid metabolism which has not been documented 
before. Additionally, increased expression of the Hedgehog ligand would indicate pathway 
activation in these populations. 
On the other hand, expression of the receptor PTC1 was up-regulated 3-fold in differentiating 
cells, and 14-fold in terminally differentiated sebocytes (Fig. 13 A). PTC1 is a target gene of 
the hedgehog pathway, thus its expression could be partially induced by pathway activation 
due to increased levels of IHH in differentiated populations as stated before. The strong 
induction in terminally differentiated cells suggests an additional or alternative regulatory 
mechanism by the lipid metabolism, too. 
Transcript levels of co-receptor SMO were also increased during differentiation. But in 
contrast to PTC1, SMO was more up-regulated, almost by 12-fold, in differentiating cultures 
and only by 3-fold in terminally differentiated cells compared to undifferentiated sebocytes 
(Fig. 13 A). 
Additionally, mRNA levels of the major downstream transcriptional activators GLI1 and GLI2 
were only found increased in differentiating populations by 2- and 3-fold, respectively, 
suggesting a role in pathway activation in these cells. On the contrary, GLI1 transcript levels 
even reflected a reduction in expression to 0.4-fold after treatment with arachidonic acid (Fig. 
13 B), whereas GLI2 expression did not differ significantly compared with those levels seen 
in undifferentiated sebocytes (Fig. 13 A). Notably, the transcription factor GLI1 is also a direct 
target gene of the Hedgehog pathway, and represents a meaningful readout for Hedgehog 
signalling activity. Thereby, GLI1 reinforces activation of the Hedgehog pathway by a positive 
feedback loop. 
Thus, these findings support the idea that differentiating SZ95 cells are the major state of 
Hedgehog signalling activity. 
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Figure 14: Expression analysis of Hedgehog pathway components by endpoint PCR which 
were not detectable in undifferentiated SZ95 cells. IHH expression levels were identical to those 
seen by quantitative real-time PCR (compare with Fig. 13), and thus confirmed correct amplification 
reaction in all samples. GAPDH served as loading control and cDNA from human fetal thymus (HFT) 
as positive control. SHH, Sonic Hedgehog; DHH, Desert Hedgehog; HHIP, Hedgehog interacting 
protein; PTC2, Patched 2.  
 
Noticeably, both ligands, Sonic Hedgehog (SHH) and Desert Hedgehog (DHH), as well as 
the receptors Patched 2 (PTC2) and Hedgehog interacting protein (HHIP) could not be 
detected in undifferentiated SZ95 cells. Thus, we were not able to compare the expression 
levels of these genes in the different sebocyte populations. Therefore, cDNA from human 
fetal thymus cell was employed as positive control template, to validate our primers. 
Furthermore, expression of these genes was analysed in samples of differentiating and 
terminally differentiated SZ95 cultures by endpoint PCR analysis (Fig. 14). Analysis of IHH 
expression served as control for reproducibility of the obtained results by qRT-PCR 
technique (Fig. 13 A). 
Strikingly, DHH transcripts could not be detected in any of the three differently differentiated 
SZ95 populations (Fig. 14), thus ruling out a role of this ligand in the regulation of 
proliferation and differentiation in human sebocytes under physiological conditions. 
Conversely, weak expression of SHH could be only detected in sebocytes induced to 
terminally differentiate by arachidonic acid treatment (Fig. 14). 
In addition, strong expression of HHIP and PTC2 were found in cells induced to terminally 
differentiate (Fig. 14). So, not only the production of Hedgehog ligands seems to be 
increased in these cells, but also the expression of factors known to inhibit the pathway. 
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The data suggest an important role for the lipid metabolism in regulating the expression of 
Hedgehog components as demonstrated by the effects of arachidonic acid treatment in 
terminally differentiated cultures. 
 
 
Figure 15: Schematic overview of expression patterns of Hedgehog pathway components in 
SZ95 cells. Undifferentiated sebocytes served as reference and show lowest expression levels of all 
analyzed components of the Hedgehog pathway. Strongly up-regulated components are highlighted. 
 
Due to a lack of specific antibodies we were not allowed to study protein production of 
endogenous Hedgehog ligands and all three Gli transcription factors in the human (and also 
rodent) system at the time of this work. These proteins share high sequence homology which 
could not be distinguished by a range of commercial antibodies we tested. Hence, it was not 
possible for us to analyse these regulation processes on protein level in more detail. 
 
 
3.2.2. Hedgehog signalling activity is increased in differentiating SZ95 cells 
 
The findings suggested that Hedgehog pathway activation occurs during the differentiation 
process of sebocytes. To determine the activity of Hedgehog signalling, SZ95 cells were 
transfected with the Gli-specific luciferase reporter 8 x 3'Gli-BS Luc and the control plasmid 8 
x m3'Gli-BS Luc at different differentiation stages. Additionally, pRLTK was introduced into 
the cells for transfection efficiency control. Importantly, 8 x 3'Gli-BS Luc is stimulated by all 
three Gli transcription factors, thus monitoring the combined effect of these factors in the 
different populations. 
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Figure 16: Hedgehog pathway activity in SZ95. Pathway activity was determined by Gli luciferase 
reporter assay in unconfluent cultures and those with increasing confluency (after 1 day and 3 days), 
as well as after treatment with fatty acids (arachidonic acid, linoleic acid and solvent control with 
EtOH). GLI1-transfected cells served as positive control. Results are presented as mean values ± SD 
of triplicates from an experiment that was repeated at least three times. 
 
The activation levels of the functional Gli luciferase reporter 8 x 3'Gli-BS Luc were compared 
with those of 8 x m3'Gli-BS Luc. Interestingly, the hedgehog signalling activity increased with 
the differentiation progress in SZ95 cells (Fig. 16). While undifferentiated cells only showed 
an 1.5-fold activation, the differentiating cultures showed an activation by 2.7- and 3.8-fold 
after one day and three days confluent growth, respectively. The activity of the latter 
condition was even comparable to the 4-fold activation in cells transfected with the human 
full-length GLI1 expression construct serving as positive control. In contrast to this, terminally 
differentiated sebocytes exhibited no significant activation of the Hedgehog pathway. 
These results confirm a model, where terminally differentiated cells are not susceptible for 
Hedgehog pathway activation, but, as observed in undifferentiated and differentiating 
populations, may play a role in transmitting the signal to their environment and in activating 
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the pathway in undifferentiated and/or lesser differentiated sebocytes by paracrine secretion. 
Thereby, the increased expression of pathway inhibitors seen in terminally differentiated cells 
may provide a negative feedback mechanism to prevent pathway activation in this cell type. 
 
 
3.3. Effects of overexpressed human GLI constructs on proliferation and 
differentiation in SZ95 cells 
 
To investigate the function of the transcription factors GLI1, GLI2 amd GLI3 in proliferation 
and differentiation of human sebocytes in more detail, GLI overexpression experiments were 
performed. Therefore, SZ95 cells were transfected with human HA-tagged GLI1, human 
Myc-tagged GLI2 or human GLI3-GFP-fusion expression constructs. 
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Figure 17: Transfection and detection of Gli expression constructs in SZ95 cells. (A) Schematic 
diagram of the three human GLI expression constructs. (B) Human Gli1 and (C) human Gli2 
expression constructs were detected by immunofluorescence staining for associated tags HA- and 
Myc-tag, respectively. (D) GLI3 expression was monitored by attached GFP fusion protein. Detection 
of (E) Gli1-HA and (F) Gli2-MYC by immunoblot. α-Tubulin served as loading control. ZFD: zinc-finger 
domain. 
 
Positive immunostaining for HA-tag of GLI1 and the MYC-tag of GLI2 expression constructs 
(Fig. 17 A + B) as well as detection of the GLI3 fusion protein (Fig. 17 A) confirmed their 
correct expression in SZ95 cells. Expression was also studied by Western blotting. Thereby, 
GLI2-MYC expression displayed multiple protein bands suggesting that different isoforms are 
produced and/or the protein is partly degraded in sebocytes besides the expected full-length 
protein of about 190 kda. In contrast, HA-tagged GLI1 protein displayed the expected single 
band of full-length protein at approx. 160 kDa. Unfortunately, antibodies directed against 
GFP for detection of GLI3 expression construct resulted in strong background signals 
preventing a clear blotting signal. 
 
 
3.3.1. GLI1 and GLI2 expression induce Hedgehog pathway activation in human 
sebocytes 
 
Next, the GLI transcription factors were analysed for their ability to stimulate the Hedgehog 
pathway in human sebocytes. Therefore, undifferentiated SZ95 cells were co-transfected 
with human GLI1, GLI2 and GLI3 expression constructs and the Gli luciferase reporters as 
well as pRLTK. First, SW480 was used as control cell line, because these cells were easily 
transfectable and shown to have an inactive Hedgehog pathway background similar to 
undifferentiated SZ95 cells [342]. 
GLI1 expression led to the strongest activation of the reporter construct by 29- and by 8-fold 
in SW480 (Fig. 18 A) and SZ95 cells (Fig. 18 B), respectively. Compared to this, GLI2 only 
increased reporter activity by 13- and 3-fold in both cell lines (Fig. 18 A & B), respectively. 
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Figure 18: Gli luciferase reporter assay of the three GLI expression constructs in (A) SW480 
control and (B) SZ95 cells. GLI1 showed the strongest activator capacity, followed by GLI2. GLI3 
displayed strong inhibitory effects, as illustrated by combined transfection with GLI1 or GLI2. Results 
are presented as mean values ± SD of triplicates from an experiment that was repeated at least three 
times. 
 
GLI3 overexpression alone displayed no activation at all by reaching only 0.8-fold activation 
of the Gli reporter construct. Instead, its presence repressed the reporter activity dramatically 
in SW480 cells to 5.9-fold and 3.5-fold when co-transfected with GLI1 or GLI2 (Fig. 18 A), 
respectively, thus demonstrating its inhibitory effect on the Hedgehog pathway. Interestingly, 
reporter activity was significantly decreased to 2.6-fold when GLI3 was co-expressed with 
GLI1 in human sebocytes compared to GLI1 alone (8-fold). But combined expression of GLI3 
and GLI2 (2.5-fold) only resulted in a minor reduction compared to the pathway activation 
capacity of GLI2 alone (3-fold) (Fig. 18 B). 
Furthermore, co-expression of GLI2 with GLI1 (3.2-fold) decreased the signal output of GLI1 
alone (8-fold) to almost the same extent in SZ95 cells. 
One possible explanation may be that the specific setup of pathway activating molecules, 
which prevent the degradation and support the maintenance of GLI full-length activators, 
limits pathway activation capacity in undifferentiated sebocytes. Thereby, remaining full-
length GLI molecules are constantly processed to GLI repressors or proteasomally 
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degraded. Hence, GLI2 molecules may also be partially processed to the repressor form and 
not only act as activators. As consequence, GLI2 repressor variants could compete with the 
strong activator GLI1 like GLI3. On the other hand, GLI2 activator variants could interfere 
with the repressor GLI3 by binding to the same reporter constructs. 
  
 
3.3.2. GLI1 and GLI2 differentially induce expression of key Hedgehog pathway 
components in human sebocytes 
 
To further dissect the specific function of the different GLI transcription factors in human 
sebocytes, the expression levels of key Hedgehog pathway components and target genes 
were analysed in GLI overexpressing cells. Therefore, mRNA of transfected SZ95 cells at a 
subconfluent stage was isolated and used for quantitative real-time PCR.  
 
Figure 19: Expression analysis of Hedgehog pathway components after overexpressing the 
transcription factors GLI1, GLI2 or GLI3 as determined by qRT-PCR. Due to common human 
origin it was not possible to distinguish between endogenous GLI and GLI construct expression. 
Therefore, the corresponding values were represented as asterisks. Results are presented as mean 
values ± SD of triplicates from an experiment that was repeated at least three times. 
 
Additionally, expression of the receptors and target genes PTC1, PTC2 and HHIP were 
significantly up-regulated by 19-, 9.4- and by 8.5-fold, respectively (Fig. 19, green bars) 
compared to its expression level in mock transfected cells (Fig. 19, blue bars). Furthermore, 
GLI1 induced a slight increase of co-receptor SMO expression level by 1.9-fold. These 
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findings imply that GLI1 expression results in both, a major recruitment of the negative 
pathway regulators PTC1, PTC2 and HHIP as well as in increased expression of the 
pathway activator SMO. Thereby, the cell could be desensitized or sensitized to Hedgehog 
signals depending on cellular PTC to SMO ratio. 
Similarly, GLI2 overexpression resulted in a significant up-regulation of both target genes 
PTC1 and GLI1 by 5.7- and 4.4-fold, respectively (Fig. 19, purple bars). However, to our 
surprise GLI2 significantly increased expression of the transcriptional repressor GLI3 by even 
13.5-fold. The regulation of GLI3 expression by GLI2 has not been documented before. 
Moreover, GLI2 induced expression of the ligand IHH by 8.5-fold, the main pathway inductor 
in human sebocytes. Thus, on the one hand, GLI2 induces the repression of Hedgehog 
target genes by up-regulating GLI3 expression. On the other hand, GLI2 represents an 
important Hedgehog pathway activator by increasing IHH ligand production in human 
sebocytes. 
In contrast, overexpression of GLI3 did not lead to an increase in any component of the 
Hedgehog pathway which would fit to its role as transcriptional repressor (Fig. 19, red bars). 
Instead, expression levels were comparable to those detected in the mock-transfected 
control cells (Fig. 19, blue bars) with exception of HHIP. HHIP expression was decreased to 
0.4-fold of the control level upon GLI3 overexpression. Hence, GLI3 has no or only 
repressive effect on the transcription of Hedgehog components. 
In conclusion, the three GLI transcription factors showed differential effects on expression 
levels of Hedgehog components (Fig. 20). Interestingly, GLI3 and IHH have not been 
described as Hedgehog pathway target genes before. The question arises whether they are 
regulated directly by the GLI transcription factors or indirectly be secondary effects. Promoter 
studies of these genes will be necessary to answer this question. 
 
 
Figure 20: Schematic overview of up-regulated Hedgehog components upon GLI1, GLI2 and 
GLI3 overexpression in SZ95 cells as determined by quantitative real-time PCR. Strongly up-
regulated components are highlighted by bold print. 
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3.3.3. GLI1 and GLI2 expression promotes sebocyte proliferation 
 
To investigate the function of the individual GLI transcription factors in human sebocytes, we 
first analyse the impact of GLI1, GLI2 and GLI3 overexpression on cell proliferation. 
Therefore, undifferentiated SZ95 cells were transfected either with mock, GLI1, GLI2 or GLI3 
expression constructs and used for BrdU incorporation assay. 
 
 
Figure 21: Proliferation assay in SZ95 cells transfected with either GLI1, GLI2 or GLI3 
expression constructs. Mock transfected cells served as reference population. BrdU positive cells 
(BrdU+) are indicated as percentage of the total population. Results are presented as mean values ± 
SD of triplicates from an experiment that was repeated at least three times. 
 
Strikingly, GLI2 overexpression led to an increase in the proliferation rate by 46.2% (+12% 
BrdU+ cells) in SZ95 cells in comparison to mock transfected cells as indicated by BrdU 
incorporation (Fig. 21). Similarly, GLI1-transfected sebocytes displayed an increase of 23.1% 
(+6% BrdU+ cells) of proliferative cells (Fig. 21). On the contrary, overexpression of GLI3 
showed no effect on the proliferation behaviour of SZ95 cells (Fig. 21). 
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These results suggest that GLI1 and, in particular, GLI2 are both mediators of sebocyte 
proliferation, whereas GLI3 is not. 
 
 
 
Figure 22: Localisation of BrdU incorporation and GLI expression constructs in SZ95 cells. 
Cells were stained by using antibodies directed against BrdU in combination with either HA (GLI1) or 
Myc (GLI2). Accordingly, GLI3 expression was detected by the associated GFP-fusion protein. Mock 
transfected cells served as negative control. Sebocytes treated with the secondary antibody alone 
(sec. ctrl) served as control of the specificity of primary antibodies. White arrows mark double stained 
cells. 
 
Next, we investigated whether GLI expression has a cell-autonomous effect on proliferation 
or not. Therefore, double staining of transfected SZ95 cells for BrdU and either for GLI1 or 
GLI2 expression constructs was performed and analysed for co-localisation. Accordingly, 
staining of BrdU incorporation and expression of GLI3 by the associated GFP fusion protein 
were analysed in the same manner. 
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Thereby, GLI1 expression was found in proliferating cells, as depicted by co-localisation with 
BrdU (Fig. 22, first row, white arrows), suggesting that GLI1 is promoting proliferation in 
sebocytes. 
Strikingly, GLI2 expression did not co-localise with BrdU incorporation (Fig. 22, second row). 
This raises the question, whether GLI2 increases proliferation rate in sebocytes by a 
paracrine mechanism, for example by induction of the Indian Hedgehog ligand. 
As expected, expression of GLI3 did not co-localise with BrdU positive cells (Fig. 22, lower 
row). This is in line with the previous finding that GLI3 had no effect on sebocyte proliferation 
rate (Fig. 21). 
 
 
3.3.4. GLI2 and GLI3 expression up-regulate the keratinocyte proliferation and 
sebaceous duct fate marker Keratin 6 and terminal sebocyte differentiation 
marker MC5R in SZ95 cells 
 
To address the question whether GLI transcription factors also regulate differentiation in 
human sebocytes, undifferentiated SZ95 cells were transfected either with GLI1, GLI2 or 
GLI3 expression constructs and analysed for expression of differentiation marker molecules. 
Therefore, mRNA was isolated and used in quantitative real-time PCR to determine the 
transcription levels of the selected molecular markers including those initially presented in 
chapter 3.1.2. which are MC5R, PRDM1, SCD1, K15, ADFP, AR and PPARγ. Furthermore, 
we chose Keratin 6 a (KRT6a) which has been characterised as bulge marker [343] and is 
found in hyperproliferative keratinocytes [344].  Interestingly, KRT6a has also been described 
to be marker of duct fate in sebaceous glands and to be regulated by GLI2 [253]. 
Strikingly, GLI3 led to a 5.7-fold increase in transcript levels of the terminal differentiation 
marker MC5R (Fig. 23, red bars). This result suggests that MC5R is up-regulated by the 
inhibition of a target gene and/or pathway by GLI3 repressors. Moreover, assuming that 
increased MC5R expression reflects increased differentiation level of sebocytes as 
previously observed (Fig. 10), GLI3 displays characteristics of a sebaceous differentiation 
inducing factor. 
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Figure 23: Determination of expression levels of molecular differentiation markers in GLI1-, 
GLI2-, GLI3- and mock transfected SZ95 cells by qRT-PCR. Results are presented as mean values 
± SD of triplicates from an experiment that was repeated at least three times. 
 
In this context, GLI2 was also found to up-regulate MC5R expression by 2.1-fold (Fig. 23, 
purple bars). Thus, GLI2 represents also a potential regulator of MC5R expression and/or 
sebocyte differentiation. The question arises whether this regulation process occurs directly 
by GLI2 or indirectly by induction of GLI3 expression as seen in a previous experiment after 
overexpression of GLI2 in SZ95 cells (Fig. 19, purple bars). 
Similarly, GLI3 and GLI2 increased transcript levels of the sebaceous gland duct marker 
KRT6a by 2.5- and 1.7-fold, respectively (Fig. 23 red and purple bars). 
GLI1 expression resulted only in a modest increase of the early differentiation marker SCD1 
by 1.9-fold in SZ95 cells (Fig. 23, green bars). This finding proposes that GLI1 plays a role in 
the early period of the maturation process of human sebocytes by inducing early lipogenic 
pathways. 
For the rest, transcription of PRDM1, K15, ADFP, AR and PPARγ was not regulated by GLI1, 
GLI2 or GLI3 expression (Fig. 23). 
Thus, a model emerges, where Hedgehog pathway activation stimulates sebocyte 
proliferation, whereas pathway inhibition promotes sebocyte differentiation (Fig. 24). On the 
other hand, ADFP expression and lipid droplet formation were not increased upon GLI 
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overexpression. This indicates that Hedgehog pathway function may be downstream of the 
lipid metabolism. 
 
 
Figure 24: Schematic summary of GLI transcription factor effects in SZ95 cells. Strongly up-
regulated components and processes are highlighted by bold print. 
 
 
3.4. Knockdown of GLI transcription factors in SZ95 cells 
 
As GLI2 and GLI3 were shown to be predominantly expressed compared to GLI1 in the 
SZ95 cells (Fig. 13), we were interested to investigate the effects of knocking down these 
two transcription factors in human seboyctes. Therefore, SZ95 cells were either transfected 
with siRNA oligos or lentivirally infected with shRNA transducing particles directed against 
human GLI2 and human GLI3 mRNA. Thereby, cells were taken at differentiating stage, 
because increased expression levels of GLI2 and GLI3 were found under this condition (Fig. 
13). 
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3.4.1. Knockdown of GLI2 and GLI3 by siRNA oligos in SZ95 cells 
 
In a first set of experiments, specificity and efficiency of a range of commercially available 
siRNA oligos with different target sequences directed against human GLI2 and human GLI3 
were tested in the control cell line SW480. These cells were shown to express these 
transcription factors endogenously [342]. The aim of these initial studies was to select for the 
siRNA oligos with the best target specificity and knockdown effect for the subsequent 
experiments in human sebocytes. 
 
 
Figure 25: GLI2 and GLI3 knockdown assay by siRNA oligos in SW480 control cell line. qRT-
PCR analysis of GLI2 (A) and GLI3 (B) knockdown after transfection of selected siRNA oligos into 
SW480 cells. (C) MAPK1 siRNA oligos were provided as validated positive control by the 
manufacturer. SW480 cells treated with non target siRNA oligos served as reference. Results are 
presented as mean values ± SD of triplicates from an experiment that was repeated at least three 
times. 
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To demonstrate that the siRNA knockdown assay works in our hands, we transfected SW480 
cells with control siRNA oligo directed against human MAPK1. Importantly, this siRNA oligo 
had been shown to efficiently block expression of MAPK1. As expected treatment with anti-
MAPK1 siRNA oligo significantly decreased MAPK1 transcript levels, thereby achieving 66% 
repression. SW480 cells transfected with siRNA directed against human GLI2 showed a 
significant decrease in GLI2 expression of 71% and 72% by employing two distinct target 
sequences, respectively (Fig. 25, A, oligo 7 and oligo 8). As expected, the combined 
treatment with both oligos enhanced the knockdown effect, and GLI2 expression was down-
regulated by 83% in comparison to the non-target siRNA control. SiRNA oligos targeting 
human GLI3 (Qiagen, Hilden) decreased the GLI3 transcript levels by 36% and by 74%, 
respectively (oligo 2 and oligo 3) (Fig. 25, B). These results also demonstrated that siRNA 
oligo 2 was less efficient than siRNA oligo 3. The combined treatment of SW480 cells by 
these oligos did not lead to an enhanced knockdown effect. 
To further check the specificity of the target sequences, expression levels of GLI2 and GLI3 
were analyzed in parallel in all assays. Thereby, no unspecific inhibitory effect could be found 
(Fig. 25, A-C). All in all, the siRNA oligos were specific for their target sequences, and 
therefore were used to inhibit GLI2 and GLI3 expression in human sebocytes.  
 
Figure 26: GLI2 and GLI3 knockdown assay by siRNA oligos in SZ95 cells. qRT-PCR analysis of 
GLI2 and GLI3 knockdown after transfection of selected siRNA oligos by lipofection into SZ95 cells. 
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MAPK1 siRNA oligos were provided as validated positive control by the manufacturer. Sebocytes 
treated with non target siRNA oligos served as reference. Results are presented as mean values ± SD 
of triplicates from an experiment that was repeated at least three times. 
 
 
Neither siRNA oligos directed against GLI2 and GLI3 nor the validated MAPK1 siRNA 
showed any significant knockdown effect in SZ95 cells (Fig. 26, A and B). Different 
transfection protocols (lipofection vs. nucleofection) and various transfection conditions were 
applied without successful knockdown of the target genes. Reasons for these observations 
may be that sebocytes are generally difficult to transfect because of their high lipid content, 
and/or this cell line is not as much responsive to siRNA as compared to other cell types. 
 
 
3.4.2. Knockdown of GLI2 and GLI3 by shRNA transducing lentiviral particles in SZ95 
cells 
 
Next we used a different method to knockdown endogenous GLI2 and GLI3 expression by 
lentiviral particles (Sigma-Aldrich, Hamburg) which transduce shRNA expression against 
these transcription factors in human sebocytes. Lentiviral shRNA have the advantage to 
attain efficient transfection rates and to generate stable knockdown cell lines for long-term 
gene silencing studies. 
First, GFPTurbo transducing particles with a range of MOI (multiplicity of infection) from 0.5 
to 5.0 were applied to infect SZ95 cells and to test the transduction efficiency. 48 hours later, 
cells were incubated in selection medium with addition of puromycin for up to 10 days. 
During this time frame, stably infected clones were selected showing increasing expression 
of the GFPTurbo control construct. In particular, a MOI of 5.0 turned out to be the best 
concentration for infecting SZ95 cells with an efficiency of about 80% as observed 10 days 
after infection (Fig. 27). Therefore, a MOI of 5.0 was used for GLI2 and GLI3 shRNA 
transducing particles in following experiments. 
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        GFPTurbo        light              overlay 
 
Figure 27: Optimisation of infection rate in SZ95 cells by using GFPTurbo transducing lentiviral 
particles. MOI of 0.5, 1.0, 2.0 and 5.0 were compared for infection efficiencies. 48 hours after 
infection cells were treated with puromycin to select infected cells during 10 days. 
 
To knockdown GLI2 expression in human sebocytes we purchased and tested five different 
sets of shRNA transducing particles each directed against a distinct target sequence of 
human GLI2 (Fig. 28, target 1-5). SZ95 cells were infected according to the previously 
optimised protocol with a MOI of 5.0, and selected in puromycin for 48 hours. Afterwards, 
cells were splitted and cultured as individual subpopulations (Fig. 28, clone A-E).  After three 
weeks of selection, GLI2 transcript levels were determined in remaining vital cultures by 
quantitative realtime PCR. 
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Figure 28: Knockdown of GLI2 by shRNA by lentiviral infection technique in SZ95 cells. qRT-
PCR analysis of GLI2 transcripts after infection of SZ95 cells using different GLI2 shRNA transducing 
lentiviral particles. Different GLI2 shRNA expressing clones were selected by puromycin treatment and 
checked for GLI2 expression after 48 hours and after 3 weeks. SZ95 clones infected with non target 
shRNA particles served as reference. Results are presented as mean values ± SD of triplicates from 
an experiment that was repeated at least three times. 
 
None of the selected GLI2 shRNA clones of any of the five employed target sequences 
showed a significant knockdown of GLI2 transcripts in SZ95 cells after 48 hours and 3 weeks 
of puromycin treatment (Fig. 28). 
Furthermore, SZ95 cells were infected with a set of four different shRNA transducing 
lentiviral particles each including a specific target sequence of human GLI3. The same 
procedure was applied as for infection with particles containing GFPTurbo or anti-GLI2 
shRNA. 
3. Results 
 
87 
 
 
Figure 29: Knockdown of GLI3 by shRNA by lentiviral infection technique in SZ95 cells. qRT-
PCR analysis of GLI3 transcripts after infection of SZ95 cells by using different GLI3 shRNA 
transducing lentiviral particles. Different GLI3 shRNA expressing clones were selected by puromycin 
treatment and checked for GLI3 expression after 48 hours and after 3 weeks. SZ95 clones infected 
with non target shRNA particles served as reference. Results are presented as mean values ± SD of 
triplicates from an experiment that was repeated at least three times. 
 
GLI3 knockdown clones were more promising (Fig. 29). Among these, two target sequences, 
target 1 and target 4, were shown to down-regulate GLI3 expression in almost each selected 
clone by at least 50%. Therefore, only clones of these two target sequences were chosen for 
further studies. 
Combined treatment of target 1 and target 4 resulted in a decrease in GLI3 knockdown 
efficiency in SZ95 cells compared to single infection (Fig. 29). 
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Figure 30: Analyses of selected GLI3 knockdown clones. Comparison of GLI3 mRNA (A) and 
protein (B) levels after infection of SZ95 cells by using two different GLI3 shRNA transducing lentiviral 
particles. Clones were selected by puromycin treatment and checked for GLI3 expression after 3 
weeks. Results are presented as mean values ± SD of triplicates from an experiment that was 
repeated at least three times. 
 
To test whether knockdown of GLI3 mRNA (Fig. 29 & Fig. 30 A) was also reflected on protein 
level, we performed western blot analyses of the corresponding clones (Fig. 30 B). Following 
3 weeks after infection, target 1 and target 4 clones displayed an average reduction of GLI3 
transcript levels by 66% and by 57% as determined by qRT-PCR, respectively (Fig. 30 A). By 
applying an antibody specifically detecting GLI3, two bands of repressor variants could be 
detected with 70 and 89 kDa molecular weight (full-length protein: 190 kDa) (Fig. 30 B). 
Evaluation of protein bands of GLI3 repressor forms revealed that target 1 clone displayed 
30% decrease of GLI3 protein levels, whereas target 4 clone only 10% compared to the non 
target shRNA reference clones (Fig. 30 B). Thus, GLI3 protein levels were not significantly 
affected by shRNA knockdown. 
One explanation for these observations may be that the GLI3 transcription levels in the 
knockdown clones may be still sufficient to produce physiologically normal levels of this 
protein. On the other hand, GLI3 repressor variants may be efficiently stabilised in these 
cells. 
Taken together, the results obtained from these knockdown assays showed no significant 
knockdown of GLI protein levels in human sebocytes, and thus did not allow investigating the 
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consequences of specific inhibition of GLI2 and GLI3 in human sebocytes. Therefore, a 
different strategy has to be chosen for these analyses. 
. 
 
3.5. Application of specific GLI inhibitor GANT61 in SZ95 cells 
 
To investigate the consequences of inhibiting GLI transcription factors, SZ95 cells were 
treated with specific inhibitors. Recently, Matthias Lauth and colleagues had demonstrated 
that GANT61 selectively and efficiently inhibits GLI-mediated gene trans-activation 
downstream of Smoothened by interfering with the DNA binding domain of GLI molecules 
[345]. 
 
 
3.5.1. GANT61 decreases Hedgehog pathway activation by GLI1 and decreases 
proliferation rate in SZ95 cells 
 
First, the functionality of the GANT61 inhibitor (Calbiochem, Darmstadt) was tested in the Gli 
luciferase reporter cell line SHH light II. Therefore, cells were transfected with GLI1 
expression construct to induce pathway activation and treated with GANT61 at 
concentrations raging from 10 to 50 µM. 
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Figure 31: Treatment of SHH light II cells with GANT61 inhibitor. GANT61 efficiently inhibited 
GLI1-dependent reporter activation at a concentration of 30 µM and higher. Results are presented as 
mean values ± SD of triplicates from an experiment that was repeated at least three times. 
 
GANT61 treatment displayed a strong inhibitory effect at concentrations of 30 µM and 50 µM. 
Thereby GLI1-mediated reporter activation was decreased by 56% and by 92% in SHH light 
II cells, respectively (Fig. 31, left half). A concentration of 10 µM seemed not to be high 
enough for GANT61 to suppress the activation capacity of GLI1 as no inhibitory effect could 
be detected (Fig. 31, left half). Mock-transfected cells also showed a slight decrease of 
background Hedgehog pathway activity upon GANT61 treatment (Fig. 31, right half). 
To further study the effect of blocking the GLI transcription factors on proliferation behaviour 
in human sebocytes, SZ95 cells were treated with GANT61 at a concentration range of 10 to 
100 µM. Additionally, SZ95 cells were transfected with GLI1 to directly determine the 
influence of GANT61 on GLI-induced proliferation. 
For comparison, SZ95 cells were treated with different concentration of the Smoothenend 
inhibitor cyclopamine ranging from 5 to 50 µM. Cyclopamine has been previously shown to 
decrease the proliferation rate in human sebocytes and increasing their differentiation rate 
[43]. 
 
 
Figure 32: BrdU proliferation assay in GLI1 stimulated SZ95 cells after treatment with 
Smoothened inhibitor cyclopamine and GLI inhibitor GANT61. Blocking the pathway with both 
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cyclopamine or GANT61 decreased proliferation in the human sebocytes. Results are presented as 
mean values ± SD of triplicates from an experiment that was repeated at least three times. 
 
Strikingly, GANT61 treatment significantly decreased the number of BrdU-positive cells from 
34% in the solvent control to 9% with negative correlation of applied inhibitor concentrations 
in GLI1 overexpressing sebocytes (Fig. 32, right part). 
The decrease of proliferation rate was similar to that observed in cyclopamine treated SZ95 
cells. In this case, the number of BrdU-positive cells decreased significantly from 30% in the 
solvent control to 9% depending on cyclopamine concentrations (Fig. 32, left part; see also 
Niemann et al. 2003). 
In accordance with the findings of GLI overexpression experiments (Fig. 21), these results 
demonstrate that GLI transcription factor function is repressed to mediate proliferation 
stimulation by Hedgehog signalling. In addition, pathway inhibition of Smoothened by 
cyclopamine treatment modulates the GLI response. This was observed by suppression of 
sebocyte proliferation following cyclopamine treatment even when GLI1 was overexpressed 
in these cells (Fig. 32, left part). Thus, depending on the upstream activation state of the 
Hedgehog pathway, overexpression of GLI1 is not able to rescue the negative effect of 
upstream inhibition on proliferation. On the other hand, upstream inhibition by cyclopamine 
may result in constant degradation of GLI1 which is subsequently prohibited to activate target 
genes promoting proliferation in the SZ95 cells. 
 
 
3.5.2. Gli inhibitor GANT61 has no effect on lipid production 
 
Next, we wanted to analyse the impact of GLI inhibition, and thus, of GANT61 on the 
differentiation of human sebocytes. Cyclopamine has been previously shown to inhibit the 
proliferation and promote the differentiation in these cells [43]. The question arises whether 
inhibition of GLI function by GANT61 also promotes differentiation in human sebocytes in 
addition to its inhibitory effect on cell proliferation. Previously, we showed that lipid droplet 
production can be used as differentiation readout in human sebocytes (see chapter 3.1.1.). 
Therefore, SZ95 cells were grown on cover slips, treated with 50 µM GANT61 and fixed after 
48 hours. Then, cells were subjected to Nile red staining for detection of lipid droplets. 
Thereby, neutral lipids like cholesteryl esters of lipid droplets emit a green fluorescent signal 
[346], which can be used to monitor the differentiation state of sebocytes. 
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Figure 33: Structural analysis of SZ95 cells treated with 50 µM GANT61 or solvent control 
(EtOH). (A) Nile red staining of lipid droplets. (B) Classification of sebocytes according to their cell 
size. 
 
GANT61 treatment of SZ95 cells led to no increase of lipid droplet production compared to 
the control population (Fig. 33 A). This is in contrast to the positive effect of cyclopamine on 
lipid droplet formation observed in human sebocytes [43]. But the mean cell size was 
increased in GANT61-treated sebocytes. Thereby, most of the sebocytes were allocated to 
the group of 600-1200 µm2 sized cells instead of 100-600 µm2 as seen in the control 
population (Fig. 33 C). 
If GLI transcription factors play a major role in regulating lipid droplet formation, and hence, 
sebocyte differentiation, this process may depend on the function of GLI repressors by 
inhibiting potential target genes. For example, GLI3 was shown to induce the expression of 
sebaceous differentiation markers (Fig. 23). Thus, complete blocking of GLI repressor 
function by GANT61 which interferes with the DNA binding domain is not sufficient to 
promote lipid production.  
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3.6. Interaction between Wnt/β-catenin and Hedgehog/GLI pathways in human 
sebocytes 
 
In addition to the Hedgehog pathway, the canonical Wnt/β-catenin pathway has been shown 
to play a crucial role during the development of skin and its appendages. Particularly in 
respect of sebaceous glands, several studies suggest that an inactive Wnt pathway is 
required for correct sebaceous lineage selection (see chapter 1.5.). 
Given the multitude of interactions between the Wnt and Hh signalling pathways during 
development and homeostasis of several tissues, it is of great interest to address the 
question whether such kind of interconnection also exists for the regulation of proliferation 
and differentiation of human sebocytes. 
First indications of an interaction between these pathways could be found in previous work of 
our group, where ∆NLef1, a dominant negative truncated variant of Lef1 incapable to bind to 
ß-catenin and to transmit its signal, was found to increase Ihh expression in SZ95 cells and 
to promote proliferation in undifferentiated sebocytes [43]. In vivo, mice that express ∆NLef1 
under control of the K14 promoter develop spontaneous sebaceous-like tumours. In these 
tumours, transcript levels of Ihh and its receptor Patched 1 were significantly increased.  
Therefore, we wanted to investigate the mechanism underlying the down-regulation of Wnt/β-
catenin signal transduction and potential interaction with the Hedgehog pathway in human 
sebocytes. 
 
 
3.6.1. No significant canonical WNT signalling activity is detected in SZ95 cells 
 
To monitor the endogenous signalling activity of TCF/Lef-dependent WNT/β-CATENIN 
signalling at different differentiation stages in SZ95 cells, TOPFLASH/FOPFLASH luciferase 
reporter assays were performed. 
No significant changes of WNT/β-CATENIN signalling activity in differentiated SZ95 cells 
compared to undifferentiated cells were detected. The activation of the TOPFLASH reporter 
only ranged from 1.3- to 1.9-fold, displaying no or at least low activity levels of the WNT/β-
CATENIN pathway in human sebocytes (Fig. 34). Thus, activity of this pathway remains 
suppressed throughout the differentiation process in these cells. This is in accordance with 
the model where low Wnt/β-catenin signalling in the skin is necessary for sebaceous 
differentiation.  
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Figure 34: Correlation between Wnt pathway activity and differentiation of human sebocytes. 
Endogenous pathway activity was determined by TOPFLASH/FOPFLASH luciferase reporter assay 
under unconfluent and increasing confluence (after 1 day and 3 days), as well as after treatment with 
arachidonic acid and EtOH as solvent control. Results are presented as mean values ± SD of 
triplicates from an experiment that was repeated at least three times. 
 
 
3.6.2. Inhibitors of the WNT/β-CATENIN pathway are expressed in SZ95 cells 
 
Several Wnt ligands have been reported to be expressed during organogenesis and 
homeostasis of the skin (Wnt 3a, Wnt 4, Wnt 5a, Wnt 10a, Wnt 10b, Wnt 11) [347-349]. But 
there is a lack of data for WNT ligand expression in sebocytes.  
One potential mechanism to inhibit Wnt/β-catenin signalling in human sebocytes would be by 
expression of endogenous inhibitors specific for this pathway. For this reason, we wanted to 
study if inhibitory factors are expressed during differentiation of human sebocytes. Therefore, 
mRNA from SZ95 cells of each differentiation state was isolated, transcribed into cDNA, and 
analysed for expression of selected pathway inhibitors by quantitative real-time PCR. 
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Figure 35: Expression of Wnt/β-catenin pathway inhibitors in SZ95 cells at different 
differentiation stages. Transcript levels of detectable secreted and nuclear inhibitors were 
determined by quantitative real-time PCR. Results are presented as mean values ± SD of triplicates 
from an experiment that was repeated at least three times. 
 
In this context, secreted Wnt antagonists are involved in regulating Wnt signalling output. 
These Wnt inhibitors are divided into two main groups [350], which contain either secreted 
frizzled-related proteins (sFrps) binding directly to Wnt ligands or the Dickkopf (Dkk) proteins 
binding to Lrp5/Lrp6 [351-352]. The sFrp family comprises five sFrps [sFrp 1–5; sFrp3 is also 
known as Frizzled B (FrzB)] and Wnt inhibitory factor 1 (WIF1). The Dickkopf class includes 
Dkk1, Dkk2, Dkk3 and Dkk4 [351]. 
Interestingly, we found SFRP1, SFRP3 and DKK1 expressed at all differentiation stages in 
human sebocytes (Fig. 35). SFRP3 was significantly up-regulated by 6.6 and 4.2-fold in 
differentiating and terminally differentiated cultures, respectively. This suggests that SFRP3 
could play a major role in suppressing WNT/β-CATENIN signalling activity at receptor level in 
mature human sebocytes. 
There are also nuclear factors that have been shown to block Wnt/β-catenin signalling.  
Chibby encodes a small nuclear coiled coil protein and was shown to inhibit the 
transcriptional activity of β-catenin by competing with the transcription factor Lef-1 for binding 
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to β-catenin [353]. Chop is a member of the CCAAT/enhancer binding protein (C/EBP) family 
of transcription factors and was presented to specifically inhibit the Wnt/β-catenin pathway by 
binding to the transcription factor Tcf [354]. 
Interestingly, both inhibitors were up-regulated upon differentiation in SZ95 cells (Fig. 35). 
Transcript levels of CHIBBY were increased by 5.4 and 4.6-fold in differentiating and 
terminally differentiated sebocytes, respectively. In addition, CHOP expression was up-
regulated by 2.5 and even 12.6-fold at both differentiation stages, respectively. 
Another mechanism to inhibit the canonical Wnt pathway is proteasomal degradation of 
cytoplasmic β-catenin by phosphorylation and subsequent targeting for ubiquitination (see 
chapter 1.4.3.). 
To investigate, if the destruction complex of β-catenin plays a role in human sebocytes, we 
analysed the transcript levels of its key component AXIN1 at different differentiation stages in 
SZ95 cells. Thereby, AXIN1 was detectable in all sebocyte populations but displayed only 
minor changes in expression levels (Fig. 35). In differentiating and terminally differentiated 
cells these were increased by 1.9 and 1.6-fold, respectively. 
These data suggest that SFRBP-3, CHIBBY, CHOP and AXIN1 represent potential factors 
specifically inhibiting the Wnt/β-catenin signalling activity in human sebocytes. Further 
experiments will be necessary to demonstrate if these inhibitors are indeed expressed during 
sebaceous gland development in vivo and to determine their functional relevance. 
 
 
3.6.3. SMAD7 transcript levels are up-regulated in differentiated SZ95 cells 
 
Next, we wanted to address the question whether WNT/β-CATENIN signalling is additionally 
regulated by SMAD7 in human sebocytes. Smad7 was shown to induce degradation of β-
catenin and promote sebaceous gland growth in an inducible mouse model overexpressing 
Smad7 in the skin [241] (see chapter 1.6.2.). 
To investigate the regulation of SMAD7 expression and its implication in inhibiting WNT/β-
CATENIN signalling in human sebocytes, we performed qRT-PCR analysis of transcript 
levels at different differentiation stages in SZ95 cells. 
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Figure 36: Expression of SMAD7 in SZ95 cells at different differentiation stages. Transcript 
levels were determined by quantitative real-time PCR. Results are presented as mean values ± SD of 
triplicates from an experiment that was repeated at least three times. 
 
In SZ95 cells we detected an increase of SMAD7 transcript levels by 2.5- and 2.4-fold in 
differentiating and terminally differentiated cultures, respectively (Fig. 36). The presence of 
SMAD7 mRNA in all sebocyte populations suggest an additional suppression of Wnt/β-
catenin signalling by degradation of β-catenin in these cells. 
In summary, pathway inhibitors as well as enhanced degradation of β-CATENIN during 
sebocyte differentiation may play a key role in the inhibition of canonical WNT signalling 
activity in human sebocytes. 
 
 
3.6.4. Level of active β-CATENIN is elevated in differentiated sebocytes 
 
Next, we wanted to know if and how endogenous β-CATENIN expression and protein levels 
are modulated in the process of sebocyte differentiation in accordance with abolished 
canonical WNT signalling activity which we previously could observe (Fig. 34). 
We first determined transcript levels of β-CATENIN by quantitative real-time PCR at different 
differentiation stages of human sebocytes. 
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Figure 37: Expression of β-catenin in SZ95 cells at different differentiation stages. Transcript 
levels were determined by quantitative real-time PCR. Results are presented as mean values ± SD of 
triplicates from an experiment that was repeated at least three times. 
 
Our analysis revealed no significant changes in expression levels of β-CATENIN during 
sebocyte differentiation. The transcript levels displayed only slight increases of 1.5- and 1.2-
fold in differentiating and terminally differentiated cells, respectively (Fig. 37). 
Then, levels of total cytoplasmic β-CATENIN protein were determined in SZ95 cells at each 
differentiation stage to check if β-CATENIN protein concentrations are affected by 
differentiation of human sebocytes. To do so, we performed Western Blot analyses with an 
antibody directed against full-lenght β-CATENIN and quantified the detected signals by 
ImageJ software. 
Total amount of β-CATENIN protein (94 kDa) did also not differ significantly, and was even 
slightly increased by 1.6-fold in differentiating, as well as by 1.7-fold in terminally 
differentiated cells (Fig. 38 A). 
Finally, we specifically determined active β-CATENIN protein levels in the three SZ95 
populations with the same procedure, as the N-terminally dephosphorylated pool of β-catenin 
is crucial to transmit the Wnt signal into the nucleus [355]. Therefore, a specific antibody 
directed against dephosphorylated β-catenin was applied to compare its levels with total β-
catenin levels in Western Blots. 
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Figure 38: Western blot analysis of β-catenin in SZ95 cells at different differentiation stages. 
Specific antibodies against (A) total β-catenin and (B) active/dephosphorylated β-catenin were applied. 
Detected protein levels were determined by ImageJ. 
 
Surprisingly, the active form of β-CATENIN (92kDa) protein was found to be increased in 
differentiating human sebocytes by 3.2-fold and in terminally differentiated cells by 2.5-fold 
(Fig. 38 B). 
These results strongly suggest that WNT/β-CATENIN pathway activation in human 
sebocytes can occur in sebocytes. However, this is in contrast to our previous findings that 
pathway is inactive in these cells (Fig. 34).  
So, the question arises what is the underlying mechanism to block the pool of active β-
CATENIN and to prevent induction of WNT signal activation in human sebocytes. 
 
 
3.6.5. GLI2 and GLI3 overexpression increase level of active β-CATENIN but decrease 
Wnt/β-catenin signalling activity 
 
Previous studies suggest that β-catenin and Gli transcription factors can form a complex and 
interact directly on the protein level [227, 356]. In particular, Gli3 was shown to inhibit Wnt/β-
catenin signalling activity. To test, if this interaction could be the underlying mechanism to 
inhibit WNT/β-CATENIN signalling in human sebocytes, we investigated the potential role of 
the GLI transcription factors in modulating the phosphorylation state of β-CATENIN in human 
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sebocytes. Therefore, we co-transfected unconfluent SZ95 cells with GLI1, GLI2 and GLI3 
expression constructs and checked the lysates for protein levels of β-catenin protein after an 
incubation period of 48 hours.  
 
Figure 39: Regulation of active β-catenin and Wnt/β-catenin pathway activity by overexpression 
of GLI transcription factors. (A) Cell fractionation of SZ95 cells revealed accumulation of active β-
catenin in the nucleus when overexpressing GLI2 or GLI3. GAPDH and TBP served as cytosolic and 
nuclear loading controls, respectively. (B) GLI2 and in particular GLI3 expression decrease Wnt/β-
catenin reporter activity. Results are presented as mean values ± SD of triplicates from an experiment 
that was repeated at least three times. C: cytosolic fraction; N: nuclear fraction; T2: stabilised form of 
β-catenin. 
 
Strikingly, we could show for the first time that GLI2 and GLI3 overexpression result in a 
significant increase in protein levels of active β-CATENIN in the nucleus as demonstrated 
after cell fractionation of SZ95 cells (Fig. 39 A, bottom). On the other hand, no changes in 
total β-CATENIN protein levels were detected upon transfection of all three GLI transcription 
factors in comparison to mock transfected human sebocytes (Fig. 39 A, top). 
The presence of increased levels of dephosphorylated β-CATENIN levels suggests that 
WNT/β-CATENIN pathway is activated in GLI2- and GLI3-transfected cells. 
Hence, to monitor the impact of each GLI transcription factor on pathway activation and 
inhibition, SZ95 cells were either co-transfected with mock or with a non-degradable and 
hence constitutive active form of β-CATENIN (T2). The latter served to induce activation of 
the TOPFLASH luciferase reporter and to detect possible inhibitory effects on it by co-
transfected GLI transcription factors. 
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Importantly, GLI1, GLI2 and GLI3 alone did not influence the Wnt reporter activity (Fig. 39 B). 
This finding show that activation of the WNT/β-CATENIN signalling cascade is not induced 
by GLI2 and GLI3 through accumulation or stabilisation of active variants of β-CATENIN. 
Interestingly, GLI2 and, in particular, GLI3 significantly decreased β-CATENIN-dependent 
Wnt/β-catenin reporter activity by 39.3% and 75.3%, respectively (Fig. 39 B). This result 
unveils a new aspect of β-CATENIN regulation by both GLI transcription factors. 
Thus, the question arises whether GLI2 and GLI3 directly interact with β-CATENIN, thereby 
preserving it in its active state and blocking subsequent WNT/β-CATENIN pathway 
activation. We also previously showed that GLI2 induces expression of GLI3 in SZ95 cells 
(Fig. 19). As consequence, GLI3 instead of GLI2 may be the key factor to inhibit active β-
CATENIN in GLI2-transfected human sebocytes. 
Further studies will be necessary to resolve the underlying mechanism in more detail. 
 
 
3.6.6. Addition of stabilised β- CATENIN enhances GLI1 signalling activity 
 
The important finding that GLI2 and GLI3 expression impede WNT/β-CATENIN signalling in 
human sebocytes prompted us to investigate if β-CATENIN expression has vice versa an 
impact on Hedgehog signalling activity. Therefore, undifferentiated SZ95 cells were co-
transfected with GLI1, GLI2, GLI3 and mock or the constitutive active form of β-catenin (T2) 
expression constructs for Gli luciferase reporter assays. 
As shown before (Fig. 18), GLI1 and GLI2 alone induced Gli luciferase reporter activity by 
5.1 and 3.5-fold, respectively, whereas GLI3 decreased the activity to 0.6-fold compared to 
the mock control (0.9-fold) (Fig. 40, left part). Transfection of T2 alone did not significantly 
alter Gli reporter activity which did not exceed 1.3-fold activation under this condition. 
Analogously to our previous experiments (Fig. 18), combination of two different GLI 
transcription factors displayed lower activation capacity of the Gli luciferase reporter by 4.1- 
(GLI1+GLI2), 3.4- (GLI1+GLI3) and 2.3-fold (GLI2+GLI3), respectively (Fig. 40, central part). 
Strikingly, combined expression of GLl1 and T2 caused a 53-fold activation of the Gli reporter 
(Fig. 40, central part). Thus, GLI1 activation capacity was dramatically enhanced by the 
presence of high concentrations of active β-catenin. 
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Figure 40: Regulation of Gli luciferase reporter by constitutive active β-catenin and combined 
expression with GLI transcription factors. GLI1 signalling activity was significantly enhanced by 
upon β-catenin expression. Results are presented as mean values ± SD of triplicates from an 
experiment that was repeated at least three times. 
 
In contrast, no significant changes in luciferase activity levels could be detected after co-
transfection of GLI2 (2.8-fold) or GLI3 (0.5-fold) with T2 when compared to transfecting GLI2 
(3.5-fold) and GLI3 (0.6-fold) alone (Fig. 40, central part). 
Interestingly, upon combined expression of GLI1 and GLI2 with T2 or GLI1 and GLI3 with T2, 
the activation levels of the luciferase reporter were increased by 6.8- and even 9.7-fold, 
respectively (Fig. 40, right part). Thus, T2 supported activation of the luciferase reporter 
when compared to co-transfection of GLI1 and GLI2 (4.1-fold) or GLI1 and GLI3 (3.4-fold) 
without T2. However, activation of the reporter was significantly lower than combined 
expression of GLI1 and T2 only (53-fold). One explanation for this observation could be that 
all three GLI transcription factors compete to bind to the Gli luciferase reporter. But only GLI1 
activation capacity is enhanced in presence of active β-catenin, and hence competition for 
the binding sites by the GLI transcription factors leads to a decreased total signal output 
despite co-transfection of T2. 
On the other hand, when GLI2 was replaced by the inhibitor GLI3 in the presence of GLI1 
and T2, the reporter activity reached an unexpected higher activation level (9.7-fold 
compared to 6.8-fold) (Fig. 40, right part). The reason for this may be that GLI3 can interact 
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with β-catenin, as suggested by our previous experiments (Fig. 39). This interaction may 
impede the inhibitory effect of GLI3 on the Gli luciferase reporter in addition to the 
enhancement of activation potential of GLI1 by T2. 
Furthermore, the combined expression of GLI2 and GLI3 with T2 led to a 2.4-fold increase of 
the Gli luciferase reporter (Fig. 40, right part) which was comparable to the activation 
capacity of co-expression of GLI2 and GLI3 (2.3-fold) (Fig. 40, central part). In this case, 
stabilised β-catenin had no visible effect on the reporter activity. 
Our results indicate a complex network of mutual regulation between the GLI transcription 
factors and β-CATENIN which are the main effectors of the Hedgehog and canonical Wnt 
pathways, respectively. As a consequence, Hedgehog signalling is strengthened on 
expenses of Wnt signalling activity. 
 
 
3.6.7. β-CATENIN transcription is not regulated by GLI transcription factors nor vice 
versa 
 
To confirm, that our previous observations are not based on mutual transcriptional regulation 
by β-CATENIN and GLI transcription factors, we analysed transcript levels of β-CATENIN 
and GLI factors as well as additional key Hedgehog pathway components by quantitative 
real-time PCR in GLI-1, GLI2-, GLI3- and T2-transfected cells, respectively. 
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Figure 41: Expression of (A) β-catenin and (B) Hedgehog components in SZ95 cells after 
overexpressing GLI1, GLI2, GLI3 or stabilised β-catenin, respectively. Transcript levels were 
determined by quantitative real-time PCR. Mock transfected cells served as reference population. 
Results are presented as mean values ± SD of triplicates from an experiment that was repeated at 
least three times. 
 
Upon overexpressing the GLI transcription factors, no changes were detected in transcript 
levels of endogenous β-CATENIN (Fig. 41 A). These findings are well in line with our 
previous data showing that total β-CATENIN protein levels are not altered in transfected 
sebocytes (Fig. 39). 
Furthermore, there were no significant changes in expression levels of GLI1, GLI2, GLI3, 
IHH, PTC1, SMO, PTC2 or HHIP in SZ95 cells transfected with T2 (Fig. 41 B), thus 
excluding a role of β-CATENIN signalling in regulating Hedgehog pathway components in 
human sebocytes. 
These observations confirmed our previous data that interaction between the Hedgehog and 
canonical Wnt pathways most likely occurs on the protein level in human sebocytes. 
Therefore, future studies should focus on protein-protein interaction between β-CATENIN 
and the GLI transcription factors serving as interconnection point for both signalling 
cascades. 
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In summary, the previous findings propose an important interaction between the Gli 
transcription factors and β-catenin to regulate the Hedgehog and Wnt pathways. Further 
studies are necessary to unveil the underlying molecular mechanism in more detail. 
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4. Discussion 
 
 
4.1. What is the biological function of Hedgehog signalling in human 
sebocytes? 
 
Morphogenesis of skin-derived organs, such as hair, teeth and whiskers depends on 
signalling between mesenchyme and epithelium. Gene-deletion studies have demonstrated 
the requirement of Hh signalling pathway in these processes [21, 35-36]. In particular, these 
studies have mainly focussed on the function of Shh, whose deletion leads to lack of hair 
follicles and associated sebaceous glands in mice [21, 35]. Moreover, other studies imply a 
direct role of Hedgehog signalling in the promotion of sebaceous gland growth. For example, 
skin-specific overactivation by Smo expression results in increase of number and size of 
sebaceous glands [112].  
Previous work by our group and others has demonstrated that enhanced sebaceous 
differentiation is accompanied by increased expression of Ihh and not Shh in sebaceous 
glands of the skin of transgenic mice [43, 241]. A positive correlation between sebaceous 
differentiation and IHH expression as well as its target gene PTC1 has also been observed in 
the human sebocyte cell line SZ95 [43]. 
This let us assume that most likely IHH plays an important role in regulation of sebaceous 
gland homeostasis, while SHH is required for establishing the pilosebaceous unit and cycling 
of hair follicle during skin homeostasis [109-111]. This is further supported by the observation 
that Shh is able to compensate for loss of Ihh but not vice versa in the skin, thereby 
demonstrating redundant functions of these ligands [44]. 
But the underlying molecular mechanism of how the Hedgehog pathway regulates sebocyte 
proliferation and sebaceous differentiation still remained unveiled. This prompted us to 
analyse the biological function of IHH pathway in human sebocytes in detail by this thesis. In 
particular, we distinguished between different sebaceous stages of differentiation to compare 
Hedgehog pathway activity and to identify potentially Hedgehog signal transmitting and 
receiving cells for the first time by using an in vitro model sharing the physiological 
characteristics of sebaceous glands in vivo [319-321]. This approach has the advantages 
that each differentiation stage of sebocytes can be precisely isolated allowing us high 
flexibility for a magnitude of descriptive and functional assays. 
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4.1.1. Paracrine vs. autocrine Indian Hedgehog signalling in human sebocytes 
 
In this thesis, we showed that Hedgehog pathway is only activated in differentiating 
sebocytes but not in undifferentiated and terminally differentiated populations. By analyzing 
the expression pattern of key Hedgehog pathway components we found that positive 
regulators as IHH, SMO and GLI2 as well as the target genes PCT1 and GLI1 were up-
regulated in differentiating sebocytes, thus confirming pathway activation at this stage. 
Terminally differentiated cells displayed the strongest increase of the ligand IHH, and to a 
similar extent also of its receptor PTC1. Additionally, transcript levels of negative regulators 
PTC2, HHIP and transcriptional repressor GLI3 were found up-regulated in these cells. 
Importantly, despite high expression of IHH and the target genes PTC1 and PTC2 no 
Hedgehog signalling activity was detected. The reason for this observation could reside in 
recruitment of endogenous pathway inhibitors. These would prevent potential autocrine 
pathway activation through endogenous IHH production. This is supported by the fact that 
PTC1 efficiently suppresses and overcomes pathway activation through SMO in a ratio of 
1:250 [68]. Under these circumstances, GLI activators would be continuously processed to 
repressor form and/or degraded by proteasomes due to stabilisation of the cytoplasmic 
complex in the off-state of the Hedgehog pathway in these cells [94, 96-97]. 
Noteworthy, we only detected low levels of SHH in mature sebocytes and no DHH at all 
differentiation states, thus identifying IHH as the major ligand which plays a role in the 
regulation of sebaceous gland homeostasis by activation of the Hh pathway [43, 241]. 
Based on these findings, mature sebocytes may represent a major source of Hedgehog 
signals in the sebaceous gland, hence inducing pathway activation through IHH by a 
paracrine mechanism in neighbouring, less differentiated and/or undifferentiated cells. 
Following this, GLI1 expression could be induced in Hedgehog target cells. Therefore, we 
proposed the following model (Fig. 42): 
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Figure 42: Model of Indian Hedgehog signalling in human sebocytes (I). Undifferentiated 
sebocytes are susceptible for the paracrine Hedgehog signal. Differentiated sebocyte produce and 
transmit the Indian Hedgehog ligand, but suppress autocrine Hedgehog pathway activation by up-
regulating endogenous pathway inhibitors. 
 
A similar paracrine feed-back regulation between differentiated and undifferentiated cells by 
Ihh signalling has also been shown to play a major role during development of the 
endochondral skeleton [357] and colonic epithelial differentiation [228]. During osteoblast 
differentiation, pre-and early hypertrophic chondrocytes transmit Ihh signals to immature 
chondrocytes, thereby inducing proliferation [357]. In colonic epithelium, terminally 
differentiated absorptive colonocytes were shown to activate differentiation program and 
inhibit proliferation of precursor cells by Ihh pathway [228, 358]. 
The sebaceous gland also consist of two main cell population where undifferentiated cells 
reside in the peripheral zone and are mitotically active, while differentiated sebocytes settle 
in the maturation and necrosis zone (Fig. 4) [267-268]. Thereby, the rate of immature 
sebocytes recruited for proliferation and consequently for differentiation would depend on the 
amount of secretion of Hh ligands, and hence on terminally differentiated cells. This could 
represent a key process in the regeneration of the sebaceous gland, as holocrine secretion 
demands continuous replenishment by new cells. 
 
 
4.1.2. Effects of Hedgehog pathway activation and inhibition in human sebocytes 
 
We further addressed the question what is the biological function of Ihh signalling in human 
sebocytes. In particular, we wanted to investigate the individual role of each GLI transcription 
factor by overexpression and inhibition experiments as there are three in mammals. 
First Gli knock-out studies showed that Gli1-deficient mice are phenotypically normal 
suggesting that Gli2 is able to compensate for the lack of activator Gli1 [359]. On the other 
hand, mice lacking functional Gli2 or Gli3 display severe developmental malformations [359]. 
However, this phenotype can be rescued by replacing the Gli2 locus by Gli1 knock-in, 
demonstrating that Gli1 can compensate for loss-of-function of Gli2 [100]. Indeed, Gli 
proteins have partially redundant and partially distinct functions by regulating distinct set of 
.target genes. Thus, their combinatorial functions need to be tightly co-ordinated depending 
of affected tissue and species. For example, while Gli1 and Gli2 were shown to induce motor 
neurons in the spinal cord of frogs, Gli3 represses this function [360]. However, Gli1 induces 
4. Discussion 
 
109 
 
floorplate differentiation in the same species, whereas Gli2 and Gli3 inhibit this function [360]. 
In contrast, Gli2 but not Gli1 is primarily involved in induction of floor-plate development in 
mice [361-362]. 
Therefore, to analyze potential differences and overlapping functions of the GLI transcription 
factors and the impact of Hh pathway modulation in human sebocytes, we performed GLI 
overexpression and inhibition experiments. 
There is accumulating evidence that Hh signalling plays a role in the development of other 
tissues by regulating proliferation and differentiation processes. On the one hand, GLI1 and 
GLI2 have been proposed to play a crucial role in promoting proliferation in haematopoiesis 
[363], central nervous system [364] skin [365] and lung [366]. On the other hand, a range of 
tumours are induced by over-active Hh pathway activity. For example, mutations of the 
components PTC (loss-of-function) [125-128] and SMO (gain-of-function) [129-130] result in 
familial and sporadic BCCs of the skin, respectively. Furthermore, Hh ligand-dependent 
overactivation was found in colon, pancreatic and ovarian carcinoma [367]. Thereby, 
cancerous epithelial cells express Hh ligand and may abnormally activate the Hh signalling 
pathway in adjacent stromal cells. In turn, these cells may then provide a growth-promoting 
microenvironment for the tumour [367]. 
With regard to the Gli transcription factors, skin-specific overexpression of Gli1 and, in 
particular, Gli2 was sufficient to induce BCC and promote proliferation in mouse skin and 
human keratinocytes, too [368-369]. Analyses of target gene expression after induction of 
GLI1 and GLI2 in HaCaT keratinocytes illustrated the proliferation enhancing and 
differentiation-opposing effects of these two oncogenic transcription factors [101]. 
Additionally, amplification of GLI1 gene has been attributed to development of glioblastoma 
[138-141]. Additionally, reduction of Gli1 [370] and Gli2 [371-372] function was shown to 
reduce proliferation or even lead to regression in growth of prostate as well as BCC-like 
tumours and melanoma, respectively. 
In line with these observations, overexpression of the transcriptional activators GLI1 and 
GLI2, but not repressor GLI3, induced proliferation in undifferentiated sebocytes. Thus, we 
demonstrated the capacity of active Hedgehog pathway to promote growth in this type of 
cells. Interestingly, level of proliferation rate did not correlate with level of pathway activation. 
We previously showed that GLI1 has the highest capacity to activate Hedgehog pathway 
compared to GLI2. However, highest induction of proliferation was achieved by GLI2 and not 
by GLI1. This suggests that GLI1 and GLI2 have a different activation pattern of target 
genes. 
On the one hand, this could be caused by structural differences in the N-terminal domain of 
GLI transcription factors. Thereby, GLI1 lacks the repressor domain found in the N-terminus 
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of GLI2 like GLI3 and affecting transcriptional outcome of these factors [373]. This has been 
also exemplified by skin-specific overexpression of a constitutively active Gli2 mutant lacking 
the repressor domain (Gli2∆N2). This led to development of several types of skin tumours, 
including trichoblastomas, cyclindromas, trichoepitheliomas, and BCCs similarly to Gli1 
induction [368]. By contrast, transgenic mice overexpressing full-length Gli2 developed only 
BCC in the skin under same conditions [368]. 
Other groups also reported that GLI transcription factors display overlapping and also distinct 
DNA binding specificities of target genes [101, 368]. Interestingly, overexpression of Gli2∆N2 
resulted in an increase of the Hedgehog target genes Gli1, Ptc1 and Ptc2 compared to 
overexpression of wild-type Gli2 [368]. Target gene profiles of both transcription factors also 
revealed differences for a small set of activated genes by GLI1 and constitutively active 
Gli2∆N2 [101]. Additionally, repression of a range of target genes occurred predominantly in 
response to GLI2 but not to GLI1 [101]. 
Accordingly, we detected major differences in the potential of GLI transcription factors to 
modulate expression of components and activity of the Hedgehog pathway. More precisely, 
GLI2 seems to play a master role as positive regulator of the Hedgehog pathway. Only GLI2 
induced expression of the ligand IHH in human sebocytes. Thus, we provided first evidence 
that Hh expression can be regulated by Hedgehog pathway in these cells. In addition to this, 
GLI2 also increased transcript levels of transcriptional activator GLI1. On the other hand, 
ectopic expression of GLI2 did not co-localise with proliferating cells, although it induced the 
strongest proliferative effect. Moreover, GLI2 up-regulated endogenous levels of repressor 
PTC1 and interestingly GLI3 which could potentially counteract pathway activation. Thereby, 
we identified GLI3 as potential target gene of the hedgehog pathway, too. 
Compared to GLI2 overexpression, total Hedgehog pathway activity was higher upon GLI1 
expression. This resulted in the highest increase in expression of target genes PTC1 and 
specifically of both target genes PTC2 and HHIP. Importantly, Transfected GLI1 expression 
constructs could be detected in proliferating cells. Hence, GLI1 and not GLI2 would represent 
the promoter of proliferation in human sebocytes. 
These findings suggest that despite promoting proliferation GLI1 and GLI2 have distinct 
functions and expression patterns in human sebocytes. This is also in line with previous work 
auf our group, where Gli1 is activated in sebocyte progenitors, whereas Ihh is expressed in 
differentiated sebocytes of normal human and mouse sebaceous glands and in sebocyte 
tumours [43]. Thus, expression of Ihh could depend on Gli2 expression in differentiated 
sebocytes and consequently induce proliferation and Gli1 expression in undifferentiated cells 
by a paracrine mechanism. Additionally, Gli2 would recruit pathway inhibitors like Ptc1 and 
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Gli3 to inhibit autocrine activation of Hedgehog pathway in differentiated cells. Thus, we 
could extend our previously proposed model as follows (Fig. 43): 
 
 
Figure 43: Model of Indian Hedgehog signalling in human sebocytes (II). Undifferentiated 
sebocytes are susceptible for the paracrine Hedgehog signal, which promotes proliferation. 
Differentiated sebocyte produce and transmit the Indian Hedgehog ligand, but suppress autocrine 
Hedgehog pathway activation by up-regulating pathway inhibitors. 
 
In contrast to the transcriptional activators GLI1 and GLI2, GLI3 did neither up-regulate 
transcripts levels of key Hedgehog pathway components, nor affect the proliferation rate in 
human sebocytes. Instead, GLI3 displayed a mutually exclusive localisation with proliferative 
cells like GLI2. In this case, all negative effects indicated that GLI3 acts as repressor in 
human sebocytes. Thus, overexpression of this transcription factor should already provide us 
information on the impact of Hh pathway inhibition in these cells. 
As far as sebaceous differentiation markers are concerned, GLI2 and in particular GLI3 were 
shown to induce expression of MC5R and KRT6a. Remarkably, the extent of up-regulation of 
these genes is more pronounced in sebocytes overexpressing GLI3 than in ones 
overexpressing GLI2. In a previous study, Li-Hong Gu and Pierre A. Coulombe showed 
modest transactivation of Krt6a expression by Gli2 in mice [253] but without demonstrating 
the underlying molecular mechanism. Thus, the question arises whether MC5R and KRT6a 
transcription is directly promoted by both transcription factors or just by GLI3 as a 
consequence of its overexpression or induction by GLI2. On the other hand, GLI2 may also 
act as repressor like GLI3 in human sebocytes. Inhibition of Hedgehog target genes could be 
necessary for induction of sebaceous differentiation, thereby suggesting that GLI3 is more 
effective than GLI2 as repressor and that GLI2 plays a dual role as both, activator and 
repressor. However, the importance of the in vivo function of GLI2 as repressor still remains 
a matter of debate. Genetic evidence indicates that the mouse Gli2 acts as a primary 
activator of Hh target genes in vivo, but it may also function as a weak repressor in Hh 
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signaling [96, 100, 362, 374-377]. On the one hand, Pan and colleagues confirmed that Gli2 
is proteolytically processed into a transcriptional repressor in vivo [96]. On the other hand, 
Gli2 repressor function could be only shown under experimental but not physiological 
conditions [368, 376-379]. 
Furthermore, we applied specific inhibitors to abolished endogenous Hedgehog signalling on 
the level of SMO receptor and GLI transcription factors. Inhibition of SMO by cyclopamine 
resulted not only in decreased proliferation but also in increased differentiation in human 
sebocytes as shown in this thesis and previous work of our group [43]. In comparison to this, 
pathway inhibition on GLI transcription factor level by GANT61 also decreased proliferation 
rate, but did not significantly induce differentiation in human sebocytes, as demonstrated by 
unchanged amounts of cytoplasmic lipid droplets. In this case, difference may rely on the 
different nature of the inhibitor’s impact on the pathway. Cyclopamine blocks SMO activity, 
so that the cytoplasmic complex is stabilised, and GLI transcription factors are consequently 
degraded (GLI1 and GLI2) or processed to generate GLI repressors (GLI3) [380]. 
Consequently, GLI repressors are present and functional by binding to and repress their 
target genes. In contrast to cyclopamine, GANT61 directly affect the GLI transcription factors, 
thereby impeding their capacity to bind to their target genes without affecting up-stream 
pathway activity [345]. In this instance, target genes are not regulated anymore, positively 
and negatively, by the GLI transcription factors. This would suggest that the presence of 
functional GLI repressors is required to promote sebocyte differentiation and the associated 
lipid droplet formation. 
In summary, the present data suggest that GLI transcription factors preferentially activate a 
distinct set of potential target genes with distinct effects on proliferation and differentiation. 
For the first time, our results strengthened the hypothesis that GLI2 recruits GLI3 to block the 
Hedgehog pathway and promote differentiation in maturing sebocytes confirmed by up-
regulation of the molecular differentiation markers KRT6a [253] and MC5R [305].  
Simultaneously, GLI2 induces the production of IHH ligand in differentiated sebocytes to 
transmit pro proliferative signals to undifferentiated cell neighbour cells. These cells would 
then express GLI1 upon pathway activation to accelerate their proliferation. 
Importantly, we showed a direct interdependence of ligand IHH, GLI2 and GLI3 expression 
for the first time. Therefore, this mechanism could also apply for other tissue and cell types. 
Consequently, we proposed the following model of mechanism of Indian hedgehog signalling 
in sebocytes (Fig. 44): 
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Figure 44: Model of Indian Hedgehog signalling in human sebocytes (III). Undifferentiated 
sebocytes are susceptible for the paracrine Hedgehog signal, which promotes proliferation. 
Differentiated sebocyte produce and transmit the Indian Hedgehog ligand, but suppress autocrine 
Hedgehog pathway activation by up-regulating pathway inhibitors. As consequence, differentiation is 
promoted in these cells as indicated by up-regulation of sebaceous differentiation markers. 
 
 
4.2. New aspects of transcriptional regulation by the lipid metabolism in 
human sebocytes 
 
As mentioned in the introduction, the lipid metabolism has been shown to be important for 
sebaceous gland development and differentiation (see chapter 1.7.3). Moreover, the main 
function of sebaceous gland is to form and accumulate lipid droplets. Thereby, differentiation 
of sebocytes culminates in the holocrine release of sebum. 
In the present work, arachidonic acid treatment was applied to induce terminal differentiation 
in human sebocytes which could be observed by increased cell volume, nuclear 
fragmentation and, in particular, by accumulation of lipid droplets. 
As a consequence, our findings revealed an additional crucial regulatory aspect of the 
arachidonic acid cascade on gene expression during sebocyte differentiation. Thereby, 
induced differentiation was accompanied by increased expression levels of the Hedgehog 
signalling components IHH, SHH, PTC1, PTC2, HHIP, SMO and GLI3, of the molecular 
markers MC5R and ADFP, as well as of the Wnt pathway regulatory factors SFRP3, 
CHIBBY, CHOP and SMAD7. These genes have not been discussed yet with regard to 
regulation by lipid metabolism. 
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As a natural constituent of membrane phospholipids, arachidonic acid undergoes signal-
mediated hydrolysis, whereby the degradation products are released into the intracellular 
space to be, on the one hand, metabolised to second messenger molecules or, on the other 
hand, to stimulate third messenger systems. Among these the most important generated 
messengers belong to the metabolite families of prostaglandins, thromboxanes, prostacyclin 
and leukotrienes [381-382], which regulate various processes like pain, inflammation, blood 
coagulation and vasoconstriction in the body. 
For a range of genes involved in fatty acid and glucose metabolism it has been shown that 
polyunsaturated fatty acids (PUFA) modulate their expression by binding to at least four 
transcription factor families including three members of the superfamily of steroid and thyroid 
hormone nuclear receptors, namely PPAR, LXR and hepatic nuclear factor 4 (HNF-4α) and 
SREBP [383]. In turn, these factors bind to specific regulatory promoter sequences sensitive 
to PUFAs, among which are PUFA responsive elements (PUFA-RE) [384-386] and PPAR 
responsive elements (PPRE) [387-388]. Interestingly, PPAR, LXR and SREBP have also 
been shown to play a critical role in the regulation of sebaceous gland function (see chapter 
1.7.3.). 
In this context, previous studies have shown that arachidonic acid acts on the transcriptional 
level to modulate mRNA stability and, thus, half-life of genes like GLUT4 and SCD1 [309, 
389]. More precisely, accumulation of arachidonic acid was found to have a negative effect 
on Scd1 expression [279, 307-309]. This effect is of particular interest as modulation of Scd1 
affects the size, and thus, the physiology of sebaceous glands [307]. 
Thus, the question arises whether the above mentioned regulated genes of this study are 
directly regulated by arachidonic acid metabolites and/or indirectly as consequence of the 
differentiation process affecting other regulatory pathways. The link between the fatty acid 
metabolism and particularly the regulation of Hedgehog and/or Wnt pathway activities in 
sebocytes needs to be elucidated. Whether these pathways are up- or downstream of the 
fatty acid metabolism or act in concert with its signalling cascades needs further profound 
investigation. 
Noteworthy, the sebum contains several derivatives of arachidonic acid or structurally similar 
substrates like sebaleic acid, the major polyunsaturated fatty acid in human sebum and skin 
surface lipids [390]. Accordingly, a potential role in gene regulation could be attributed to the 
sebum, when mature sebocytes undergo holocrine secretion and cell death releasing these 
fatty acids to their close environment. Thereby, lipid production and differentiation could be 
affected in sebocytes in the close proximity and/or the physiology of cells located on the way 
from the sebaceous gland ducts to the exit of the hair shaft channel on the skin surface, 
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which get in contact with released fatty acids by responding through PUFA-RE and/or PPRE 
stimulated pathways. 
 
 
4.3. What is the underlying mechanism of Wnt pathway repression in 
sebocytes? 
 
In addition to the Hedgehog pathway, the canonical Wnt/β-catenin pathway has been 
previously shown to play a central role during the development and homeostasis of the 
pilosebaceous unit (see chapter 1.5.). Acting like a switch, increased Wnt signalling induces 
de novo hair formation, while inhibition of this pathway results in increased sebaceous 
differentiation at the expense of hair follicle formation. Thereby, Hedgehog signalling was 
located downstream of Wnt signalling [22, 246]. 
Several Wnt ligands have been shown to be expressed in mouse and human hair follicles, 
for instance Wnt-3a, Wnt-5a, Wnt-10b and Wnt-11, which trigger Wnt pathway activity during 
hair cycles but a direct association with sebaceous gland biology has not been shown [24, 
209, 391]. Based on the observation that Wnt pathway inhibition is required for normal 
sebaceous gland development, we addressed the question, how the canonical Wnt pathway 
is regulated in sebaceous glands. Therefore, we focused on potential mechanisms of the 
pathway repression in human sebocytes by analysing several known inhibitors for their 
expression at different differentiation states for the first time. Among these, the Wnt ligand 
inhibitor SFRP3 and the nuclear inhibitors CHIBBY and CHOP were found to be up-regulated 
during the differentiation process. Thus, this not only suggests that the initiation of the Wnt 
pathway is impeded by direct ligand inhibition, but also the transcription of potential target 
genes through nuclear inhibitors. Interestingly, other detected cytoplasmic and secreted 
inhibitors were down-regulated at the same time (e.g. AXIN1, DKK1, and SFRP1). Therefore, 
SFRP3, CHIBBY and CHOP may compensate for the vanishing presence of other down-
regulated inhibitors in differentiating sebocytes. Thereby, endogenous pathway inhibition 
would be preserved which ensures sebaceous differentiation without affecting the close 
environment of the sebaceous gland. 
When analysing amounts of β-CATENIN in human sebocytes at different stages, total mRNA 
and protein levels remain stable during differentiation. These observations suggest that 
expression of β-CATENIN is not modulated during sebocyte maturation. However, non-
phosphorylated, transcriptionally active β-CATENIN is found increased in differentiating SZ95 
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populations, but not Wnt signalling activity. Therefore, the present pool of active β-CATENIN 
is not able to induce Wnt signal activation in these cells.  
One obvious mechanism to prevent β-catenin activity is its degradation. A previous study in 
mouse skin identified Smad7 as inductor of β-catenin degradation resulting in the inhibition of 
canonical Wnt signalling [241]. Transcript levels of SMAD7 were also found up-regulated in 
differentiated SZ95 cells, thus suggesting that SMAD7 induces β-catenin degradation and 
Wnt pathway inhibition at this stage in human sebocytes. But protein levels of total and active 
β-CATENIN were not decreasing and/or did not show degradation during sebocyte 
differentiation. Thus, suppression of β-CATENIN signalling must be mainly achieved by 
action of the previously mentioned nuclear factors CHIBBY and CHOP or by an alternative 
mechanism. 
Further mechanisms to block active β-CATENIN and potential functions exerted by this pool 
of β-CATENIN will be discussed below. 
 
 
4.4. How is β-catenin regulated in sebocytes? 
 
We searched for potential levels of interactions between Hedgehog and Wnt pathways like it 
has been presented for other cellular systems (see chapter 1.6). However, our expression 
analyses showed no influence of overexpressed GLI1, GLI2 and GLI3 on β-CATENIN 
transcription level and vice versa in human sebocytes. 
An alternative mechanism of how β-catenin activity is affected by Hedgehog pathway has 
been suggested by F. Ulloa and colleagues. Investigating the consequences of SHH 
deficiency on neural tube development in mouse embryos they found Wnt responsive genes 
like Axin2 to be decreased [227]. This led to their hypothesis that Wnt signalling is decreased 
in the absence of Shh signalling. By overexpressing a construct coding the repressor form of 
Gli3 (Gli3R) they prevented ß-catenin mediated reporter gene expression in several cell lines 
and during development of Xenopus embryos [227]. The authors demonstrated by co-
immunoprecipitation that there was a direct interaction between Gli3R and the carboxy-
terminal domain of ß-catenin which includes the transactivation domain. 
We investigated if this mechanism of β-catenin inhibition by Gli3 is also true for human 
sebocytes. Therefore, we analysed the effect of different combinations of co-transfected 
stabilised β-catenin and human GLI expression constructs on Wnt responsive reporter 
constructs concomitantly with determination of the endogenous ratio of active versus total β-
CATENIN protein levels. Strikingly, these assays confirmed an inhibitory effect of GLI3 on β-
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CATENIN induction of the TOPFLASH reporter construct. Moreover, these experiments also 
unveiled a similar role for GLI2 for the first time. Like GLI3, addition of GLI2 also resulted in a 
remarkable decrease of the β-CATENIN-sensitive reporter output. 
If only the repressor form of GLI3 is able to bind to β-CATENIN, and hence to inhibit its 
function to activate target gene transcription, a similar mechanism applies to GLI2. By this 
way, a fraction of GLI2 could be proteolytically processed to generate a shortened variant 
containing the repressor domain which is capable of binding to β-CATENIN. Other studies 
have confirmed phosphorylation of Gli2 by PKA required for processing and suggested an 
important role of Gli2 processing during Hh-regulated mouse embryonic patterning in vitro 
and in vivo, respectively [97, 377]. Furthermore, Gli2 was shown to be partially processed 
and, as consequence, to also act as repressor in addition to activator functions in Drosophila 
[392]. Interestingly, Gli3 repressor activity is regulated by Hh, but not Gli2 repressor activity. 
Alternatively, GLI2 was shown to induce the expression of GLI3, which may lead to an 
increased presence of GLI3 repressor and, only then, subsequent inhibition of β-CATENIN. 
Surprisingly, as stated before for differentiated sebocytes, protein levels of active β-
CATENIN were found increased in SZ95 cells transfected with GLI2 and GLI3 expression 
constructs, whereby cell fractionation analysis allocated this accumulation to the nucleus. 
These data suggest that the active form of β-CATENIN is prevented from initiating 
transcription of target genes by interacting with the repressor forms of GLI transcription 
factors, analogously to the effect of the nuclear repressor CHIBBY [353]. 
Other studies also reported similar effects for a Kruppel-like transcription factor, namely Gli-
similar 2 (Glis2), which exhibits different functions dependent on gene and associated 
promoter sequence as an activator or repressor. It has been shown that Glis2 and in 
particular its repressor form is able to directly bind to β-catenin and to p120 which is known 
to be part of adherens junction containing β-catenin, too [393-394]. By binding to β-catenin, 
Glis2 represses Tcf-mediated transcriptional activation. Owing to the similarity of Glis2 and 
Gli1-3 transcription factors, one could envision an analogous mechanism for GLI2 and GLI3 
[395]. 
 
 
4.5. Does WNT/β-CATENIN signalling affect GLI function in sebocytes? 
 
We also addressed the question whether β-CATENIN interferes with Hedgehog signal 
transduction. Indeed, co-expression of GLI1 and stabilised β-catenin displayed a strong 
induction of the Gli reporter constructs but without mutually affecting transcript levels. Our 
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results are in line with previous findings by O. Meada and colleagues [396]. They showed 
that β-catenin enhances the Hedgehog signal through GLI1 without increasing the amount of 
expression and/or changing intracellular distribution of GLI1 in various human cancer cell 
lines. Moreover, β-catenin had a similar effect on GLI2-mediated Hh pathway activity but to a 
smaller degree [396]. However, they reported no complex formation between GLI1 and β-
catenin.  
By contrast, the activity of the Gli reporter construct was not changed when GLI2 or GLI3 
were co-expressed with stabilised β-catenin compared to cells only transfected with GLI2 or 
GLI3 in our experiments. These results suggest, that the potential fraction of GLI2 and/or 
GLI3 interfering with β-CATENIN (see chapter 4.4.) has no influence on the Hedgehog 
pathway. Furthermore, addition of GLI2 or GLI3 resulted in a significant decrease of the 
enhancing effect of stabilised β-catenin on the activation of the Gli reporter by GLI1. These 
observations might be indicative for competing direct and/or indirect interactions of the GLI 
transcription factors with β-CATENIN, whereby GLI2 and GLI3 are favoured and limit the 
inducing effect of β-CATENIN on Wnt signalling as well as on Hedgehog signalling. 
However, it is also conceivable that β-CATENIN counteracts the inhibitory effects of a 
potential GLI2 repressor variant itself, of GLI2 due to subsequent recruitment of GLI3 
repressor and/or of GLI3 repressor which results in the observed increase of the Gli reporter 
activity compared to co-expression of GLI1 and GLI2 as well as of GLI1 and GLI3 without the 
presence of stabilised β-catenin. 
During our expression analyses only low endogenous levels of GLI1 were detectable in 
undifferentiated sebocytes which would explain why addition of exogenous β-CATENIN 
alone only resulted in a weak induction of the Gli luciferase reporter. 
 
 
4.6. Proposed model of GLI and β-CATENIN interference 
 
One important aspect is that β-CATENIN may act as transcriptional co-factor by binding to 
GLI1 and enhancing its function as transcriptional GLI activator in human sebocytes. A 
similar role has been previously described in human cancer cell lines overexpressing both 
factors [396]. Thus, not only GLI1 expression alone but also β-CATENIN protein levels would 
have a significant impact on the Hedgehog signal response. But there is still a lack of 
evidence of a direct protein-protein interaction between GLI1 and β-CATENIN. 
GLI2 and GLI3 might also play a role as inhibitors of the Wnt pathway by impeding the 
transcriptional activation capacity of β-CATENIN potentially through direct binding as 
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demonstrated by the work of Ulloa and colleagues [227]. The question still remains whether 
GLI2 directly influences β-CATENIN activity or indirectly by induction of GLI3 expression, 
because there is also no evidence that GLI2 can bind to β-CATENIN, too. 
GLI2 and GLI3 transcription factors could also serve to stabilise and store active β-
CATENIN, as our experiments showed that this variant accumulates in the nucleus of cells 
overexpressing one of these transcription factors. 
In this context, cadherins were shown to antagonise the accumulation of β-catenin in the 
cytoplasm by attaching it to the membrane as structural component of adherens junctions. 
Regarding this, the decreased cadherin expression leads to increased Wnt signalling in fly 
and mouse development [149-150]. Conversely, the overexpression of cadherins results in a 
reduction of Wnt signalling activity [151]. Importantly, conformational changes of β-CATENIN 
have been observed to direct binding preferences towards either cadherins or members of 
the Tcf/Lef transcription factor family [152]. A similar mechanism could be implicated in the 
regulation of β-CATENIN variants by GLI2 and/or GLI3 in the nucleus. 
Other molecules which bind both, Gli transcription factors and β-catenin, could also 
contribute to the cross-link of Wnt and Hedgehog pathways and the observed effects. For 
example Su(Fu), Pka, CkI and Gsk3β (see chapters 1.1.4, 1.4.3 and 1.6.1) are all involved in 
regulation of Gli transcription factors and β-catenin activity by direct physical interaction and 
modification. Therefore, a direct binding of Gli transcription factors to β-catenin might not be 
necessary and modulation of activity occurs through recruitment other factors. 
To summarise we propose the following general model of Hedgehog and Wnt pathway 
interaction on protein level: Active Hedgehog pathway leads to expression and stabilisation 
of the transcription factor Gli1 whose capacities as transcriptional activator is enhanced in 
presence of β-catenin. In turn, decreased Hedgehog signalling would promote Gli repressor 
formation and thereby not only inhibit Hedgehog target gene activation but also canonical 
Wnt pathway activation by interference of Gli repressors with β-catenin. As a result, active β-
catenin accumulates in the nucleus, but the function or fate of this pool still remains unclear. 
Considering that expression and total protein levels of β-CATENIN remain stable throughout 
sebocyte maturation, modulation and distribution of distinct β-CATENIN pools by GLI 
transcription factors may represent a key regulatory feature not only of Hh but also of Wnt 
targets. 
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Figure 45: Model for (A) GLIActivator and (B) GLIRepressor interaction with β-CATENIN. (A) β-
CATENIN enhances transcriptional GLIActivator activity possibly as transcriptional co-factor. (B) 
GLIRepressor prevents β-CATENIN from activating Wnt target genes through members of the TCF/LEF 
family and promotes accumulation of active β-CATENIN in the nucleus. 
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Taken together, this interaction would constitute a novel and important regulation point in 
several processes and disorders resulting from misregulation of one or both factors or 
pathways. New therapeutics could be designed to target both, Wnt and Hedgehog signalling 
pathways. 
 
 
4.7. Outlook 
 
This thesis investigated the molecular mechanism and role of Indian Hedgehog signalling in 
human sebocytes. The results demonstrated a pro-proliferative function of the active Indian 
Hedgehog pathway in human sebocytes. Conversely, pathway inhibition reduced this effect 
significantly and promoted the expression of sebaceous differentiation markers suggesting 
that an inactivated Hedgehog pathway is necessary for correct maturation of this type of 
cells. Thereby, we also presented that expression and distribution of GLI transcription factors 
are differentially regulated during sebaceous differentiation. Furthermore, overexpression 
experiments of each GLI transcription factor revealed not only overlapping, but also specific 
functions like regulation of proliferation rate and expression levels of pathway components as 
well as differentiation markers. 
The results presented here are based on analyses of transcripts levels in combination with 
reporter assays as functional read-out on protein level. Hence, the question still remains 
open how Hedgehog pathway proteins are presented and distributed in human sebocytes in 
a time-dependent manner during differentiation. As consequence, the identity of Hh signal 
transmitting and receiving cells has not been clearly shown, yet. 
To address this, specific antibodies (in particular for Hh ligands and Gli transcription factors) 
are required to perform co-localisation analyses with components of the Hh pathway and 
differentiation markers (e.g. lipid droplets and molecular markers). 
Additionally, fluorescence-activated cell sorting (FACS) could be applied for isolation of 
sebocytes in dependence on sebaceous differentiation markers for subsequent profound 
analysis of Hedgehog pathway transmission and activation on expression (e.g. gene and 
protein analyses) and functional level (e.g. proliferation and reporter assays). 
To further investigate the differences in GLI functionalities, FACS would help to isolate GLI1-, 
GLI2-, GLI3-overexpressing as well as GLI1-, GLI2- and GLI3-deficient sebocytes and to 
further determine the individual role of these transcription factors during sebaceous gland 
homeostasis. In this context, alternative methods would be necessary to generate GLI1-, 
GLI2- and GLI3-deficient sebocytes, since it was not possible to suppress GLI expression by 
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siRNA and shRNA methods in our hands (see chapter 3.4.). Recently, a new technique for 
gene editing, knock-out and knock-in, previously described in gene therapy, is commercially 
available for the research cell culture using synthetic zinc finger nucleases (ZNFs), which are 
specifically designed for the customer needs. Introducing a complete knock-out would 
definitively circumvent not only low gene silencing efficiency observed by the GLI knock-
down assays, but also decrease the risk of off-target effects [397-398]. Alternatively, an 
inducible knockout model specifically directed against Gli1, Gli2 and Gli3 in sebaceous gland 
of mice would represent an effective tool do perform these analyses. 
We also described that the lipid metabolism plays a crucial role in the regulation of key 
Hedgehog pathway components and Wnt inhibitors when we treated sebocytes with 
arachidonic acid. 
Hence, profound promoter sequence analyses of the presented regulated genes in human 
sebocytes would be necessary to dissect the mechanism which underlies their regulation by 
the lipid metabolism. Thereby, known fatty acid response elements (e.g. PUFA-RE and 
PPRE) could be searched for. This is of particular interest, as sebaceous glands represent a 
lipid-enriched microenvironment where gene regulation by fatty acid could play a major 
physiological role. 
Moreover, we demonstrated that β-catenin and Gli proteins mutually interfere during 
induction of specific reporter constructs suggesting that the outcomes of Hh and Wnt 
pathway activity are modulated by direct or indirect interactions between these factors. 
The question whether a direct interaction or an indirect effect through other factors underlies 
the interference between Gli and β-catenin function also needs to be answered. Therefore, 
co-immunoprecipitation experiments with these factors have to be performed. Moreover, site-
directed mutagenesis of potential binding domains would provide information about the 
mechanism of interaction and physiological role of GLI-dependent regulation of β-CATENIN 
in human sebocytes and in other tissues, too. 
Benefiting from these data, new in vivo models could be generated, which positively or 
negatively affect the Hedgehog pathway and its interaction with the Wnt pathway. These 
would not only greatly extend our knowledge of the underlying molecular mechanisms during 
sebaceous gland development and homeostasis but also of their implication in other tissues. 
Thereby, potential targets for the treatment of skin disorders like acne and skin cancers could 
be identified and give rise to new therapies. 
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